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Behorende bij het proefschrift 
 
Barrier properties of human skin equivalents: rising to the surface 
 
1. The culture conditions play a crucial role in determining the stratum corneum 
barrier properties of human skin equivalents. (this thesis) 
 
2. Human skin equivalents are able to synthesize all skin barrier lipids, including 
the twelve ceramide subclasses present in human stratum corneum. (this thesis) 
 
3. The reduced free fatty acid level and its altered composition may play an 
important role in the decreased permeability barrier observed for human skin 
equivalents. (this thesis) 
 
4. The detection of increased levels of mono-unsaturated fatty acids in the stratum 
corneum of human skin equivalents offers new opportunities to mimic the 
stratum corneum lipid properties of human skin more closely. (this thesis) 
 
5. The mammalian stratum corneum is a remarkable structure that appears lifeless 
and trivial to the histologist but in reality has almost unbelievable complexities, 
subtleties, and importance. (Marks, R., J Nutr 134, 2017S, 2004) 
 
6. The important role of ceramide EOS in the formation of the 13.4 nm lamellar 
phase and the transition from a hexagonal to an orthorhombic phase induced 
by free fatty acids have been observed in mixtures prepared with isolated SC 
lipids as well as in intact human stratum corneum. (Bouwstra, J. et al., Skin 
PharmacolAppl Skin Physiol 14 Suppl 1, 52, 2001) 
 
7. It is the stated goal of all manufacturers to fit their skin models with a barrier 
similar to human skin in vivo, but it is not foreseeable if or when they will 
succeed. (Netzlaff, F. et al., Eur J Pharm Biopharm 60, 167, 2005) 
 
8. While I have tried to discuss some of what is known about the role of lipids in 
the formation of this complex stratum corneum lamellar membrane that 
mediates permeability barrier function, it should be obvious to the reader that 
much work remains to be done to fully understand the formation and 
regulation of the epidermal permeability barrier. (Feingold, K.R., J Lipid Res 48, 
2531, 2007) 
 
9. The beginning of knowledge is the discovery of something we do not 




10. Employ your time in improving yourself by other men’s writings, so that you 
shall gain easily what others have labored hard for. (Socrates) 
 
11. I am among those who think that science has great beauty. A scientist in his 
laboratory is not only a technician: he is also a child placed before natural 
phenomena which impress him like a fairy tale. (Marie Curie) 
 
12. Being a graduate student is like becoming all of the Seven Dwarves. In the 
beginning you're Dopey and Bashful. In the middle, you are usually sick 
(Sneezy), tired (Sleepy), and irritable (Grumpy). But at the end, they call you 
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FUNCTION AND STRUCTURE OF THE SKIN 
The skin is the largest organ of the body with a surface area of approximately 1.5 
m2 in adults and accounts for roughly 15% of the body weight 1. The principal 
function of the skin is to protect the body’s interior from the external 
environment. It prevents the entry of pathogens and exogenous substances into 
the body and regulates heat and water loss from the body. The stratum corneum 
(SC) is the uppermost layer of the skin and has a very hydrophobic character. Due 
to this property it forms an excellent physical barrier against penetration of foreign 
substances and is concomitantly able to prevent excessive water loss 2, 3. When 
exogenous substances partition into the viable skin, defence mechanisms provided 
by the immunological and biochemical barrier (e.g. detoxification by metabolic 
enzymes) play an important role 4, 5. To maintain the body’s core temperature the 
skin exchanges heat with its surrounding through moisture and sweat evaporation 
at the skin surface 6. The skin also functions as a sensory organ and detects stimuli 
such as heat, cold, pressure and pain 7. The skin has a complex structure consisting 
of three main regions (from inside out): the dermis, the basement membrane and 
the epidermis (figure 1). 
 
The dermis 
The dermis has a thickness up to 3 mm and can be subdivided into two layers: the 
papillary and reticular layer. The papillary layer is located 100 to 150 μm 
underneath the skin surface, while the reticular layer is located in the lower part of 
the dermis. Blood and lymphatic vessels, nerve endings, hair follicles, sebaceous 
and sweat glands are all embedded within the dermis. The nerve endings provide 
the sense of touch and heat. The vascular network of the skin provides oxygen and 
nutrients to the surrounding tissue and removes toxins and waste products. The 
vasculature of the skin also plays a role in thermoregulation and wound repair. The 
main cell type in the dermis is the fibroblast. Fibroblasts secrete collagen, which is 
the main protein in the dermis, and elastin to generate an extracellular matrix 8, 9. 




The collagen fibres give the dermis its toughness and resistance to strain, while 
elastin is responsible for the elastic properties of the dermis. In addition to 
fibroblasts, the dermis also contains endothelial cells, mast cells, macrophages, 
dendritic cells, T-lymphocytes and neutrophils. The various immune cells present 
in the dermis provide a defence mechanism against intruded pathogens and 
exogenous substances.   
 
Figure 1. Schematic overview of the structure of human skin. The dermis contains the 
skin appendages (sweat glands, sebaceous glands and hair follicles), blood and lymphatic 
vessels and nerve endings. The epidermis is the most superficial layer of the skin and can 
be subdivided into four strata: the stratum basale, stratum spinosum, stratum granulosum 
and stratum corneum. During the migration from the basal layer to the stratum corneum, 
the keratinocytes show the expression of several keratins (K1, K5, K6, K10, K14, K16, 
K17) and cornified envelope (CE) proteins in specific layers of the epidermis (dotted 
arrows). The expression of these proteins may be altered in skin disorders (black arrows). 
At the stratum granulosum-SC interface lamellar bodies containing lipid precursors are 
extruded. After enzymatic processing, the SC lipids form neatly arranged lipid lamellae 
around the corneocytes. TG-ase = transglutaminase. This figure is modified from 3, 143. 
 
The basement membrane 
The cutaneous basement membrane zone, also known as the dermal-epidermal 
junction (DEJ), is located between the dermis and the epidermis 10, 11. The DEJ 
consists of four distinctive zones: the cell membrane of the basal keratinocytes, the 





the keratinocytes contain hemidesmosomes, which attach keratin filaments to the 
basolateral epidermal surface. The hemidesmosomes also firmly attach the cell 
membranes of keratinocytes, the lamina lucida and lamina densa together, by 
connecting to anchoring filaments that originate from the lamina densa and 
traverse the lamina lucida. Anchoring fibrils in the lamina densa extend into the 
dermis and loop back into the lamina densa or are inserted into electron-dense 
anchoring plaques in the dermis. The existence of anchoring plaques, however, is 
controversial. The tight connection of the different zones in the DEJ maintains the 
structural integrity of the skin, provides support for the epidermis and influences 
keratinocyte polarity, proliferation, differentiation and migration. The DEJ 
selectively permits the passage of molecules between the dermis and epidermis 
based on their size and charge. However, migrating or invading cells, such as 
melanocytes, Langerhans cells and lymphocytes are able to pass freely.  
 
The epidermis 
The epidermis is the uppermost layer of the skin. It contains no blood vessels, but 
is nourished by the diffusion of nutrients from the blood capillaries in the upper 
dermis. Keratinocytes are the predominant cell types found in the epidermis, 
although other cells such as Langerhans cells, melanocytes, Merkel cells and T-
lymphocytes are also present. The epidermis can be subdivided into four different 
strata (from inside out): the stratum basale, stratum spinosum, stratum granulosum 
and SC (figure 1). The transit of keratinocytes through the different epidermal 
layers is a very dynamic process. The journey of a keratinocyte starts in the basal 
layer, which contains the proliferating cells of the skin. After a mitotic division, a 
daughter cell will remain in the basal layer while the other newly formed cell will 
transiently migrate upwards and start to differentiate 12, 13. During the 
differentiation process the keratinocytes will start to express several early and late 
differentiation markers. This coincides with the gradual change of keratinocyte 
function (figure 1).  In the stratum spinosum the keratinocytes express keratin 10. 




Simultaneously the keratinocytes start to produce lipid-enriched lamellar bodies. In 
the upper spinous layers the keratinocytes become flatter and move into the 
direction of the stratum granulosum. Once in the stratum granulosum, the 
keratinocytes accumulate keratohyalin granules, which contain a number of barrier 
proteins, such as profilaggrin, loricrin and involucrin 14, 15. Additionally, the 
production of lamellar bodies is enhanced. At the stratum granulosum/SC 
interface the keratinocytes initiate the terminal differentiation programme and 
many processes take place in a very short period. The keratin filaments aggregate 
into a keratin matrix after interaction with the filaggrin subunit of profilaggrin. 
Additionally, enzymes will start to degrade the cell components, such as the 
nucleus and cell organelles. Furthermore, desmosomes, which link the 
keratinocytes together, are transformed into corneodesmosomes and a cornified 
envelope is formed around the plasma membrane. The cornified envelope is 
composed of several structural proteins like involucrin, loricrin and the small-
proline rich proteins, which are cross-linked by transglutaminases. The lipid and 
enzymatic content of the lamellar bodies is extruded via exocytosis at the stratum 
granulosum/SC interface (figure 1) and a major change in lipid composition occurs 
16, 17. All these changes in the keratinocytes and the secretion of the lipids into the 
intercellular regions consequently lead to the formation of the SC. The SC consists 
of dead flattened cells, referred to as corneocytes, which are embedded in a 
continuous hydrophobic lipid matrix. The corneocytes in the SC are devoid of a 
nucleus and have replaced the plasma membrane with the highly impermeable 
cornified envelope, which is chemically coated by a lipid envelope. 
Corneodesmosomes, which are incorporated in the cornified envelope, link the 
corneocytes together to maintain SC cohesion. The formation of the SC is a 
fundamental process that leads to the development of a barrier against excessive 
water evaporation and protection against penetration of exogenous substances. It 
generally comprises 10-15 cell layers and is 10-20 μm thick 18, 19.  During the 





corneodesmosomes are gradually degraded. This finally leads to shedding of the 




PROPERTIES OF THE STRATUM CORNEUM 
Although the SC consists of dead cells, it is considered as a very dynamic tissue 
due to the continuous formation of new SC layers and the many enzymatic 
processes that take place. The following sections will provide a more detailed 
description of the SC structure and mechanisms that maintain the SC properties.  
 
Stratum corneum lipid composition  
The corneocytes contain a densely cross-linked protein envelope that is 
surrounded by a covalently attached lipid layer, also known as the lipid envelope 20. 
The major constituents of the lipid envelope are -hydroxyceramides, which have 
a long -hydroxy fatty acid that is linked to sphingosine (ceramide A) 21 or 6-
hydroxy-4-sphingenine (ceramide B) 22 through an amide bond. The lipid envelope 
is thought to serve as a scaffold for the proper arrangement of the intercellular SC 
lipids. 
The densely cross-linked protein envelope is rather impermeable, which reduces 
the partitioning of most substances into the corneocytes . Therefore, the pathway 
for compound penetration is thought to mainly proceed via the SC lipid domains 
23, 24. The composition and organization of the SC lipids is therefore essential for 
the permeability barrier of the skin. Changes in the composition and consequently 
the organization of the SC lipids are known to have detrimental effects on the 
barrier function of the skin 25. The SC lipid matrix is composed of cholesterol, free 
fatty acids and ceramides in an approximately equimolar ratio 16, 17. Human SC 
consists of heterogeneous species of free fatty acids and ceramides. The free fatty 
acids mostly have a saturated acyl chain with a chain length varying from 14 carbon 




atoms up to 32 carbon atoms. The most abundant free fatty acid species in human 
SC are lignoceric acid (C24:0) and cerotic acid (C26:0) 26, 27. Free fatty acids are 
generated by the catabolism of phospholipids, which are extruded from lamellar 
bodies, by phospholipases 16, 28. Ceramides have a sphingoid base to which a fatty 
acid is linked. Human SC contains twelve ceramide subclasses 29, which are named 
according to their chemical structure 30, 31. Ceramides can have a sphingosine (S), 
dihydrosphingosine (dS), phytosphingosine (P) or 6-hydroxysphingosine (H) base 
to which an esterified -hydroxy (EO), -hydroxy (A) or non-hydroxy (N) fatty 
acid with a varying acyl chain length is linked (figure 2). Among the SC ceramides 
the acylceramides (EO ceramides) have a unique structure. They have a very long 
-hydroxy fatty acid chain containing up to 34 carbon atoms to which linoleic acid 
(C18:2) is linked 32.  Human SC ceramides are generated from two different lipid 
precursors present in the lamellar bodies, namely glucosphingolipids and 
sphingomyelin 33, 34, by the action of -glucocerebrosidase 35 and sphingomyelinase 
36 respectively.  
Figure 2. The structure and nomenclature of ceramide subclasses present in human SC. 






Stratum corneum lipid organization 
Cholesterol, free fatty acids and ceramides form neatly arranged lipid layers (i.e. 
lipid lamellae) that are stacked on top of each other oriented approximately parallel 
to the skin surface (figure 3). The distance over which a lipid layer is repeated is 
referred to as the repeat distance. In native human SC two types of lipid lamellae 
are observed, each with a different repeat distance. The long periodicity phase 
(LPP) has a repeat distance of approximately 13 nm and the short periodicity phase 
(SPP) has a repeat distance of around 6 nm 37-41. The LPP is considered to be 
important for the barrier function of the skin, as its presence is detected in the SC 
of all species studied so far. Additionally, recent studies have shown that the LPP 
plays an essential role in the barrier function of the skin 42, 43.  
The packing of the lipids within the lipid lamellae is referred to as the lateral 
organization. This packing is also of importance for the barrier function of the skin 
(figure 3). The liquid, hexagonal and orthorhombic packing have an increasing 
packing density. At a physiological temperature the SC lipids are mostly arranged in 
an orthorhombic lattice, although some lipids also form the hexagonal or liquid 
packing 44-46.  
 
Epidermal lipid metabolism 
The viable epidermis is an active site for lipid synthesis, since it requires the 
production of a considerable amount of lipids to form the SC. Additionally, many 
of these lipid species are unique and are only synthesized in the skin. Fatty acids 
can be synthesized de novo by keratinocytes or originate from dietary sources. 
Linoleic acid (C18:2) and arachidonic acid (C20:4) are two essential fatty acids that 
cannot be synthesized by keratinocytes and are therefore derived from external 
sources. Fatty acid synthase synthesizes fatty acids up to 16 carbon atoms 47. The 
elongation of fatty acids is a four step reaction, which are all executed by fatty acid 
synthase. The elongation of fatty acids with 16 carbon atoms or more principally  




Figure 3. Schematic overview of the lamellar and lateral lipid organization of human SC 
lipids. Human SC contains lipid lamellae with a repeat distance (d) of 13 nm or 6 nm, 
referred to as the long periodicity phase (LPP) and short periodicity phase (SPP), 
respectively. The lipids in the lipid lamellae predominantly form the dense orthorhombic 
packing in native human SC, although some lipid populations also form the hexagonal or 
liquid packing. This figure is adapted from 118. 
 
involve the same processes, but requires four distinct enzymes. The first step in the 
elongation cycle is performed by elongases (ELOVLs) and is also the rate-limiting 
step. In mammals seven ELOVLs have been identified, which all have their own 
fatty acid substrate specificity 47-49. ELOVL1 and ELOVL4 are the two main 
elongases that have been shown to elongate fatty acids with  24 carbon atoms, 
suggesting that they play an important role in the formation of very long chain 
fatty acids of the SC. The fatty acids intended for the SC lipid matrix are converted 
to phospholipids and are packed into lamellar bodies.   
The formation of ceramides also involves a four step cycle. The variety in ceramide 
subclasses is generated in the final two steps of this cycle. Dihydrosphingosine, 
which is formed by the first two steps in the ceramide biosynthesis, is acylated by 





the chain length and degree of saturation of fatty acids that it attaches to 
dihydrosphingosine 51. CERS3 is the highest expressed CERS member in the 
epidermis and has a broad preference for fatty acids, including very long chain fatty 
acids. Moreover, it has recently been demonstrated that CERS3 is essential in the 
formation of acylceramides 52. In the final step, the dihydrosphingosine based 
ceramide can be converted to sphingosine, phytosphingosine or 6-
hydroxysphingosine. De novo synthesis of ceramides occurs at the cytosolic leaflet 
of the endoplasmatic reticulum. After the final synthesis step, the ceramides are 
transferred to the Golgi apparatus where they are converted to glucosphingolipids 
by linking glucose moieties to the primary hydroxy group of the ceramides, or to 
sphingomyelin by linking a phosphocholine head group to this hydroxy group 50. 
The SC lipid precursors are then packed into lamellar bodies.  
Keratinocytes are able to sense the cellular lipid levels through peroxisome 
proliferator-activated receptors (PPARs). PPARs are transcription factors that 
belong to the nuclear hormone receptor family, just as liver X receptor (LXR). 
PPARs are activated by fatty acids and their derivatives, while LXRs are activated 
by oxysterols 53. PPARs and LXR control many key events in keratinocytes, like the 
expression of differentiation markers and lipid metabolism 54-56. In the latter case it 
is demonstrated that PPAR and LXR stimulation leads to increased lipid synthesis, 
lamellar body formation, lamellar body secretion and extracellular lipid processing 
in the SC. This indicates that PPARs and LXR play an important role in the 
formation of the SC. 
 
Stratum corneum hydration 
The water content of the SC is important since it affects its physical properties, 
such as its permeability and flexibility, and the activity of several enzymes. The 
hydration level of the SC is regulated by small hygroscopic molecules, such as 
amino acids and their derivatives (e.g. pyrrolidone carboxylic acid and urocanic 
acid) and non amino-acid derived molecules such as lactate, glycerol, potassium, 




sodium and calcium. These molecules are collectively referred to as ‘natural 
moisturizing factors’ (NMFs) 57-60. Some of these NMFs are derived from sweat or 
the sebaceous lipids, while other NMFs are generated through the hydrolysis of 
filaggrin. The latter process is regulated by the SC moisture content and the 
external relative humidity. The SC contains  approximately 30% of water, while at 
the interface between the SC and viable epidermis the water content increases to 
around 70% 61. The water transport into the viable cells is facilitated by 
aquaporines. Aquaporin 3 (AQP3) is found in the membranes of keratinocytes in 
the viable epidermis and acts as a selective water and glycerol transporter 62.  
 
Desquamation  
In order to maintain a proper skin barrier function, the corneocytes in the upper 
layers of the SC are shed by a process referred to as desquamation. For this 
process to occur corneodesmosomes, the structures that link the corneocytes 
together, have to be degraded. Corneodesmosomes consist of several 
transmembrane proteins, such as desmoglein 1 and desmocollin 1. Additionally, 
corneodesmosin localizes to the extracellular parts of the corneodesmosomes and 
is covalently linked to the cornified envelope 63, 64. The degradation of desmoglein 
1, desmocollin 1 and corneodesmosin is an essential step in the desquamation 
process. The degradation of the corneodesmosomes is performed by kallikreins 
and cathepsins 63, 64. At least eight kallikreins are expressed and extruded at the 
stratum granulosum/SC extracellular space. Kallikrein 5 (KLK 5; SC tryptic 
enzyme) and kallikrein 7 (KLK7; SC chymotryptic enzyme) are thought to be the 
primary enzymes involved in this process 65-67. KLK 5 is auto-activated, but its 
activity is immediately inhibited by binding of Lympho-epithelial Kazal type related 
inhibitor (LEKTI) to prevent premature corneodesmolysis. The activity of the 
KLKs is thereby restricted to the upper layers of the SC. The association of 
LEKTI to KLKs is regulated in a pH dependent manner 68. The activity of the 





a very high hydration level in the SC will result in a suboptimal desquamation rate 
69. After degradation of the corneodesmosomes, the corneocytes are shed at the 
skin surface due to friction between the skin and the external environment. 
 
 
HUMAN SKIN EQUIVALENTS 
Active ingredients developed for topical skin formulations, either for therapeutic 
purposes or personal care, need to be assessed for their efficacy and safety. Before 
they are made available to the general public, the permeation of the formulation, its 
irritancy, corrosivity, toxicity and conversion to potential harmful metabolites by 
the skin has to be investigated. Ex vivo human or animal skin from rat, hairless 
mouse, guinea pig, pig and other species have extensively been used for these 
purposes 70-72. However, data obtained from these studies are difficult to 
extrapolate to the in vivo situation. Additionally, a reduction of the use of animals 
for testing of pharmaceutical, chemical, personal care, cosmetic, household and 
food products is demanded by the general public, as well as by the relevant 
authorities. The EU passed a ban on the use of animals in cosmetics testing 
starting in 2009, and a complete sales ban of products tested on animals effective 
in 2013. Together these factors indicate the need for a suitable replacement of 
human skin. A very attractive candidate is the three-dimensional human skin 
equivalent (HSE).  
 
Application of human skin equivalents   
HSEs may have only an epidermal compartment 73-75 or both a dermal and 
epidermal compartment 76-80. Commercially available HSEs (e.g. EpiDermTM from 
MatTek, USA; RHETM from SkinEthic, France), which mostly consist of only an 
epidermal compartment, are successfully used to predict skin corrosivity, skin 
irritation and phototoxicity of compounds 73, 81-83. Since HSEs are relatively easy to 
handle, they can also be used to investigate the transdermal application of 




promising compounds. Additionally, several skin diseases (e.g. eczema, psoriasis 
and cancer) can be mimicked with HSEs. This makes it possible to use HSEs to 
screen for new drugs, test the efficacy of lead compounds or to investigate 
mechanisms underlying skin abnormalities 84-89. HSEs are currently also used to 
screen for compounds that show beneficial effects on wound healing, aging and 
skin pigmentation 90-92. The skin has also been recognized for its metabolic capacity 
5. It is therefore possible that active ingredients that permeate into the skin are 
metabolized to compounds that have toxic, irritating or sensitizing properties. The 
use of HSEs to examine the formation of potential dangerous metabolites is 
currently under investigation. Studies performed so far have demonstrated that 
many of the skin’s metabolic enzymes are expressed in HSEs 93-98. The HSEs also 
offer an attractive tool for clinical purposes. Since the late eighties autologous and 
allogenic HSEs have already been used to treat chronic wounds and severe skin 
burns by permanently covering the wounds to accelerate skin regeneration and 
repair 99, 100. Finally, HSEs also offer the possibility to gain more fundamental 
insight into biological processes in the skin and are therefore excellent candidates 
to study the interaction between cells, and the interaction of the skin with its 
environment 101, 102.  
 
Development and generation of human skin equivalents  
The first human epidermal equivalents were generated by growing keratinocytes 
under submerged conditions in culture vessels. The resulting epidermis had a 
disorganized and irregular epithelium and an incomplete differentiation pattern 
indicated by the absence of keratohyalin granules, lamellar bodies and a SC 77, 103. In 
order to create more physiological culture conditions, keratinocytes seeded on 
collagen gels or collagen-coated filters were generated at the air-liquid interface 103. 
This resulted in the generation of cultures with a higher degree of differentiation, 
as indicated by the presence of a homogenous keratinization profile, the presence 





generation of HSEs was the combination of epidermal cells with dermal elements. 
Keratinocytes seeded on human de-epidermized dermis (DED) were cultured at 
the air-liquid interface 103-105. Alternatively, HSEs were also generated by seeding 
keratinocytes onto collagen gels embedded with fibroblasts 106, 107. These cultures 
had a better tissue architecture, an improved expression and distribution of 
terminal differentiation markers and showed the extracellular deposition of lamellar 
body content. Further optimization of the culture conditions, such as the use of 
serum-free medium and supplementation of the culture medium with lipids 108, 
growth factors 109 and vitamins 110 have resulted in further improvements in tissue 
architecture, SC lipid content and organization. Supplementation of these factors is 
crucial for the development of human epidermal skin models. With respect to the 
SC lipid composition of HSEs, major improvements were made by supplementing 
the culture medium with vitamin C. Ponec et al 110 showed that addition of vitamin 
C to the culture medium i) markedly increased the level of glucosylceramides, 
ceramide AP and AH, and ii) improved lamellar body formation, extrusion and 
thus the intercellular lipid lamellae formation and organization in the SC of HSEs.   
Nowadays HSEs are principally generated from only keratinocytes or both 
keratinocytes and fibroblasts, which are obtained from juvenile foreskin or excised 
skin obtained from donors undergoing abdomen or mammary reduction. The cells 
are isolated after separation of the dermis from the epidermis. The keratinocyte 
and fibroblast cell suspensions are produced by digestion of the epidermis and 
dermis, respectively 111-113. Both cell types are separately expanded in monolayer 
cultures. After reaching an appropriate confluency, the cells are either subcultured, 
stored deep-frozen or used to generate HSEs. The dermal compartment of HSEs 
may comprise fibroblasts, endothelial cells 114, myofibroblasts 115 and T-cells 85 or 
only a biological matrix, which may consist of different types of collagen. HSEs 
containing melanocytes and Langerhans cells in the epidermis are now also 
successfully generated 116, 117. Some of the developed HSEs are commercially 
available. In the initial stage of HSE generation, the cultures are grown under 




submerged conditions to stimulate cell proliferation. To induce basement 
membrane formation, differentiation of the keratinocytes and formation of the 
different epidermal strata present in human skin, the HSEs are exposed to the air 
by lifting them to the air-liquid interface 103. For the remaining culture period the 
HSEs are kept air-exposed and are nourished with nutrients in the medium that 
diffuse upwards from the basolateral side. A schematic overview of the procedure 
to generate HSEs is provided in figure 4.  
In this thesis four different types of HSEs have been generated, including two 
recently developed HSEs 73, 76, 118. The full thickness collagen model (FTM) is 
generated by seeding keratinocytes onto a fibroblast-populated collagen type I 
matrix. The novel fibroblast-derived matrix model (FDM) is established by seeding 
fibroblast on an inert filter to allow them to secrete their own extracellular matrix. 
Hereafter, keratinocytes are seeded onto the developed dermal compartment. The 
Leiden epidermal model (LEM), also a recently developed HSE, is generated by 
seeding keratinocytes directly onto an inert filter. The fourth model is generated by 
expanding small skin biopsies of native human skin on a fibroblast-populated 
collagen matrix.  
 
Morphology and expression of differentiation markers in human skin 
equivalents 
Modification of the culture conditions over the past years have resulted in the 
generation of HSEs that closely mimic many aspects of native human skin 103, 108, 110, 
119-122. Nowadays, HSEs can easily be grown for 6-7 weeks or even more than 3 
months before a decrease in number of viable cell layers is observed 76, 123. 
Morphological examination of commercial and in-house HSEs has demonstrated 
that these cultures have a fully stratified epidermis, which includes a SC. The 
stratum granulosum contains keratohyalin granules and lamellar bodies 26, 124, 125. 
Additionally, the proliferation index of HSEs is comparable to native human skin 





such as keratin 10, filaggrin, loricrin and involucrin, similarly as healthy human skin 
120, 124, 127, 128. However, HSEs generally also have features of a hyperproliferative 
epidermis indicated by the presence of hyperproliferation-associated markers like 
keratin 6, 16 and 17. The expression of the latter keratins in HSEs may be 
dependent on the number of fibroblasts present in the dermal layer 120. This 
demonstrates that epidermal homeostasis is not completely reached in several of 
the HSEs. 
Figure 4. Keratinocytes and fibroblasts isolated from fresh human skin biopsies are 
cultured separately in monolayer cultures. Dermal substrates are generated by e.g. 
incorporation of fibroblasts in a collagen type I matrix. Keratinocytes are seeded on 
different cellular or acellular (biological) substrates. The cultures are initially grown under 
submerged conditions to stimulate keratinocyte proliferation. Hereafter, the cultures are 
lifted to the air-liquid (A/L) interface to induce keratinocyte differentiation. This results 
in the formation of a HSE with a completely stratified epidermis. 




Stratum corneum barrier properties of human skin equivalents  
HSEs mimic human skin in many aspects. However, they have not extensively 
been used for permeation testing of substances due to their overestimation of 
compound penetration, even though improvements in their SC barrier function 
has been established 129-136.  The SC barrier properties of several HSEs have been 
investigated to determine the cause of their decreased barrier function. 
Characterization of the SC barrier properties has mainly been limited to assessing 
the SC lipid composition, with only few studies focusing on the SC lipid 
organization. The evolution of the SC barrier properties of HSEs will be described 
together with improvements made in culture conditions. HSEs generated with 
serum and epidermal growth factor (EGF), but without vitamin C in the culture 
medium showed the presence of cholesterol, free fatty acids and ceramides in their 
SC 137, 138. These HSEs had an incomplete lamellar body extrusion process, a less 
uniform distribution of extracellular SC lipids and a poor lamellar ordering 
compared to native human SC 137, 138. The lateral lipid organization of these HSEs 
occasionally showed the presence of some orthorhombic domains in their SC, but 
the majority of the lipids were thought to form a hexagonal or liquid packing. 
Optimization of the culture medium by omitting serum (and reduction of 
supplemented EGF) resulted in an a lipid profile that more closely resembled that 
of native human SC 122. Additionally, the LPP was detected in the SC of these 
HSEs. Further optimization of the culture medium by addition of vitamin C 
profoundly improved the glucosphingolipid, ceramide AP and AH content in the 
SC of HSEs 110. Additionally, the lamellar body extrusion process was complete 
and the extruded SC lipids were processed into lipid lamellae. Moreover, the 
presence of the LPP could clearly be demonstrated in the investigated HSEs, 
indicative of an improved SC lamellar lipid organization. HSEs generated with 
vitamin C were shown to have a mainly hexagonal packing 139. When focussing on 
the commercially available HSEs, it is not possible to discuss the composition of 





barrier properties of these HSEs was investigated after the beneficial effects of 
vitamin C supplementation was demonstrated. It is therefore possible that the 
culture medium contained vitamin C. Examination of the SC lipid composition 
revealed that the commercial HSEs contain the three main lipid classes, 
cholesterol, free fatty acids and ceramides in their SC 26, 83, 124, 125. However, 
ceramide AH was absent in all models, and ceramides AS and AP were present in 
low quantities compared to native human SC. Additionally, in some commercial 
models the processing of lamellar bodies was disturbed 125. In all HSEs lipid 
lamellae were observed in the SC. These lipid lamellae formed the LPP, although 
in some commercial models the population of lipids forming an LPP was limited 
125.  
During the last decades the SC barrier properties have greatly improved since the 
first establishment of HSEs. However, the SC lipid composition and organization 
of HSEs show some differences when compared to native human SC. A common 
difference observed between HSEs and human skin is a reduced free fatty acid 
content in the SC 110, 122, 125, 131, 138, 140. Additionally, HSEs have a pronounced 
hexagonal packing as opposed to the dense orthorhombic packing observed in 
human SC 44. The reduced free fatty acid content and the predominant hexagonal 
packing are observed in HSEs irrespective of the substrates or cell types that are 
used to generate the HSEs. With regard to the lamellar lipid organization, HSEs 
only show the presence of the LPP, while human SC shows the presence of both 
the LPP and SPP 37. The SC barrier properties of HSEs were determined in only a 
few studies that were conducted more than a decade ago, indicating that little is 
known about their current status. Furthermore, the results from these studies 
demonstrated that the SC barrier properties of some of the commercial HSEs were 
known to show large deviations from the SC barrier properties of native human 
skin. Another limitation relating to the SC barrier properties of HSEs is the 
impaired desquamation process observed in all HSEs developed so far 141, 142. As a 
result, the SC of the HSEs increases in thickness as the culture period is prolonged. 




Since the SC forms the main barrier for diffusion of substances across the skin, the 





The HSEs developed so far generally show a high resemblance to native human 
skin, but have an unreliable in vitro- in vivo correlation for permeation studies 129, 131, 
133-136 due to their decreased SC barrier function and impaired desquamation 
process 141, 142. Improvement of the culture conditions of HSEs during the past 
years have led to major advances in epidermal organization and differentiation and 
consequently SC barrier function. However, more research is needed to generate 
HSEs that harbor a competent SC barrier that even more closely resembles the SC 
barrier function of native human skin than the current HSEs. Nevertheless, 
relatively little research is devoted to the optimization of SC barrier properties of 
HSEs. Additionally, only a few studies are published in which the SC barrier 
properties of HSEs are investigated in detail 26, 83, 110, 125, 137. In this thesis the 
suitability of two novel in-house HSEs for the replacement of human skin for 
permeation studies is examined. Furthermore, the SC lipid organization of several 
in-house HSEs is investigated in detail and correlated to the SC lipid composition. 
Using novel sophisticated techniques new insights into the SC lipid composition of 
HSEs have been obtained, which provide new opportunities to optimize the SC 
barrier properties of HSEs. In addition, the cause of the impaired desquamation 











The main goal of this thesis was to answer the following questions: 
1. Do the SC barrier properties of our novel in-house HSEs resemble the SC 
barrier properties of native human skin? 
2. How does the SC lipid composition of the in-house HSEs relate to their SC 
lipid organization?  
3. To what extent do the culture conditions influence the SC barrier properties of 
HSEs? 
4. How can the SC barrier properties of HSEs be improved? 
 
Outline 
In chapter 2 a method to generate HSEs with a fully differentiated epidermis, while 
closely mimicking the in utero environment, is presented. The developed model is 
used to study the epidermal development ‘in utero’ and to determine whether air-
exposure is a requirement to generate a proper HSE. The expression of 
differentiation markers and the epidermal lipid content of HSEs submerged in 
amniotic fluid or culture medium are investigated and compared to HSEs 
generated at the air-liquid interface. 
In chapter 3 studies are reported focussing on three in-house developed HSEs. The 
barrier properties of these HSEs are compared to the barrier properties of native 
human SC. The barrier function of the HSEs and native human SC are examined 
by performing diffusion studies using benzocaine as a model drug. The barrier 
function of the HSEs is also correlated to the SC lipid composition and 
organization. 
In chapter 4 studies are described aiming to determine whether culture conditions or 
the isolation of keratinocytes are the main factor for the abnormalities in the skin 
barrier properties of HSEs. Native human skin explants were expanded in vitro 
under the same conditions as the HSEs described in chapter 2. The expression of 
differentiation markers and the SC lipid composition and organization of the 




epidermis that grew from the skin explants are examined and compared to 
properties observed for native human skin and the HSEs reported in chapter 2. 
In chapter 5 a comprehensive analysis of the lipid composition of the HSEs is 
provided. A novel LC/MS method is used to determine the free fatty acid and 
ceramide (subclass) chain length distribution and degree of saturation, while 
HPTLC is used to quantify the SC lipid (sub)classes.  
Based on the results of the free fatty acid profiles obtained with LC/MS, in chapter 
6 studies are reported aiming to improve the SC free fatty acid composition and 
lipid organization. In these studies, HSEs were generated with a modified medium 
composition. 
In chapter 7 the desquamation process in HSEs is reported. The expression pattern 
of specific desquamatory enzymes is investigated in several HSEs, ex vivo human 
skin and native human skin. Additionally, the activity of KLK5 and KLK7 in the 
superficial SC layers of the full thickness collagen model and in vivo skin are 
compared. 
In chapter 8 the results of this thesis are summarized and discussed and suggestions 
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In this study, we generated human skin equivalents (HSEs) under submerged 
conditions to mimic the aqueous in utero environment and investigated the 
morphology and differentiation process of the formed epidermis. Furthermore, the 
skin barrier, which resides in the stratum corneum (SC), was characterized by its 
lipid content, hydration level and natural moisturizing factor level. The submerged 
HSEs show comparable tissue morphology and similar expression of several 
differentiation markers and SC lipid composition compared to HSEs grown at the 
air-liquid interface and native human skin. The SC of the submerged HSEs, 
however, contained more free water and less natural moisturizing factors 
compared to the air-exposed counterparts. These results show that the presented 
cell culture method can be utilized to generate HSEs under submerged conditions 















   
 





The epidermis is the most superficial layer of the skin and can be subdivided into 
four different strata: stratum basale, stratum spinosum, stratum granulosum and 
stratum corneum (SC). The SC is in direct contact with the external environment 
and therefore forms the first and most important barrier against foreign substances 
and micro-organisms.  
It is ironic to notice that the barrier that protects the human body from desiccation 
develops in an aqueous environment, i.e. the amniotic fluid. The formation of 
human skin starts early during embryogenesis and at first consists of only one cell 
layer of multipotent epithelial cells. This epithelium is covered by a second 
epidermal layer, called the periderm, which serves as a protective shield between 
the amniotic fluid and the epidermis while it keratinizes 1, 2 . The periderm is shed 
at approximately 24 weeks of estimated gestational age (EGA) when the epidermis 
is fully differentiated and comprises the first few SC layers. During the third 
trimester the SC is fully exposed to the surrounding amniotic fluid while it matures. 
At 34 weeks EGA barrier formation is complete. Full-term neonates (40 weeks 
EGA) are therefore born with a competent skin barrier that resembles that of 
adults.  
Several attempts have been made to simulate the intrauterine epidermal 
development by culturing keratinocytes under submerged conditions in petri dishes 
or culture flasks 3-7. In these culture systems the medium was only supplied from 
the apical side of the keratinocytes. The resulting cultures, referred to as human 
skin equivalents (HSEs), show drastic differences with human skin, such as a 
disorganized epithelium and an incomplete differentiation indicated by the lack of 
a SC, the absence of keratohyalin and membrane-coating granules or the lack of 
expression of high-molecular-weight keratins. Only when keratinocytes  are seeded 
on an appropriate substrate and are subsequently cultured at the air-liquid interface 
do HSEs show high resemblance to human skin in many aspects like morphology, 





microenvironment of a HSE affects its differentiation process, in utero epidermal 
development may differ from epidermal development at the air-liquid interface. In 
the present study we have developed a novel method to generate HSEs under 
aqueous conditions by submerging HSEs in culture media, ensuring that the apical 
and basolateral side of the developing epidermis are surrounded by an aqueous 
environment, which mimics the in utero environment very closely. The morphology 
and differentiation process of the epidermis generated under these submerged 
conditions was examined by determining the expression of various differentiating 
markers. As the lipids of the SC are crucial for maintaining a proper barrier 
function, the lipid composition of the SC was examined as well. In addition, the 
natural moisturizing factor (NMF) and hydration level in SC were determined. Our 
studies showed for the first time that under submerged conditions a well organized 
epidermis, including a SC, can be formed.  
 
 
MATERIALS AND METHODS  
Cell culture  
Normal human keratinocytes (NHKs) and human dermal fibroblasts were 
obtained from adult donors undergoing mammary or abdomen surgery and were 
established as described previously 16.  
 
Dermal equivalents 
Dermal equivalents were generated as described earlier 16, 17.  In brief, 1 mL of a 1 
mg/mL collagen type I solution was pipetted into filter inserts (Corning Transwell 
cell culture inserts, membrane diameter 24 mm, pore size 3 μm; Sigma, 
Zwijndrecht, The Netherlands) and was allowed to polymerize for 15 minutes at 
37oC. Subsequently, 3 mL of a 2 mg/mL collagen type I solution, with a fibroblast 
suspension reaching a final density of 0.4 x 105 cells/mL collagen, was pipetted 
into the inserts. After polymerization, DMEM (Invitrogen, Breda, The 




Netherlands) supplemented with 5% FBS (Hyclone, Utah, USA), 1% 
penicillin/streptomycin and 0.45 mM vitamin C (Sigma, Zwijdrecht, The 
Netherlands) was added to each culture. The dermal compartments were kept 
under submerged conditions for 1 week. During this period the medium was 
refreshed once. 
 
Human skin equivalents (HSEs) 
Generated on dermal equivalents: HSEs grown on collagen matrices were generated as 
described before 9, 16. First or secondary NHKs were seeded onto fibroblast-
populated collagen gels (0.5-1 x 106 cells/gel). To mimic the aqueous in utero 
environment, the cultures were kept under submerged conditions during the entire 
culture period. To investigate the epidermal development under submerged 
conditions over time, HSEs were grown for 8, 16 and 24 days, after seeding of the 
NHKs, at 37oC, 93% relative humidity and 8% CO2. As a control HSEs were also 
generated under air exposed conditions by seeding keratinocytes on the dermal 
compartment and lifting them to the air-liquid interface 1 day hereafter. During the 
culturing period the submerged and air-exposed HSEs were nourished with media 
as described by Bouwstra et al. 16  
Generated on inert filter: to generate HSEs under submerged conditions NHKs (1.0 x 
106 cells/filter) were seeded directly onto cell culture inserts (Corning Transwell 
cell culture inserts, membrane diameter 24 mm, pore size 0.4 μm; Corning, The 
Netherlands). After 4 days the culture medium was supplemented with 1 ng/mL 
epidermal growth factor (Sigma, Zwijdrecht, The Netherlands) during the 
remaining culture period, using the same incubator conditions as the HSEs 
generated on the collagen substrate. As a control NHKs were also seeded onto cell 
culture inserts and were lifted to the air-liquid interface after 4 days. The filter 







Amniotic fluid-treated human skin equivalents 
Human amniotic fluid samples were obtained from amniocentesis, provided by 
Leiden University Medical Centre, from women undergoing caesarean section at 
37-39 weeks of pregnancy. Amniotic fluid samples were centrifuged for 6 minutes 
at 1000 rpm to obtain a cell free solution and were stored at -20oC until use. To 
closely mimic the in utero environment HSEs generated on a collagen substrate 
were kept submerged with medium or grown at the air-liquid interface for 8 days. 
Hereafter, a metal ring with a diameter of 10 mm was placed on top of the HSEs 
and 200 μL amniotic fluid of one donor was applied at the apical side of the HSE 
until day 24. Amniotic fluid was refreshed twice a week. The amniotic fluid-treated 
HSEs were nourished with the same media as the collagen HSEs.   
 
Morphology and immunohistochemistry 
Harvested HSEs were fixed in 4% (w/v) paraformaldehyde (Lommerse Pharma, 
Oss, The Netherlands) overnight and sequentially dehydrated in 70%, 80%, 90%, 
96% and 100% ethanol, xylene and liquid paraffin for 1 hour each. The dehydrated 
samples were subsequently embedded in paraffin. 5 μm sections were cut, 
deparaffinized and rehydrated in preparation for morphological analysis and 
immunohistochemical staining of keratin 10 and 16, filaggrin, involucrin and 
loricrin. The primary and secondary antibodies used in this study are listed in table 
1. Morphological analysis was performed by light microscopic examination of 
haematoxylin and eosin stained sections.  Immunohistochemical analysis for 
keratin 10, keratin 16 and filaggrin was performed as described before 16. Staining 
of involucrin and loricrin was performed as described with the following 
modifications: treatment with the citrate buffer was omitted, an additional wash 
with 0.5% Triton X-100 (Sigma, Zwijndrecht, The Netherlands) was performed 
prior to the incubation with human serum, and incubation with the first antibody 
was performed for 1 hour at room temperature.  
 




Table 1 Primary and secondary antibodies for immunohistochemical staining 
Antibodies Clone Dilution Company 
Primary antibodies  
Mouse cytokeratin 10 Ab-2 DEK10 1:100 Neomarkers, USA 
Mouse cytokeratin 16 Ab-1 LL0025 1:20 Neomarkers, USA 
Mouse filaggrin Ab-1 FLG01 1:150 Neomarkers, USA 
Mouse involucrin SY5 1:200 Sanbio, The Netherlands
Rabbit loricrin AF62 1:400 Covance, USA 
Secondary antibodies  
Biotinylated goat anti-mouse 1:200 Dako, The Netherlands 
Biotinylated swine anti-rabbit 1:300 Dako, The Netherlands 
 
Lipid extraction and analysis 
The lipids from human epidermis and the epidermis of HSEs were consecutively 
extracted according to a modified Bligh and Dyer procedure 18 with the addition of 
0.25M KCl to extract polar lipids. The extracted lipids were redissolved in a 
suitable volume of chloroform: methanol (2:1) and stored at -20oC until use. The 
lipid extracts of three HSEs generated under the same culture conditions were 
pooled to obtain a sufficient amount of lipids for analysis. Amniotic fluid of 3 
donors was extracted accordingly. The extracted lipids were analyzed by means of 
one-dimensional high performance thin layer chromatography (HPTLC) as 
described previously 19 with the solvent systems provided in table 2A and 2B. Co-
chromatography of a standard lipid mixture was performed to identify the various 











Table 2A Solvent system used for barrier lipids analysis 
Eluent Composition (v/v) Distance
1 DCM: EA: A: M (80: 8: 4: 1) 40 mm 
2 C: A: M (76: 8: 16) 20 mm 
3 H: C: A: M (6: 80: 12: 2) 70 mm 
4 H: C: HA: A: M (6: 80: 0.1: 10: 4) 95 mm 
A: acetone, C: chloroform, DCM: dichloromethane, DE: diethyl ether, E: ethanol, EA: 
ethyl acetate, H: hexane, HA: hexyl acetate, M: methanol. 
 
Table 2B Solvent system used for total lipid analysis 
Eluent Composition (v/v) Distance 
1 DCM: EA; A: M (88: 8: 4: 1) 40 mm 
2 C: A: M (76: 8: 16) 10 mm 
3 H: C: HA: A: M (6: 80: 0.1: 10: 4) 70 mm 
4 C: EA: EMK: 2P: E: M: W: AA (36: 6: 6: 6: 16: 28: 2: 1) 20 mm 
5 C: EA: EMK: 2P: E: M: W (48: 6: 6: 6: 6: 24: 4) 25 mm 
6 H: C: A: M (2: 80: 10: 8) 80 mm 
7 H: DE: EA (78: 18: 4) 95 mm 
2P: 2-propanol, A: acetone, C: chloroform, DCM: dichloromethane, DE: diethyl ether, E: 
ethanol, EA: ethyl acetate, EMK: ethyl methyl ketone, H: hexane, HA: hexyl acetate, M: 
methanol, W: water. 
 
Cryo-scanning electron microscopy (Cryo-SEM)  
The harvested HSEs were processed as described elsewhere 16. In brief, the 
samples were cryo-fixed at -180oC and planed perpendicular to the skin surface. 
The surface of the samples was visualized at -190oC with a field scanning electron 
microscope (Jeol 6400F, Japan). As a control dermatomed human skin (300 μm) 
was incubated for 24 hours at 37oC and 93% RH. Cryo-SEM images of at least 4 
different HSEs were taken per culture condition. 




Natural moisturizing factor (NMF) content determination 
The pyrrolidone carboxylic acid (PCA) content, one of the main components of 
NMF, in HSEs was determined. The HSEs were clamped between two plates with 
an opening of 1 cm in diameter in the upper plate and tape-stripped with Scotch 
Magic Tape 810 tape-strips (3M, Zoeterwoude, The Netherlands). The PCA and 




Formation of a fully differentiated epidermis, including a SC, under 
submerged conditions 
To determine whether all the epidermal layers are generated under conditions 
mimicking the in utero environment, HSEs were cultured under submerged 
conditions with amniotic fluid or medium. As a control HSEs were also generated 
under air-exposed conditions. Vertical sections stained with haematoxylin and 
eosin were used to evaluate the general tissue architecture. At day 24 the amniotic 
fluid-treated and submerged HSEs show the presence of all epidermal strata, 
including a SC. These HSEs show a similar appearance as the air-exposed HSEs, 
although some small differences are noticed (figure 1).  
HSEs were also harvested after 8 and 16 days to investigate the epidermal 
morphogenesis over time. HSEs generated on a collagen substrate under 
submerged conditions with medium contained all epidermal cell layers including 
the stratum basale, stratum spinosum, stratum granulosum and even a few SC 
layers at day 8, similar to the air-exposed HSEs (figure 1). The number of viable 
cell layers, however, was less compared to the air-exposed counterparts. At day 16 
these submerged HSEs have a fully differentiated epidermis, including a clearly 
visible SC. No difference is detected in the number of viable cell layers between 





Figure 1. Haematoxylin and eosin staining of HSEs generated under submerged 
conditions with amniotic fluid (AF) or medium (SM), and air-exposed (AE) conditions 
harvested after 8, 16 and 24 days after seeding normal human keratinocytes on a 
fibroblast-populated collagen matrix (Collagen) or inert filter (Filter). The morphology of 
at least three HSEs per culture condition was examined. HS = human skin. Scale bars 
represent 50 μm.  
 
thickness, while the number of viable cell layers again did not change. HSEs 
generated under air-exposed conditions show a decrease in the number of viable 
cell layers from day 8 to 16, whereas the number of SC layers increases. Although 
the submerged and air-exposed HSEs develop differently over time, at day 24 the 
submerged and air-exposed HSEs show many similarities: all viable epidermal cell 
layers and the SC were generated resembling the morphology of human skin.   
The submerged HSEs generated on a filter consisted of only 3 to 4 cell layers at 
day 8, similarly to the air-exposed HSEs generated on filter (figure 1). At this time 
point a stratum granulosum and SC were not yet uniformly present. However, at 




day 16 all the strata in the submerged and air-exposed HSEs were formed, 
including the stratum granulosum and the SC. Nevertheless, the stratum spinosum 
consisted of only 1 to 2 cell layers and the stratum granulosum was thicker than 
observed in human skin. At day 24, the submerged and air-exposed HSEs 
generated on filters show a similar morphology. Under both culture conditions the 
number of stratum spinosum cell layers did not normalize at the end of the culture 
period.  
 
Submerged and air-exposed HSEs show similar expression of protein 
differentiation markers 
To determine whether the differentiation process of the HSEs that were kept 
submerged with amniotic fluid or medium was similar to that of the air-exposed 
HSEs and human skin, the expression of several specific differentiation markers 
was investigated. Only HSEs treated with amniotic fluid from day 8 to day 24 were 
stained to examine the effect of amniotic fluid on the differentiation process. 
Furthermore, HSEs generated on a filter which were harvested after 8 days were 
not stained as these cultures did not develop a fully differentiated epidermis yet.   
HSEs generated on a collagen substrate that were kept submerged with amniotic 
fluid or medium showed similar expression of the protein differentiation markers 
keratin 10, keratin 16, filaggrin, loricrin and involucrin as the air-exposed HSEs 
irrespective of the culture period (figure 2). Keratin 10, a differentiation-specific 
marker, was located in all the viable cell layers, except the basal layer, whereas 
filaggrin and loricrin expression was confined to the granular layer. The expression  
of these proteins is similar to the expression detected in human skin. In contrast, 
the expression of involucrin and keratin 16 differed from the expression observed 
in human skin. The submerged as well as the air-exposed HSEs showed suprabasal 
expression of keratin 16 and involucrin at day 16 and day 24. In human skin 
involucrin is only expressed in the stratum granulosum and keratin 16 is only 






Figure 2. Immunohistochemical staining of keratin 10 (K10), keratin 16 (K16), filaggrin 
(Fil), loricrin (Lor) and involucrin (Inv) of HSEs generated under air-exposed and 
submerged conditions either on fibroblast-populated collagen matrices or on filters, and 
collagen HSEs treated with amniotic fluid. Grey-coloured squares indicate that the 
differentiation marker is expressed in the corresponding layer of the viable epidermis. 
The expression of the majority of proteins was similar irrespective of the dermal 
substrate used, with the exception of K16, where the (half-tone) black-coloured squares 
indicate that expression of this differentiation marker was additionally detected in the 
basal cell layer in HSEs generated on an inert filter. HSEs generated on filter and 
harvested after 8 days are not included in this figure. Examples of submerged collagen 
HSE sections are shown. SG = stratum granulosum, SS = stratum spinosum, SB = 








The submerged HSEs generated on filters also showed similar expression of 
keratin 10, filaggrin and loricrin as the air-exposed HSEs and human skin from day 
16 to day 24 (figure 2). Again the expression pattern of involucrin and keratin 16 in 
HSEs generated on filters differed from the expression detected in human skin. 
From day 16 to day 24 involucrin could be detected throughout the entire viable 
epidermis of both the submerged and air-exposed HSEs. At day 16 keratin 16 
expression was also detected in the entire viable epidermis of the submerged 
HSEs, but only in the suprabasal layers of the air-exposed HSEs. However, at day 
24 the air-exposed HSEs also showed weak keratin 16 expression in the basal layer.  
 
Submerged and air-exposed HSEs have similar SC lipid profiles 
The lipid profiles of the HSEs generated under submerged conditions with 
amniotic fluid or culture medium and under air-exposed conditions were 
investigated to determine whether qualitative changes occurred when culturing 
under different conditions. Lipid analyses show that the SC lipid profiles of HSEs 
grown submerged in culture medium and air-exposed conditions, both in the case 
of HSEs generated on a collagen substrate or filter, are very similar at day 24 
(figure 3A). The lipid profiles of the submerged and air-exposed HSEs reveal the 
presence of all barrier lipids - cholesterol, free fatty acids and ceramides - that are 
also present in human SC. Moreover, all ceramide subclasses are present in the 
submerged and air-exposed HSEs, but the free fatty acid levels in the HSEs are 
lower than in the native tissue. Furthermore, the lipid profile of the submerged 
HSEs shows a lower level of free fatty acids and ceramide EOS than the air-
exposed counterparts. Additionally, when cultured on a collagen substrate, the 
presence of an additional ceramide with a Rf value between that of ceramide EOS 
and ceramide NS-A can be detected in the submerged HSEs. The detailed 






 Lipid analyses of amniotic fluid-treated HSEs (figure 3B) show the presence of all 
barrier lipids, which appeared to be present in slightly higher amounts than in 
HSEs that were not treated with amniotic fluid (data not shown). However, further 
analysis showed that all barrier lipids were also present in amniotic fluid (figure 
3B).  
Figure 3. Lipid profiles of human epidermis (HE), submerged (SM) HSEs, generated on 
fibroblast-populated collagen matrices (Collagen) or an inert filter (Filter) and air-exposed 
(AE) HSEs harvested after 24 days of culturing are shown in figure A. The lipids were 
fractionated according to the solvent system provided in table 2A. Figure B shows the 
lipids present in amniotic fluid-treated collagen HSEs and amniotic fluid extracts. The 
amniotic fluid-treated HSEs were generated for 8 days under submerged (AF SM) or air-
exposed (AF AE) conditions prior to application of amniotic fluid. The lipid extracts 
from these cultures were fractionated according to the solvent system provided in table 
2B. Extracted lipids from 3 HSEs generated under the same conditions were pooled and 
separated using HPTLC. CHOL = cholesterol, FFA = free fatty acids, * = unidentified 








Submerged and air-exposed HSEs acquire more barrier lipids as the culture 
period is prolonged 
The lipid profiles of HSEs submerged with medium and air-exposed HSEs were 
quite similar at day 24. In order to investigate the generation of the epidermal 
barrier in time under submerged and air-exposed conditions, the changes in barrier 
lipid content were also monitored. For this purpose the HSEs were harvested after 
8, 16 and 24 days of culturing. HSEs generated on a filter and harvested after 8 
days were not examined, since these HSEs had not formed a SC yet.  
The HSEs generated on collagen substrates and filters, grown under submerged 
and air-exposed conditions, show an increase in all barrier lipid classes over time 
(figure 4). The HSEs generated on a collagen substrate even clearly show the 
presence of ceramide NS-A and NS-B at day 8. However, the HSEs show a 
difference in one ceramide subclass over time. At day 8 both the submerged and 
air-exposed collagen HSEs show the presence of the unidentified lipid with an Rf 
value between that of ceramide EOS and NS-A. In the submerged HSEs the 
presence of this lipid diminishes at day 16, but increases again at day 24. Under air-
exposed conditions, the collagen HSEs show the presence of this lipid only at day 
8.  
Analysis of the phospholipids in the submerged and air-exposed collagen HSEs at 
day 8, 16 and 24 show that the phospholipids form the major lipid fraction in the 
early phase of epidermal development. However, their presence decreases over 
time (data not shown), especially from day 16 to day 24. The ceramide precursors, 
(acyl)glucosphingolipids (AGC and GSL, respectively), are both present at day 8. 
The overall GSL content does not change with increasing culturing time, while the 
AGC content shows a decrease after day 16. The level of both lipid classes is 






Figure 4. Lipid profiles of air-exposed (AE) and submerged (SM) cultures generated on 
fibroblast-populated collagen matrices or inert filters harvested after 8, 16 and 24 days of 
culturing. Lipid extracts of 3 HSEs grown under the same conditions were pooled. 
CHOL = cholesterol, FFA = free fatty acids, * = unidentified ceramide. 
 
Generating HSEs under submerged conditions increases the hydration level 
of SC 
To investigate whether the culture conditions affect the water level and water 
distribution in SC, cryo-SEM images were made of HSEs generated under 
submerged conditions with medium and of air-exposed HSEs harvested after 16 
and 24 days. These time points were chosen because morphological examination 
showed a substantial SC layer. Since the composition of amniotic fluid varies, the 
amniotic fluid-treated HSEs were not analyzed. Human skin equilibrated in an 
incubator at 37oC and 93% RH for 24 hours served as a control, as the HSEs were 
also generated under these conditions.  




Figure 5. Cryo-SEM images of submerged (SM) and air-exposed (AE) collagen HSEs 
harvested at day 16 or at day 24, and human skin (HS) equilibrated in an incubator for 24 
hours. Scale bars represent 10 μm. SC = stratum corneum, VE = viable epidermis, EWP 








Cryo-SEM images can be interpreted by the contrast in an image, which is created 
at the planed surface by the sublimation of free water. Regions with contrast  
correspond to areas where free water was located prior to its evaporation. Areas 
without free water appear as low contrast regions in the image. The HSEs 
generated on a collagen substrate and grown under submerged conditions reveal a 
high SC hydration level (figure 5). At day 16 the upper layers of the SC are 
hydrated, while the inner most layers show low levels of water. The water present 
in the hydrated regions is mainly present within the corneocytes at this time point. 
At day 24, the submerged HSEs show a high hydration level in the central region 
of the SC. The water in the hydrated central region of the SC was mainly present 
inside the corneocytes, but was occasionally also observed in the intercellular 
space. The SC of collagen HSEs grown under air-exposed conditions increases in 
thickness between day 16 and 24, but continues to have low water levels 
throughout the entire SC, as indicated by the low contrast in the images. Similar 
results were obtained from submerged and air-exposed HSEs generated on a filter 
(data not shown). 
Corneocytes in SC of human skin equilibrated in the incubator for 24 hours appear 
swollen and show a high contrast intracellularly, indicating that these cells contain a 
considerable amount of free water. The corneocytes in the inner part of the SC 
contain almost no free water, as these cells show almost no contrast.  
 
Generating HSEs under submerged conditions leads to decreased NMF 
levels 
As the NMF level is reported to be one of the factors that influences the hydration 
level of the SC 20, its content in the SC of the submerged and air-exposed HSEs 
generated on a collagen substrate was also determined. The NMF level is expressed 
as the PCA/protein ratio, in which PCA is one of the main components of the 
NMFs. Figure 6 shows that HSEs grown under submerged conditions have a 
lower total PCA/protein ratio compared to the HSEs grown under air-exposed 




conditions. This indicates that the submerged HSEs contain less NMFs compared 
to the air-exposed HSEs. However, both air-exposed and submerged HSEs 












Figure 6. Total SC NMF content, represented by PCA/protein ratios, of human skin, 
air-exposed (AE) (n=18) and submerged (SM) (n=9) HSEs. All HSEs were generated on 
fibroblast-populated collagen matrices and harvested after 24 days of culturing. The 
PCA/protein ratio for  human skin was obtained from Bouwstra et al. 16. The error bars 




Several studies have been performed in which human keratinocytes have been 
cultured in petri dishes or culture flasks under submerged conditions 3-7. However, 
the degree of stratification or the organization and lipid content of the SC of these 
submerged cultures generally showed key differences between cultures grown at 
the air-liquid interface and human skin.  In this study we have developed a 
culturing method to mimic the aqueous conditions found in utero more closely than 
in previous studies to determine whether a fully differentiated epidermis can also 
be formed under submerged conditions in vitro. The most important result was that 





a fully differentiated epidermis that contained all the strata present in human 
epidermis, including a SC. The submerged HSEs generated on a collagen substrate 
even showed the presence of all viable epidermal layers as well as a few SC layers 
after 8 days of culturing. Furthermore, not only all main lipid classes were present 
in HSEs generated under submerged conditions, but even all the ceramide 
subclasses were synthesized under these conditions. To mimic the in utero 
environment even closer, additional studies were performed with HSEs generated 
on a collagen substrate that were kept submerged with amniotic fluid at the apical 
side. These amniotic fluid-treated HSEs showed a fully differentiated epidermis 
with a similar morphology, a similar expression of the differentiation markers and 
lipid profile as the HSEs that were kept submerged with culture medium. 
However, as the biological amniotic fluid varies in composition, it was decided to 
carry out most of our studies under well defined medium conditions. 
It has been shown that the expression of several receptors is related to the 
differentiation state of keratinocytes 21, 22. Basal keratinocytes in submerged cultures 
grown in petri dishes or culture flasks receive nutrients only from the apical side. 
Therefore, the epidermal layers that develop above the basal layer in these cultures 
may decrease the availability of essential nutrients from the culture medium 
towards the basal keratinocytes, which may hamper the epidermal development. In 
our present studies keratinocytes receive stimulating factors, which are present in 
the medium or secreted by fibroblasts, at the basal side in addition to the apical 
side. This tissue culture method mimics the in utero situation closer than the 
described method in petri dishes or culture flasks. Feeding of the keratinocytes 
from the basal side might therefore be a crucial prerequisite to develop a fully 
stratified epidermis under submerged conditions. This hypothesis is in agreement 
with previous studies that reported an incomplete differentiation of submerged 
keratinocyte cultures that received nutrients only from the apical side 3-7.  
This study also shows that HSEs generated on an inert filter are also able to form a 
differentiated epidermis under submerged conditions in the absence of fibroblasts. 




This finding further supports our hypothesis that feeding of keratinocytes from the 
basal and apical side is important to generate a differentiated epidermis. However, 
it should be noted that the presence of fibroblasts improves the epidermal 
morphology. Several literature findings indicate that fibroblasts have a stimulatory 
effect on keratinocyte proliferation and appearance of the epidermis 9, 10, 23, 24.    
Although the submerged and air-exposed HSEs show similarities in their 
morphology, some differences were observed concerning the expression of several 
differentiation markers and SC lipid composition. In the early stage of epidermal 
development the submerged HSEs generated on a collagen substrate had fewer 
viable epidermal layers compared to the air-exposed HSEs. This indicates that 
exposure of HSEs to air results in enhanced proliferation and differentiation of the 
keratinocytes in the first few days compared to the submerged conditions.  
At present the function of each ceramide class remains to be elucidated. However, 
it is suggested that ceramide EOS is important for the barrier properties of the 
skin, as this ceramide promotes the formation of the characteristic 13 nm long 
periodicity phase 25, 26.  Furthermore, free fatty acids are also thought to play a 
crucial role in the tight packing of the SC lipids 27. The lower level of ceramide 
EOS and free fatty acids in the submerged HSEs may therefore lead to decreased 
barrier properties compared to the air-exposed HSEs. The higher ceramide 
precursor levels in the submerged HSEs may be a result of the aqueous 
environment surrounding the developing epidermis. 
The submerged HSEs had a much higher SC water content and a paradoxally 
lower NMF level compared to the air-exposed HSEs. Both the submerged and air-
exposed HSEs were grown at a relative humidity of 93%. This environment has a 
higher humidity level than generally found in vivo. As the humidity of the 
surrounding environment directs the conversion of filaggrin to NMFs, it is 
plausible that the current culturing conditions lead to decreased NMF levels in the 
HSEs compared to human SC 20. However, it is likely that the SC water content of 





medium. This increased water level could consequently have led to a further 
decrease in the conversion of filaggrin to NMFs.  
 
CONCLUSION 
This study shows for the first time that HSEs grown under submerged conditions 
are able to form a fully differentiated epidermis. The submerged HSEs show 
similar expression of many differentiation markers and comparable lipid profiles as 
the air-exposed HSEs and human epidermis. During the last weeks of pregnancy, 
the developed epidermis is fully exposed to the surrounding amniotic fluid. The 
described culture method mainly mimics this stage of epidermal development and 
can therefore be used to study the effect of an aqueous environment on the 
development of the epidermis during that period. In addition, the presented 
culturing method may also provide information on the changes that occur in the 
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Human skin equivalents (HSEs) are three dimensional culture models that are used 
as a model for native human skin. In this study the barrier properties of two novel 
HSEs, the Fibroblast Derived matrix Model (FDM) and the Leiden Epidermal 
Model (LEM), were compared with the Full Thickness collagen Model (FTM) and 
human skin. As the main skin barrier is located in the lipid regions of the upper 
layer of the skin, the stratum corneum (SC), we investigated the epidermal 
morphology, expression of differentiation markers, SC permeability, lipid 
composition and lipid organization of all HSEs and native human skin. Our results 
demonstrate that the barrier function of the FDM and LEM improved compared 
to that of the FTM, but all HSEs are more permeable than human skin. 
Furthermore, the FDM and LEM have a relatively lower free fatty acid content 
than the FTM and human skin. Several similarities between the FDM, LEM and 
FTM were observed: 1) the morphology and the expression of the investigated 
differentiation markers were similar to that observed in native human skin, except 
for the observed expression of keratin 16 and premature expression of involucrin 
which were detected in all HSEs  2) the lipids in the SC of all HSEs were arranged 
in lipid lamellae, similar to human skin, but show an increase in the number of lipid 
lamellae in the intercellular regions, and 3) the SC lipids of all HSEs show a less 
densely packed lateral lipid organization compared to human SC. These findings 
indicate that the HSEs mimic many aspects of native human skin, but differ in 













The skin provides a possible delivery route of active compounds either to the 
various skin layers or to the systemic circulation. Penetration studies with 
preferably ex vivo human skin can be performed to investigate whether compounds 
show promise for dermal or transdermal application. However, the use of ex-vivo 
skin is not always possible due to practical issues. The use of human skin 
equivalents (HSEs) can therefore provide an alternative for native human skin. 
HSEs have already been used for various applications such as the treatment of 
burn wounds 1-3, cutaneous irritation and toxicity testing of substances 4-7 and the 
generation of diseased skin models 8-11. Many HSEs have a fairly similar 
morphology and a comparable expression of several differentiation markers as 
native human skin 12-17. However, when HSEs are evaluated for their resemblance 
to native human skin it is also important to examine their barrier properties. The 
stratum corneum (SC), which is the outermost layer of the epidermis, forms the 
first and main barrier of the skin against penetration of exogenous substances. The 
SC consists of protein rich dead cells that are embedded in a lipid matrix. As the 
lipids form a continuous pathway in the SC, the lipid domains play a crucial role in 
the barrier properties of the skin. The SC consists of three main lipid classes, 
which are cholesterol, free fatty acids and ceramides. These lipids form two 
lamellar phases with a repeat distance of approximately 13 nm or 6 nm, referred to 
as the long periodicity phase (LPP) and short periodicity phase (SPP), respectively 
(see figure 1A) 18-21. Besides the lamellar organization the lateral packing is also 
important for a proper barrier function of the SC. The lateral packing discloses 
information about the density of the lipids within the lipid lamellae. In native 
human skin, the majority of the SC lipids within the lipid lamellae form crystalline 
phases.  A large fraction of lipids forms the very dense orthorhombic packing, but 
a small population of lipids also forms the less dense hexagonal or even liquid 
packing 21-24. A schematic presentation of these crystalline and liquid phases is 





When HSEs are used for in vitro permeation studies they generally show a higher 
permeability compared to human skin, indicative of an impaired barrier function 25-
32. Several studies have been performed in which the barrier properties of various 
HSEs were examined. However, these studies mainly focused on the SC lipid 
composition. They showed that HSEs are prone to have a reduced free fatty acid 
content  14, 25, 33-36. The few studies in which the SC lateral and lamellar organization 
of some HSEs have been examined were performed more than a decade ago. 
These studies mostly showed a predominantly hexagonal packing 34, 37 in HSEs and 
the presence of the LPP 33, 35, 37. However, not all models showed a continuous 
presence of lipid lamellae in the SC or the presence of the LPP 14.  
In this study we evaluated the barrier properties of two recently developed HSEs - 
the fibroblasts derived matrix model (FDM) and the Leiden Epidermal Model 
(LEM) and compared their barrier properties, which have not been investigated 
before, with the Full Thickness collagen Model (FTM). The FDM model consists 
of a dermal compartment based on a human fibroblast-derived matrix 38, while the 
dermal equivalent of FTM consists of rat-tail collagen populated with fibroblasts 39. 
The LEM is an epidermal equivalent generated on an inert filter. To evaluate to 
which extent these three HSEs mimic the barrier properties of native human skin 
and to assess their suitability for e.g. permeability testing, we have examined their 
SC lipid composition, lipid organization and permeability and compared that with 




Figure 1. A: The SC lipids are organized into lipid layers (i.e. lamellae) stacked on top of 
each other, referred to as the lamellar phase. The most important parameter to 
characterize this phase is the repeat distance (d). This is distance over which the 
molecular structure is repeated. In native human SC the lipids are organized into two 
lamellar phases, the long periodicity phase (LPP) and the short periodicity phase (SPP) 
with repeat distances of around 13 and 6 nm, respectively. In the plane perpendicular to  




the direction of the lamellar repeats the lipid organization is referred to as the lateral 
packing. The lateral packing is liquid, hexagonal or orthorhombic. The liquid packing is 
the least dense packing, while the orthorhombic packing has the highest density of lipids. 
B: Due to atom bond vibrations, molecules absorb infrared light at characteristic 
wavenumbers.  This absorption provides information about inter- and intramolecular 
interactions. The CH2 rocking vibration of the hydrocarbon chains provides information 
about the lateral packing of the lipids. A single contour at around 719 cm-1 is observed 
when lipids are arranged in a hexagonal packing, while two peaks (around 719 and 730 
cm-1) are characteristic for an orthorhombic packing. C: X-rays that pass a sample are 
scattered by the sample, resulting in a characteristic diffraction pattern. The scattered 
intensity is plotted as a function of q, the scattering vector. q is defined as 4sin/, in 
which  is the scattering angle and  is the wavelength of the X-rays. In case of a lamellar 
phase the diffraction peaks in the pattern are all at the same interpeak distance. The 
position of the peaks (q1, q2, q3,…,qn, n being the order of the peak) are related to the 
repeat distance of a lamellar phase by d=2n/qn. As this is a reciprocal relationship, the 





MATERIALS AND METHODS 
Cell culture 
Normal human keratinocytes (NHKs) and human dermal fibroblasts were 
obtained from adult donors undergoing mammary or abdomen surgery and were 
established as described previously 39. NHKs used to create HSEs with only an 
epidermal compartment were generated with the Dermalife K medium complete 
kit (Lifeline Cell Technology, Walkersville, MD). The NHKs were grown to a 
maximum confluency of 80% before trypsin digestion. First and second passage 
NHKs were used to generate HSEs.  
 
Dermal equivalents 
Collagen-type I containing dermal equivalents: collagen-type I containing dermal 
equivalents were generated as described earlier 39.  Collagen was isolated from rat 
tails and dissolved in 0.1% acetic acid to a concentration of 4 mg/mL. This 
solution was mixed at 4ºC with Hank’s Buffered Salt Solution (HBSS) (Invitrogen, 
Leek, The Netherlands), 0.1% acetic acid, 1M NaOH and fetal bovine serum (FBS) 
(Hyclone, Logan, UT) to obtain a final collagen concentration of 1 mg/mL. One 
mL of the mixture was pipetted into a filter insert (Corning transwell cell culture 
inserts, membrane diameter 24 mm, pore size 3 μm, Corning Life Sciences, 
Amsterdam, The Netherlands) and was allowed to polymerize for 15 minutes at 
37ºC. Hereafter, a 2 mg/mL collagen solution was prepared at 4ºC with the 4 
mg/mL collagen stock solution, HBSS, 0.1% acetic acid, 1M NaOH and a 
fibroblasts containing FBS solution (final fibroblast cell density of 0.4x105 
cells/mL collagen solution). Three mL of this mixture was pipetted onto the 
previously polymerized collagen layer. The new collagen layer was placed at 37ºC 
to polymerize. After the final polymerization step the dermal equivalents were 
placed in a 6-well deep-well plate (Organogensis, Canton, MA) and submerged in 
medium consisting of Dulbecco’s Modified Eagle Medium (DMEM; Invitrogen, 
Leek, The Netherlands), 5% FBS, 1% penicillin/streptomycin (Sigma) and fresh 




supplementation with 45 mM vitamin C (Sigma). The medium was refreshed twice 
a week.  
Fully human dermal equivalents: the dermal compartment of the FDMs were generated 
as described before 38. Briefly, 0.4x106 fibroblasts were seeded onto filter inserts 
(Corning Transwell culture inserts, membrane diameter 24 mm, pore size 0.4 μm; 
Corning Life Sciences, Amsterdam, The Netherlands). The fibroblasts were 
nourished with the medium described for the collagen type I containing dermal 
equivalents for 3 weeks, during which the cells generated a dermal matrix. The 
medium was refreshed twice a week.  
 
Generation of human skin equivalents (HSEs) 
HSEs generated on collagen dermal equivalents referred to as Full Thickness collagen Model 
(FTM): One week after generation of the collagen dermal equivalents, 0.5x106 
NHKs were seeded onto each dermal equivalent. The HSEs were kept submerged 
for 2 or 3 days with a 3:1 mixture of DMEM and Ham’s F12 medium 
supplemented with 5% FBS, 1% penicillin/streptomycin solution, 0.5 μM 
hydrocortisone, 1 μM isoproterenol and 0.5 μg/mL insulin. Hereafter, the HSEs 
were kept submerged for an additional 2 days with medium in which the FBS was 
reduced to 1% and the medium was additionally supplemented with 0.053 μM 
selenious acid (Johnson Matthey, Maastricht, The Netherlands), 10 mM L-serine 
(Sigma), 10 μM L-carnitine (Sigma), 1 μM -tocopherol acetate (Sigma), 25 mM 
vitamin C and a lipid mixture of 3.5 μM arachidonic acid (Sigma), 30 μM linoleic 
acid (Sigma) and 25 μM palmitic acid (Sigma). This medium is referred to as K1-
medium. The HSEs were subsequently lifted to the air-liquid interface. For the 
remaining culture period the HSEs were fed with a medium similar to K1-medium 
except that the FBS was omitted and the arachidonic acid concentration was 
increased to 7 μM. The culture medium was refreshed twice a week. The HSEs 





HSEs generated on fully human dermal equivalents referred to as Fibroblast Derived matrix 
Model (FDM): three weeks after seeding fibroblasts onto filter inserts, 0.5x106 
NHKs were seeded onto each dermal equivalent. The HSEs were further cultured 
as described for the FTMs. 
HSEs generated on inert filter, referred to as Leiden Epidermal Model (LEM): LEM was 
generated with minor modifications of the culture conditions described by El 
Ghalbzouri et al. 7. NHKs (0.2 x 106 cells/filter) were seeded directly onto cell 
culture inserts (Corning Transwell cell culture inserts, membrane diameter 12  mm, 
pore size 0.4 μm; Corning Life Sciences, Amsterdam, The Netherlands) and were 
kept submerged in Dermalife medium until confluency. Hereafter the HSEs were 
kept submerged in CnT medium (CellnTec, Bern, Switzerland), which was 
supplemented according to the manufacturer’s protocol, and 1% 
penicillin/streptomycin solution (Sigma, Zwijdrecht, The Netherlands), 1 μM -
tocopherol acetate (Sigma), 25 mM vitamin C (Sigma) and a lipid mixture of 7 μM 
arachidonic acid (Sigma), 30 μM linoleic acid (Sigma) and 25 μM palmitic acid 
(Sigma). After two days the HSEs were lifted to the air-liquid interface. The LEMs 
were culured at the air-liquid interface for 12 days before harvesting. 
 
Morphology and immunohistochemistry 
Harvested HSEs were fixed in 4% (w/v) paraformaldehyde (Lommerse Pharma, 
Oss, The Netherlands), dehydrated and subsequently embedded in paraffin. 5 μm 
sections were cut, deparaffinized, rehydrated and stained with haematoxylin and 
eosin for analysis by light microscopy. Immunohistochemical staining of keratin 
10, keratin 16, filaggrin, loricrin and involucrin was performed on paraffin sections 
as described before 39, 40. Immunofluorescent staining of aquaporin 3 (Santa Cruz 
Biotechnology, Santa Cruz, CA) was performed on frozen sections that were fixed 
in acetone. The aquaporin 3 antibody (1:50 dilution) was applied for 60 min 
followed by incubation with donkey anti-goat FITC-labelled secondary antibody 
(1:100 dilution) (Jackson ImmunoResearch Europe, Suffolk, UK) for 60 min. 




Sections were enclosed with Vectashield mounting medium with DAPI (Vector 
Laboratories, Peterborough, UK).  
 
Stratum corneum isolation and diffusion study  
The SC of HSEs and human skin was isolated as described by De Jager et al. 41. 
The diffusion study with benzocaine and further analysis with HPLC, to 
deteremine the flux of benzocaine through each SC sample, was performed as 
described earlier 41 with modification of the mobile phase to methanol:water (50:50 
v/v). The diffusion study was performed with at least 4 SC sheets from each HSE 
type or human skin.  
 
Lipid extraction and analysis 
SC samples were consecutively extracted according to a modified Bligh and Dyer 
procedure with the addition of 0.25M KCl to extract polar lipids as described 
before 40, 42. The extracted lipids were analyzed by means of one-dimensional high 
performance thin layer chromatography (HPTLC) as described before 40. The 
ceramides are named according to the nomenclature defined by Motta et al. 43 and 
Masukawa et al. 44. Briefly, ceramides with a sphingosine (S), phytosphingosine (P) 
or 6-hydroxysphingosine (H) are linked via an amide to a fatty acid chain, which 
can either be an estrified -hydroxy (EO), -hydroxy (A) or non-hydroxy (N) fatty 
acid. 
 
Fourier transform infrared spectroscopy (FTIR) and small angle x-ray 
diffraction (SAXD) 
The SC samples for FTIR and SAXD measurements were hydrated at room 
temperature for 24 hours over a 27% (w/v) NaBr solution. The hydrated SC 
samples for FTIR were measured as described before 45. The phase transitions of 





0ºC to 90ºC with a heating rate of 1ºC/4 min. At least 3 SC sheets of each HSE 
type or human SC were measured.   
SAXD measurements were performed at the European Synchrotron Radiation 
Facility (ESRF) in Grenoble as described before 45. SC samples were clamped in 
specially designed holders and measured at room temperature for 10 minutes. The 
scattered intensity was measured as function of q. q is defined as q= 4sin/, in 
which  is the wavelength of the X-rays and  the scattering angle. Repeat distances 
of lamellar phases are calculated from the peak positions; d= 2n/qn, in which n is 
the order of the peak and qn its position. At least 2 samples of each HSE type or 
human SC were measured.  A schematic overview of the FTIR and SAXD 
measurements is depicted in figure 1B and C, respectively. 
 
Transmission electron microscopy (TEM) 
HSEs were fixed in 2% paraformaldehyde-2.5% glutaraldehyde in 0.1M sodium 
cacodylate buffer (pH 7.4) followed by a first post-fixation in 1% osmium tetroxide 
in cacodylate buffer and a second post-fixation in 0.5% ruthenium tetroxide. 
Hereafter the samples were dehydrated in 70% ethanol and subsequently  
processed in a series of 70% ethanol/epoxy resin LX112 (LADD Research 
Industries, Williston, VT) dilutions and finally in 100% epoxy resin. Ultrathin 
sections were stained with uranyl-acetate and lead hydroxide and visualized with a 
Fei Tecnai 12 Twin (Spirit) (Fei Europa, Eindhoven, The Netherlands) electron 
microscope. At least 2 cultures per HSE type were examined and at least 20 images 




Figure 2. Haematoxylin and eosin (HE) and immunohistochemical staining of the 
expression pattern of keratin 10, keratin 16, filaggrin, loricrin, involucrin and aquaporin 3 
(green pattern in the image) in FDM, LEM, FTM and native human skin are shown. 
Scale bar represents 50 μm. 





The morphology and differentiation process show similarities between 
HSEs and native human skin 
FDM, LEM and FTM show a fairly similar morphology and expression of the 
investigated differentiation markers, except for two markers which are indicative of 
an activated epithelium, when compared to human skin (figure 2). All HSEs show 
the presence of all epidermal strata, including a SC. The keratinocytes become flat 
and elongated as they migrate and differentiate from the basal layer towards the 
upper spinous and granular layer. In the latter layer keratohyalin granules can be 
detected. Occasionally the stratum granulosum in the LEM consisted of more cell 
layers than observed for the FDM, FTM and human skin. Furthermore, all HSEs 
show similar expression of the early differentiation marker keratin 10, the 
water/glycerol transporting channel aquaporin 3 and the two terminal 
differentiation markers filaggrin and loricrin as human skin (figure 2). Filaggrin and 
loricrin are only detected in the stratum granulosum, while keratin 10 is detected in 
the suprabasal layers and aquaporin 3 in the cell membranes of all cells in the 
viable epidermis. In native human skin involucrin expression is confined to the 
granular layer and keratin 16 expression is absent. In all HSEs however, involucrin 
and keratin 16 are expressed throughout the suprabasal layers of the viable 






The SC of the HSEs contains all barrier lipid classes that are present in 
human skin 
The three lipid classes present in human SC, namely cholesterol, free fatty acids 
and ceramides, are also present in the SC of the HSEs (figure 3). In addition, the 
HSEs show the presence of all ceramide subclasses that are present in native 
human SC. However, some differences can be noticed in the relative abundance of 
free fatty acids and ceramides when the different lipid profiles are compared. The 
FDM and LEM exhibit a relatively lower level of free fatty acids compared to 
human SC. However, the lipid profile of the FTM indicates that in this model the 
free fatty acid level is higher than in the LEM and FDM and appears to be 
comparable to native human SC. Furthermore, all HSEs seem to have a higher 
relative content of ceramides EOS and EOP. The LEM and FTM have an 
additional ceramide subclass, with a retention factor between that of ceramide NP 













Figure 3. The SC barrier lipid profile of each HSE and human SC are shown. The HSEs 
contain all lipid classes that are also present in human SC, namely cholesterol (CHOL), 
free fatty acids (FFA) and ceramides. The FTM and LEM show the presence of an 
additional ceramide subclass (*) that is not detected in human SC or the FDM.  
 




Permeability assessment of HSEs and native human skin 
To investigate the barrier function of the HSEs a diffusion study was performed. 
Figure 4 shows the diffusion profile of benzocaine through the SC of the three 
HSEs and native human skin. These results show that the FDM and LEM have an 
improved barrier function compared to FTM. The calculated steady-state flux 
(figure 4) indicates that the SC of the FDM and LEM is approximately 3 times 
more permeable than native human SC, whereas the SC of FTM is about 5 times 
more permeable. The lag-time of the benzocaine flux through the SC of the FDM 












Figure 4. Benzocaine was used as a model drug to investigate the permeability of the 
three HSEs and human SC. The data represent the mean and standard deviation of at 
least 4 measurements. The estimated steady-state flux (Fluxss) and lag-time (Tlag) of 











The lateral packing in the SC of the three HSEs differs from human SC 
 The lateral packing in the SC of the three HSEs and human skin were examined 
using FTIR. The lateral packing can be determined by monitoring the rocking 
bands in an FTIR spectrum. When lipids are in a crystalline orthorhombic packing 
the CH2 rocking band consists of two vibrations at 719 cm-1 and 730 cm-1, while a 
crystalline hexagonal lateral packing results in a single vibration at 719 cm-1. An 
example of the thermotropic response of the CH2 rocking band as a function of 
temperature in the FDM, LEM, FTM and native human SC are shown in figure 5. 
In general the HSEs show a strong peak at 719 cm-1 and a smaller peak at 730 cm-1 
at lower temperatures. This indicates that in that temperature region the lipids in 
the SC mainly form a hexagonal lateral packing and a small population of lipids 
forms an orthorhombic packing. In human SC the high intensity of the 730 cm-1 
peak indicates an abundant formation of the orthorhombic lateral packing. The 
temperature at which the orthorhombic packing transforms into the hexagonal 
packing, indicated by the disappearance of the 730 cm-1 peak, varies between each 
HSE type and also between samples of the same HSE type and native human skin.  
 
Figure 5. Examples of the lateral lipid organization as a funtion of temperature are 
shown for the FDM, LEM, FTM and native human SC (HSC) (a, b, c and d, 
respectively). At lower temperatures the lipids in the FDM, LEM and FTM mainly form a 
hexagonal lateral packing (strong vibrations at 719 cm-1) and a minor population of lipids 
forms an orthorhombic packing (weak vibrations at 730 cm-1). The transition to a 
hexagonal packing, indicated by the disappearance of the 730 cm-1 peak, occurs at 
approximately 24ºC, 30ºC and 26ºC in the FDM, LEM and FTM, respectively. In human 
SC (d) a doublet is observed with a high intensity peak at 730 cm-1 , representing a 
dominant orthorhombic packing. The orthorhombic packing disappears between 28ºC to 
40ºC.  At higher temperatures only a singlet is observed signifying a hexagonal packing. 
Figure e shows the transition from a hexagonal to a liquid phase detected by the 
symmetric stretching vibrations. The liquid phase is formed between 56-84ºC in the 
HSEs and between 66-86ºC in human SC.  










In FDM the orthorhombic packing disappears at a temperature that varies between 
8-24ºC, in FTM between 14-26ºC, in LEM between 24-30ºC and in native human 
SC between 40-50ºC. At which temperature the lipids finally form a liquid phase 
can be determined from the CH2 symmetric stretching mode, which provides 
information about the conformational disorder. In a crystalline phase (hexagonal 
or orthorhombic packing) the conformational disorder is low resulting in 
symmetric stretching frequencies below 2850 cm-1. In a liquid phase, the 
conformational disordering is high resulting in symmetric stretching vibrations of 
around 2852-2854 cm-1. The transition from a crystalline to a conformational 
disordered liquid phase can therefore be distinguished by a steep increase in 
wavenumber. In human SC the CH2 symmetric stretching is around 2848.5 cm-1 at 
0ºC and increases slightly when the temperature is raised. Between 30-40ºC there is 
a steeper shift, indicating the orthorhombic to hexagonal phase transition. A 
further increase to 66ºC results in a gradual shift in wavenumber. At 66ºC a steep 
shift is noticed from 2850.9 cm-1 to 2854.0 cm-1 at 86ºC, which corresponds to the 
formation of a liquid phase (figure 5e). When focussing on the HSEs, between 0ºC 
and 56ºC a gradual increase in wavenumber from around 2849.5 to 2850.4 cm-1 is 
observed. The symmetric stretching is located at higher wavenumbers than 
observed for native human SC. Above 56ºC a steep increase in wavenumber is 
observed to 2853.2 – 2853.6 cm-1 at 82-84ºC (figure 5e) demonstrating the 
formation of the liquid phase. The liquid phase is formed at a lower temperature in 
the SC of the HSEs compared to human SC.  
 
The SC intercellular lipid regions of HSEs are composed of more lipid 
lamellae than native human skin  
Transmission electron microscopy images taken at the stratum garnulosum/SC 
interface show the lamellar body extrusion process in the HSEs similarly as 
observed in native human skin (figure 6a, c, e and g). The extruded lipids are neatly 
arranged into lipid lamellae (figure 6b, d, f and h), which is characteristic for the SC 




lipid organization. When compared to human SC it is evident that the HSEs 
contain a higher number of lipid lamellae between corneocytes. This finding 
indicates that the intercellular lipid regions in the SC of the HSEs are more 
pronounced than in human SC. 
 
Figure 6. The lipid lamellae in the SC of the three HSEs and human skin were visualized 
with TEM.  Representative images of each HSE and human SC are shown. Figure a, c, e 
and g represent the lamellar extrusion process in FDM, LEM, FTM and native human 
skin, respectively (scale bar represents 100 nm). Figure b, d, f and h show the formed 
lipid lamellae in the SC of FDM, LEM, FTM and native human skin, respectively (scale 
bar represent 50 nm). *= lamellar body. 
 
The SC lipids in HSEs form the LPP similar to native human skin  
The observed lamellar organization in the SC of the three HSEs and native human 
skin (figure 6) was also investigated by SAXD. The SAXD profiles of all three 
HSEs show the presence of three sharp diffraction peaks (figure 7; referred to as 1, 
2 and 3) that can be attributed to the LPP with a corresponding repeat distance 
varying between 11.8 - 12.6 nm, 12.6 - 12.8 nm and 11.6 - 12.5 nm for the FDM, 





attributed to the SPP. The presence of crystalline cholesterol can also be detected 














Figure 7. A representative SAXD profile of each HSE type is shown. The 1st, 2nd and 3rd 
order diffraction peaks of the LPP (indicated by 1, 2 and 3, respectively) are located at q= 
0.50, q= 1.01 and q= 1.48 nm-1 for the FDM, corresponding to a repeat distance of 12.6 
nm. For the LEM the various orders of the LPP are located at q= 0.50, q= 1.00 and q= 
1.46 nm-1, indicating a repeat distance of 12.7 nm. For the FTM the various orders of the 
LPP are located at q= 0.52, q= 1.01 and q= 1.59 nm-1, which corresponds to a repeat 
distance of 11.7 nm. At q= 1.84 nm-1 a reflection is detected in all profiles demonstrating 
the presence of phase separated crystalline cholesterol (indicated by *).  
 
DISCUSSION 
In order to obtain a suitable replacement of native human skin for penetration 
studies or for safety testing of compounds, we compared two novel in-house skin 
models with FTM and native human skin and evaluated their SC barrier properties. 
An overview of the SC barrier properties of the three HSEs and human skin is 
provided in table 1. Both FDM and LEM show an improved SC barrier function 
compared to FTM, indicated by the higher flux of benzocaine through the SC of 




FTM. Although the SC barrier function of the novel HSEs has improved and 
mimics more closely the SC barrier function of native human skin, it is still reduced 
compared to native human skin. A reduced SC barrier function has also been 
reported for other HSE types, including the commercially available models 
Epiderm (Mattek), Episkin and SkinEthic 25-32. As the lipid organization is a crucial 
determinant for the SC barrier function, we examined the lamellar phases and the 
lateral packing in all three HSEs and compared that to native human SC. 
 













Native HS LPP + SPP Orthorhombic CHOL, FFA, CERs 13.6 ± 3.5
FDM LPP Hexagonal 
CHOL, FFA 	, 
CERs EOS and 
EOP 
 
44.5 ± 4.6 
LEM LPP Hexagonal 
CHOL, FFA 	, 
CERs EOS and 
EOP 
 
47.0 ± 5.8 
FTM LPP Hexagonal 
CHOL, FFA, CERs 
EOS and EOP 
 
65.8 ± 4.0 
An overview of the SC barrier properties of native human skin (HS) and SC of FDM, 
LEM and FTM are shown. RT = room temperature, CHOL= cholesterol, FFA= free 
fatty acid, CER= ceramides, Fluxss= steady state flux, arrows indicate an increase (
) or 
decrease (	) compared to native human SC.  
 
Morphology and expression of differentiation markers 
All three HSEs show a similar morphology and expression of several 
differentiation markers as native human skin, except for the expression of 
involucrin and keratin 16, which were detected throughout the suprabasal viable 





start of the terminal differentiation program indicated by the premature expression 
of involucrin might be explained by an over-activated cell differentiation due to 
compounds or possible growth factors present in the commercial culture media, or 
by the number of fibroblasts present in the dermal matrices 15, 16. The over-
activated differentiation programme observed in the HSEs may have an effect on 
the barrier properties of the HSEs. An altered expression of differentiation 
markers has also been observed in the commercially available models 12. These 
models showed a fully differentiated epidermis and an expression pattern for 
keratin 10 and loricrin that is mainly similar to native human skin. However, all 
commercial skin models showed a premature expression of involucrin compared 
to native human skin, indicating that homeostasis was not yet achieved in these 
models. Cheng et al. 46 and El Ghalbzouri et al.13 showed that it is possible to 
generate HSEs that do not demonstrate the premature expression of involucrin 
and/or the presence of activation associated markers like keratin 6, 16 and 17. 
However, it still remains to be investigated whether a normalized involucrin 
expression or the absence of activation associated markers lead to improved SC 
barrier properties. Previous studies have shown that the SC of FTM is less 
hydrated than human SC 39. The similar expression of the water/glycerol 
transporting channel aquaporin 3 in the HSEs and native human skin indicates that 
the reduced SC hydration in FTM is not caused by the absence of aquaporin 3.  
 
Lamellar organization   
Our results demonstrate that in all three HSEs the LPP is formed, similar to native 
human skin 21, while there is no indication of the formation of the SPP. The latter 
is present in native human SC. Previous studies demonstrated that the presence of 
acylceramides, such as acylceramides EOS and EOP, induce the formation of the 
LPP 22. These ceramides are present in relatively higher amounts in the HSEs 
compared to native human skin and therefore may account for the abundant 
presence of the LPP. However, this most probably does not contribute to the 




reduced skin barrier function of the HSEs, as the LPP plays a more prominent role 
in the skin barrier function than the SPP 41. In 2000 Ponec et al.14  reported the 
lamellar organization of the EpiSkin and EpiDerm penetration models. In the 
EpiDerm model an LPP with a repeat distance of 12 nm was clearly detected, 
while the EpiSkin model showed signs of a poor lamellar organization. Although 
both the EpiDerm and Episkin models had approximately the same relative 
amount of ceramide EOS as native human skin, ceramides EOP, AS, AP and AH 
were minimally present or even absent 6, 14.  
When we examine the EM images, the SC of the HSEs seem to contain a larger 
number of lipid lamellae than observed for human SC. The sharp peaks observed 
in the SAXD profiles clearly indicate that the mean number of lipid lamellae 
between the cells is increased in the SC of the HSEs compared to native human 
SC;  the width of half maximum is proportional to 1/N, in which N is the number 
of lamellae in a stack 47. Since the penetration of substances through the SC mainly 
proceeds via the lipid domains we hypothesize that the increased number of lipid 
layers in the HSEs form wider intercellular ‘channels’ for compound penetration, 
which may attribute to the impaired skin barrier function of the HSEs. The SC 
intercellular lipid domains of the commercially available skin models have also 
been examined by EM 14. All models showed the presence of  lipid lamellae, 
however, this was not continuously observed throughout the SC in all models. 




When focussing on the lateral packing, HSEs have a hexagonal packing rather than 
an orthorhombic packing that is present in native human SC. Previous studies 18 
have shown that long-chain free fatty acids (e.g. free fatty acids with a chain length 
of 24 or 26 carbon atoms), promote the formation of an orthorhombic packing in 





formation of the hexagonal packing. These findings suggest that a reduced free 
fatty acid content in the FDM and LEM may contribute to the absence of an 
orthorhombic packing. The free fatty acid level in FTM mimics the free fatty acid 
content of human SC more closely, but nonetheless the lipids also form a 
hexagonal packing. Therefore other factors also play a role, such as a possible 
reduction in the chain length of the free fatty acids or the presence of unsaturated 
fatty acids. Based on previous studies, both of these aberrations are expected to 
reduce the formation of the orthorhombic packing 48. To gain more insight in this 
phenomenon the free fatty acid chain length distribution and degree of saturation 
in the HSEs will be subject of future studies. Whether the hexagonal packing 
contributes to the increased permeability for substances like benzocaine is not yet 
clear. Although the hexagonal packing is less dense than the orthorhombic 
packing, very recently no difference in the benzoic acid permeability was observed 
between SC lipid membranes forming either a hexagonal packing or an 
orthorhombic packing 49.  
 
Formation of a liquid phase 
The higher degree of conformational disorder observed for the HSEs at 32ºC, 
which is the normal skin temperature, suggests an increased proportion of gauche 
conformations in the alkyl chains of the fatty acids or ceramides in the SC of HSEs 
compared to human SC. This may signify that relatively more lipids may already be 
in the liquid phase at 32ºC compared to lipids in the SC of native human skin. This 
may render the HSEs more permeable.   
When examining the transition from a hexagonal to a liquid phase, this transition 
occurs at a lower temperature in the investigated HSEs compared to human SC. 
Previous studies show that a reduced free fatty acid content cannot explain this 
phenomenon, since a reduction in the free fatty acid level increases the 
temperature at which a liquid phase is formed 50. However, a reduced chain length 




of the free fatty acids or the presence of unsaturated chains may contribute to the 
decrease in transition temperature 48. 
 
Optimization of the barrier properties of HSEs 
The presented results show that the increased permeability of the investigated 
HSEs is likely caused by an increased conformational disordering of the lipids 
compared to the lipids in human SC. Furthermore, we hypothesize that a higher 
number of lipid lamellae between the cells may also reduce the SC barrier function. 
Whether the pronounced hexagonal packing also plays a role is not clear yet, but 
will be subject of future research. The change in lipid profile compared to native 
human SC indicates that the lipid metabolism in these HSEs differs from native 
human skin. Each HSE is generated under the same incubator conditions, but still 
shows (slight) differences in their lipid composition. Additionally, our in-house 
HSEs have an improved SC lipid composition and lamellar organization compared 
to the commercially available HSEs studied so far 14. Taken together this implies 
that factors such as substrates used for HSE generation, culture media or other 
culture conditions can have an influence on the lipid metabolism in the viable 
epidermis resulting in changes in the SC barrier properties. Over the past years 
modulation of e.g. culture media or culture environment have improved epidermal 
development and consequently the lipid profiles and SC barrier formation of HSEs 
15, 25, 35, 51. Ponec et al. 35 showed that addition of vitamin C to the culture medium 
improved the lamellar body formation, extrusion and thus the intercellular lipid 
lamellae formation. The epidermal lipid metabolism was altered and resulted in an 
increased amount of ceramides AS and AP and detection of ceramide AH in the 
SC. Further optimization of culture media and culture conditions may lead to 
further improvements in the epidermal lipid metabolism in HSEs, such as an 
increase in the free fatty acid synthesis to induce the orthorhombic packing. 
Additionally, improvements made in the culture conditions may also enhance 





Further optimization of the SC barrier properties of the presented HSEs, to 
resemble the SC barrier properties of native human skin more closely, will be 
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Human skin equivalents (HSEs) mimic human skin closely, but show differences in 
their stratum corneum (SC) lipid properties. The aim of this study was to determine 
whether isolation of primary cells, which is needed to generate HSEs, influences 
the SC lipid properties of HSEs. For this purpose we expanded explants of intact 
full thickness human skin and isolated epidermal sheets in vitro. We investigated 
whether their outgrowths maintain barrier properties of human skin. The results 
reveal that the outgrowths and human skin have a similar morphology and 
expression of several differentiation markers, except for an increased expression of 
keratin 16 and involucrin. The outgrowths show a decreased SC fatty acid content 
compared to human skin. Additionally, SC lipids of the outgrowths have a 
predominantly hexagonal packing, whereas human skin has the dense 
orthorhombic packing. Furthermore, the outgrowths have lipid lamellae with a 
slightly reduced periodicity compared to human skin. These results demonstrate 
that the outgrowths do not maintain all properties observed in human skin, 
indicating that changes in properties of HSEs are not caused by isolation of 


















The stratum corneum (SC) is the outermost layer of the epidermis and consists of 
dead cells which are embedded in a lipid matrix. This lipid matrix plays a crucial 
role in the skin permeability barrier. Native human SC contains three main lipid 
classes which are cholesterol, free fatty acids and ceramides. In human SC the lipids 
form two lamellar phases with a repeat distance of approximately 13 nm and 6 nm, 
referred to as the long periodicity phase (LPP) and short periodicity phase (SPP), 
respectively 1-4. The lipid organization within the lipid lamellae is referred to as the 
lateral lipid packing. In native human SC the lipids are mainly arranged in a dense 
orthorhombic packing 2, 5-7. A schematic representation of the lipid organization in 
native human SC is provided in figure 1.  
We have previously demonstrated that three different in-house human skin 
equivalents (HSEs) showed an increased permeability for benzocaine, even though 
they showed a comparable morphology and protein expression as native human 
skin 8. To understand why these HSEs showed an increased permeability for 
benzocaine, the SC lipid properties of each HSE was investigated thoroughly. We 
found that two of the HSEs had a reduced free fatty acid content. Furthermore, all 
HSEs showed the presence of the LPP, but had a hexagonal lateral packing rather 
than the orthorhombic packing that is observed in human skin. In the present 
study we determined whether the observed differences in SC lipid properties 
between the HSEs and native human skin are caused by cell isolation procedures. 
In order to engineer HSEs primary cells of fibroblasts and keratinocytes are 
isolated from human skin by enzymes. These cells are cultured and subsequently 
used to generate HSEs. This procedure may disable the isolated cells to form a 
proper SC barrier that is found in vivo. We used full thickness (FT) human skin 
explants and human epidermal sheet (ES) explants and expanded them in vitro.  In 
the FT explants the native tissue is left intact, whereas ES explants are obtained by 
enzymatic separation of the epidermis from the dermis. These skin cultures were 





house HSEs. The SC lipid properties of the FT explants, ES explants and the 
outgrowths that developed from these explants were evaluated to determine 
whether tissue dissociation is responsible for the altered SC lipid properties of 
HSEs.  
 
Figure 1. Human SC lipids are organized into lipid lamellae parallel to the skin surface. 
The repeat distance (d) is the distance over which the molecular structure is repeated. 
Native human SC lipids are arranged into two lamellar phases, the long periodicity phase 
(LPP) and the short periodicity phase (SPP), with repeat distances of around 13 and 6 nm, 
respectively. The lateral packing discloses information about the density of the lipids 
within the lipid lamellae. The liquid packing is the least dense packing, while the 
orthorhombic lateral packing has the highest density of lipids. In native human SC the 
lipids are mostly arranged in the orthorhombic packing.  
 
 
MATERIALS AND METHODS  
Generation of explant cultures 
Dermal equivalents consisting of fibroblast-populated collagen matrices were 
generated as described previously 8-10. Human skin used for the experiments was 
obtained from adults undergoing cosmetic mammary or abdomen surgery. The 
Declaration of Helsinki principles were followed when using human tissue.  




Full thickness cultures (FT explants): 4 mm fat free punch biopsies of full thickness 
(FT) skin were gently pushed into the dermal equivalents on the same day the 
dermal equivalents were prepared. The cultures were directly grown at the air-liquid 
interface and were nourished with a 3:1 mixture of DMEM (Invitrogen, Leek, The 
Netherlands) and Ham’s F12 (Invitrogen, Leek, The Netherlands) supplemented 
with 1% penicillin/streptomycin solution (Sigma), 0.5 μM hydrocortisone (Sigma), 
1 μM isoproterenol (Sigma), 0.5 μg/mL insulin (Sigma), 0.053 μM selenious acid 
(Johnson Matthey, Maastricht, The Netherlands), 10 mM L-serine (Sigma), 10 μM 
L-carnitine (Sigma), 1 μM -tocopherol acetate (Sigma), 25 mM vitamin C (Sigma) 
and a lipid mixture consisting of 7 μM arachidonic acid (Sigma), 30 μM linoleic acid 
(Sigma) and 25 μM palmitic acid (Sigma). The culture medium was refreshed twice 
a week. The cultures were grown for approximately 16 days at 37oC, 93% relative 
humidity and 8% CO2.  
Epidermal sheet cultures (ES explants): 4 mm punch biopsies of fat free full thickness 
human skin were incubated overnight at 4ºC in a dispase II solution (2.4 AU/mL; 
Roche, Almere, The Netherlands) to separate the epidermis from the dermis. The 
obtained epidermal sheets (ES) were placed on the dermal equivalents one day after 
preparation of the dermal equivalents. The ES explant cultures were fed with the 
same media and were generated under the same conditions as the FT explant 
cultures.  
 
Morphology and immunofluorescent staining 
Harvested cultures were formalin-fixed and embedded in paraffin. 5 μm sections 
were cut, deparaffinized and rehydrated in preparation for haematoxylin and eosin 
staining. For immunofluorescent staining frozen sections were fixed with acetone. 
The sections were incubated at room temperature with the first antibody and the 
secondary antibody for 60 minutes each. The sections were enclosed with DAPI-
Vectashield (Vector Laboratories, Peterborough, UK). The primary antibodies used 





(Neomarkers, Fremont, CA), filaggrin (1:75) (Neomarkers, Fremont, CA), 
involucrin (1:600) (Sanbio, Uden, The Netherlands), loricrin (1:400) (Covance, 
Princeton, NJ) and aquaporin 3 (1:50) (Santa Cruz Biotechnology, Santa Cruz, CA). 
The secondary antibodies used were Rhodamine conjugated bovine anti-mouse 
(Santa Cruz Biotechnology, Santa Cruz, CA), FITC conjugated donkey anti-goat 
(Jackson ImmunoResearch Europe, Suffolk, UK) and Texas Red conjugated 
chicken anti-rabbit (Santa Cruz Biotechnology, Santa Cruz, CA) in a 1:100 dilution. 
 
Counting stratum corneum layers 
HSEs were fixed in Tissue Tek O.C.T. compound (Sakura Finetek Europe, 
Zoeterwoude, The Netherlands) and frozen in liquid nitrogen. 5 μm sections were 
stained with a 1% (w/v) safranin (Sigma) solution for 1 minute followed by 20 
minutes incubation with a 2% (w/v) KOH solution to allow the corneocytes to 
swell. Images of the sections were taken with a digital camera (Carl Zeiss axioskop, 
Jena, Germany) connected to a microscope. The number of SC layers of at least 
three different explants and outgrowths were counted. The data represent the mean 
and standard deviation.  
 
Extraction and analysis of stratum corneum lipids 
SC of native human skin, epidermal sheets and SC of the outgrowths of the FT and 
ES explant cultures were isolated by overnight incubation with a 0.1% trypsin 
solution at 4ºC followed by incubation at 37ºC for 1 hour. The lipid extracts of 2-4 
outgrowth cultures from the same skin donor were pooled for lipid analysis. The 
SC lipid composition of the FT and ES explants could not be determined, because 
there was not enough material to extract. The extracted lipids were fractionated 
with high performance thin layer chromatography (HPTLC) using the solvent 
system described elsewhere 11. The extracted ceramides are named according to the 
nomenclature of Motta et al. 12 and Masukawa et al 13: ceramides with a sphingosine 
(S), phytosphingosine (P), 6-hydroxysphingosine (H) or dihydrosphingosine (dS) 




base are linked to an esterified -hydroxy (EO), -hydroxy (A) or non-hydroxy (N) 
fatty acid. 
 
Fourier transform infrared spectroscopy (FTIR) and small angle x-ray 
diffraction (SAXD) 
Isolated SC sheets were hydrated for 24 hours over a 27% NaBr solution 
(achieving a relative humidity level of 80%) at room temperature prior to the 
measurements. For FTIR measurements the hydrated SC sheets were sandwiched 
between AgBr windows and mounted into a specially designed heating/cooling cell. 
The IR spectra in the frequency range of 600-4000 cm-1 were obtained with a 
Varian 670-IR FTIR (Agilent Technologies, Santa Clara, CA) equipped with a 
mercury-cadmium-telluride detector. Each spectrum was collected for 4 minutes at 
a 1ºC interval within a temperature range of 0-90ºC. Each spectrum was acquired 
from the co-addition of 248 scans with a resolution of 1 cm-1. 
SAXD measurements were performed at the European Synchrotron Radiation 
Facility (ESRF) in Grenoble at station BM26B. The scattering intensity I (arbitrary 
units) was plotted against the scattering vector q (nm-1). The repeat distance of a 
lamellar phase was calculated from the position of the diffraction peaks as 
described earlier 8. At least 3 samples of the FT and ES explants, FT and ES 
outgrowths and human SC were examined with FTIR and SAXD. SAXD and 
FTIR data represent the mean and standard deviation. 
 
Visualization of lipid lamellae 
Approximately 1 mm2 of human skin, explants and outgrowths were fixed as 
described previously 8. Uranyl-acetate and lead hydroxide were used to stain 
ultrathin sections, which were visualized with a Fei Tecnai 12 Twin (Spirit) (Fei 
Europa, Eindhoven, The Netherlands) transmission electron microscope. At least 2 
samples of each explant type and their corresponding outgrowths were examined 






Explants and their outgrowths have a similar morphology as native human 
skin  
After 16 days of culturing, both FT and ES explants maintain a morphology that is 
comparable to native human skin (figure 2 and 3). The morphology of the 
outgrowths was investigated in two regions: 1) the centre of the outgrowth, which 
represents the main part of the outgrowth and 2) the periphery of the outgrowth. 
At the centre of the FT and ES outgrowths a completely stratified epidermis could 
be observed. Sometimes a SC was observed at the periphery of the outgrowths, 
while in other cultures a developing epidermis could be detected, indicated by the 
absence of a SC. No difference in morphology could be detected between the 
outgrowths of the FT and ES explants. Safranin red staining revealed that the FT 
and ES explants had a thicker SC than the majority of the outgrowth that 
developed from the explants (micrographs not shown). The FT and ES explants on 
average had 23.8 ± 2.8 and 32.7 ± 12.7 SC layers, while the centre of the FT and 
ES outgrowths had 11.0 ± 4.1 and 11.3 ± 1.5 SC layers, respectively. Native human 
skin has 11.4 ± 1.2 SC layers, which is similar to the number of SC layers observed 
















Figure 2. Haematoxylin and eosin (HE) and immunofluorescent stained sections 
showing aquaporin 3 (AQP3), filaggrin (FIL), loricrin (LOR), involucrin (INV), keratin 10 
(K10) and keratin 16 (K16) expression in the FT explant and different regions of its 
outgrowth. Dotted lines indicate the dermal-epidermal border and stratum granulosum-







Explants and their outgrowths show similar expression of differentiation 
markers 
The expression pattern of several differentiation markers was investigated to 
determine whether the differentiation process of the explants and their outgrowths 
differs from native human skin (figure 2 and 3). The FT explant and its outgrowth 
at the centre and periphery mostly showed similar expression of the water/glycerol 
transporting channel aquaporin 3, filaggrin, loricrin and keratin 10 as native human 
skin. In native human skin involucrin is expressed in the granular layer, whereas 
keratin 16 expression is absent. In the FT explant and its entire outgrowth, 
however, keratin 16 is expressed throughout the suprabasal layers and involucrin is 
expressed in the granular layer and in the upper spinous layers.  
The ES explant and the different regions of the outgrowth show a similar 
expression of most of the investigated differentiation markers. They show a 
suprabasal expression of involucrin and keratin 16, while expression of loricrin can 
be detected in the upper spinous layers and in the stratum granulosum. At the 
periphery of the outgrowth loricrin is expressed in the whole epidermis. In the ES 
outgrowth filaggrin expression is only detected in the stratum granulosum, while 
the ES explant also shows filaggrin expression in the upper spinous layers. The 
expression of aquaporin 3 and keratin 10 is similar between the ES explant, its 
outgrowth and native human skin. From these results it is evident that the FT 
outgrowths show a more normalized expression pattern of loricrin and involucrin 









Figure 3. Haematoxylin and eosin (HE) and immunofluorescent stained sections 
showing aquaporin 3 (AQP3), filaggrin (FIL), loricrin (LOR), involucrin (INV), keratin 10 
(K10) and keratin 16 (K16) expression in the ES explant, its outgrowth and native human 
skin. Dotted lines indicate the dermal-epidermal border and stratum granulosum-SC 
border. HE and immunofluorescent images 20x magnification. Scale bars represent 50 





The FT and ES outgrowths show the presence of all SC barrier lipid classes 
After examining the differentiation status of the outgrowths, we determined 
whether the outgrowths maintained the SC lipid properties as observed in native 
human skin. Therefore, we investigated the SC lipid composition of the outgrowths 
of the FT and ES explants. The FT and ES outgrowths have similar lipid profiles 
and contain all lipid classes that are present in native human skin, namely 
cholesterol, free fatty acids and ceramides (figure 4). However, the most apolar 
fragment of the free fatty acids appears to be present in a relatively lower quantity 
in both outgrowths compared to native human skin, while ceramides EOS and 
EOH are present in relatively higher quantities. Dispase treatment (used to obtain 
the ES explant) has no effect on the SC lipid profiles (figure 4).  
 
Figure 4. SC lipid profiles of native human skin obtained after trypsin digestion (lane 2), 
native human skin after dispase and trypsin digestion (lane 3), outgrowth of the FT 
explants (lane 4) and outgrowth of the ES explant (lane 5). The standards used to identify 
lipid classes are shown in lane 1. CHOL= cholesterol, FFA= free fatty acid, *= 









FT and ES outgrowths have a different lateral lipid organization compared 
to their respective explants 
The lateral lipid organization in the SC of the FT and ES explants, their outgrowths 
and native human skin was examined by measuring the thermotropic response of 
the CH2 rocking band in the FTIR spectrum (figure 5). An orthorhombic lipid 
packing can be recognized when the rocking bands consists of two peaks at 719 
and 730 cm-1, whereas a hexagonal lipid packing is characterized by a single peak at 
719 cm-1. Native human SC shows two strong peaks at 719 and 730 cm-1 at lower 
temperatures, indicating that the lipids mainly form an orthorhombic packing. 
Around 45.5ºC ± 4.4ºC a phase transition to a hexagonal packing, characterized by 
the presence of only a singlet at 719 cm-1, is observed. The FT and ES explants 
show two vibrations at 719 and 730 cm-1 until 32.7ºC ± 4.6ºC and 32.7ºC ± 6.4ºC, 
respectively. However the peak intensity at 730 cm-1 is weaker than observed for 
native human SC. This indicates that the fraction of lipids forming an 
orthorhombic packing is less than in native human SC. The FT and ES outgrowths 
mainly show a strong peak at 719 cm-1 and a very weak shoulder at 730 cm-1, which 
is only observed until a temperature of 11.0ºC ± 14.3ºC and 3.3 ± 5.8ºC, 
respectively. This indicates that the lipids are mainly organized in a hexagonal 
packing, but with the presence of some orthorhombic domains. This is different 
than observed for native human SC.  
To determine at which temperatures the lipid domains transform into a liquid 
phase the CH2 symmetric stretching frequency in the FTIR spectrum, which 
provides information about the conformational disorder, was investigated. When 
the SC lipids are organized in an ordered packing – the orthorhombic or hexagonal 
packing - the conformational disorder is low, reflected by CH2 symmetric 
stretching frequencies below 2850 cm-1. When the lipids are in a disordered packing 
- the liquid phase - the CH2 symmetric stretching frequencies increase to 2852 cm-1 





Figure 5. A, C, B and D: representative rocking vibrations in a temperature range from 0-
90ºC in FT and ES explants and their outgrowths. The rocking vibrations of human SC 
are shown figure E. An orthorhombic packing is recognized by two contours at 719 and 
730 cm-1, whereas a hexagonal packing is indicated by a single contour at 719 cm-1. * 
indicates the CH2 rocking contours at 719 and 730 cm-1. 
 




Figure 6. A: the CH2 symmetric stretching wavenumbers are plotted as function of the 
temperature. In this example the calculation is shown of the midpoint temperature of the 
order-disorder transition. WNmidpoint, WNstart and WNend indicate the wavenumber 
corresponding to the midpoint, start and end of the order-disorder transition, 
respectively. B: an example is shown of the CH2 symmetric stretching frequency as a 
function of temperature for an ES explant and its outgrowth. The higher symmetric 
stretching wavenumbers of the ES outgrowth compared to the explant illustrate that the 
ES outgrowth has an increased conformational disordering. Table: the  order-disorder 
midpoint temperatures and the symmetric stretching frequency at 32ºC, which 
corresponds to the in vivo skin temperature, are shown for the FT explants, ES explants, 
FT outgrowths, ES outgrowths and native human SC. Data represent the mean and 
standard deviation of at least 3 samples. 
 
midpoint temperature of this transition was determined for the FT and ES explants 
and their outgrowths and compared to native human skin. The table in figure 6 
shows that the midpoint temperature of the steep shift in CH2 symmetric stretching 
frequency of the order-disorder transition (an example profile is shown in figure 
6A) occurs at lower temperatures in both explants compared to native human skin. 





show that the FT and ES explants and their outgrowths do not retain the same SC 
lipid properties as native human skin. We also observed that at temperatures 
ranging from 0ºC until the order-disorder transition the symmetric stretching CH2 
frequency of the outgrowths is higher compared to that of their respective explants 
and native human SC (figure 6B). This is indicative of an increased conformational 
disordering in the SC of the outgrowths.  
 
FT and ES explants and their outgrowths show the presence of the LPP 
The lamellar organization is an important determinant in the skin barrier function 
and was therefore examined in the FT and ES explants and their outgrowths. The 
SAXD profiles of the explants and their outgrowths show the presence of three 
diffraction peaks (figure 7) indicating the presence of only the LPP in the SC. The 
average repeat distance of the LPP in the FT and ES explants are 12.3 ± 0.2 nm 
and 12.1 ± 0.3 nm. The outgrowths of the FT and ES explants have a LPP with a 
repeat distance of 12.3 ± 0.3 nm and 11.7 ± 0.4 nm, respectively. The diffraction 
profiles of the explants and outgrowths also show the presence of crystalline 
cholesterol similar to human SC. Occasionally an additional peak with a q-value 
around q= 0.78 nm-1 could be observed in the SAXD profiles of the explants or 
outgrowths, which might be assigned to phase separated acylceramides 14. In this 
and previous studies the diffraction profile of native human SC revealed the 
presence of both the SPP and the LPP (figure 7) 2. The repeat distance of the LPP 
in human SC is around 13 nm, as published previously 2.  
The lamellar lipid organization of the FT and ES explants and their outgrowths 
were visualized with transmission electron microscopy (figure 8). The FT and ES 
explants and their outgrowths show a similar lamellar body extrusion process at the 
stratum granulosum/SC interface as native human skin. The extruded lipids are 
subsequently neatly arranged into lipid lamellae. The lipid lamellae in the 
outgrowths are comparable to native human skin, but sometimes appear to have a 
higher number of intercellular lipid layers.   





Figure 7.  Example SAXD profiles of a FT and ES explant, their outgrowths and native 
human SC are shown. The first, second and third order diffraction peak of the LPP are 
indicated as 1, 2 and 3, respectively. Most probably the SPP (indicated by I) is also present 
in human SC, but the 1st order diffraction peak of the SPP is obscured by the 2nd order 
diffraction peak of the LPP. For this reason the repeat distance of the LPP or SPP in 
human SC cannot directly be calculated from the SAXD profile. The corresponding 
repeat distance of the LPP in the FT and ES explants and outgrowths of the FT and ES 
explants are 12.2 nm, 12.2 nm, 12.3 nm and 12.2 nm, respectively. The reflection 
indicated by * is attributed to phase separated crystalline cholesterol. The arrow head may 




















Figure 8. Figures a, c, e, g and i 
show the lamellar body extrusion 
process in the FT explant, FT 
outgrowth, ES explant, ES 
outgrowth and native human SC, 
respectively. Figures b, d, f, h and 
j show the arrangement of the 
extruded lipids in the SC in the 
FT explant, FT outgrowth, ES 
explant, ES outgrowth and native 
human SC, respectively. *= 
lamellar body. Figure a: scale bar 
represents 100 nm. Figures b, c, d, 
f, h, and j: scale bar represents 50 
nm. Figures e, g and i: scale bar 
represents 200 nm.  





The barrier properties of our previously investigated HSEs differ to some extent 
from native human skin 8. In this study we determined whether the differences 
between the in vitro and in vivo barrier properties are caused by the isolation of 
keratinocytes prior to the generation of HSEs. The elevated expression of 
involucrin and/or loricrin indicate that the explants and their outgrowth are not in 
homeostasis 15, 16. Additionally, the presence of keratin 16 in the explants and 
outgrowths indicates that the epidermis is in an activated state, since keratin 16 is 
only expressed in wounded or stressed skin 17-20. The difference in expression of the 
investigated differentiation markers occasionally observed at the periphery of the 
outgrowths is due to the still developing epidermis, causing activation of the 
keratinocytes 10, 21. The expression of keratin 16 and the premature expression of 
involucrin were also detected in our in-house HSEs 8.  
The results reveal that the outgrowths contain relatively less free fatty acids, but 
higher levels of ceramides EOS and EOH compared to native skin. The decreased 
free fatty acid level was also observed in two in-house HSEs, while the increase in 
ceramide EOS was observed in all three investigated HSEs 8. Examination of the 
lamellar lipid organization shows that in the FT and ES outgrowths the LPP is 
prominently present. Previous studies demonstrated that the formation of the LPP 
is promoted by increasing the level of acylceramides such as ceramide EOS 5. The 
relatively higher ceramide EOS and EOH content in the SC of the outgrowths is 
therefore expected to enable the outgrowths to form only the LPP, similar as in the 
previously investigated HSEs 8.  
The reduction of lipids forming an orthorhombic packing in the FT and ES 
outgrowths compared to their respective explants demonstrates that the 
outgrowths do not maintain the same lipid organization as the native tissue. The 
mainly hexagonal packing that is detected in the outgrowths may be caused by the 
reduced free fatty acid content as observed in previous studies 1. However, the 





crystalline to liquid phase transition and the increased symmetric stretching 
frequency at 32ºC.  Other factors, such as an increased presence of short-chain free 
fatty acids and/or unsaturated free fatty acids may play a role in the decreased 
order-disorder midpoint temperature. All these differences were also detected in 
the previously examined HSEs 8. Additionally, HSEs developed by other groups or 
commercially available models also have a reduced SC free fatty acid content, a 
mainly hexagonal packing and generally show the presence of the LPP 22-28. It 
should be noted that the SC lipid properties of commercially available models were 
investigated several years ago. The current status of their SC lipid properties is 
therefore not known.  
All our observations suggests that under the used culture conditions native human 
skin will not be able to form a SC with lipid properties similar to that observed in 
vivo. Moreover, the outgrowths that develop from human skin will mimic the lipid 
composition and organization of the previously investigated HSEs. This indicates 
that the SC lipid properties or epidermal morphogenesis of our in-house HSEs are 
not noticeably affected by the isolation procedure of primary cells, but are affected 
by the culture medium and/or environmental factors. This most probably also 
applies to other developed HSEs considering that they show some similar SC lipid 
properties as our in-house HSEs. The results of these studies therefore direct 
future research by offering the opportunity to further improve the culture medium 
and environmental factors to establish HSEs with improved epidermal homeostasis 
and SC barrier properties. The reduction in free fatty acid content and increase in 
acylceramide species in the FT and ES outgrowths and in HSEs demonstrate that 
the culture conditions lead to alterations in epidermal lipid metabolism. The altered 
lipid metabolism is also indicated by the presence of diacyl- and triacylglycerides in 
the SC of the HSEs and FT and ES outgrowths (data not shown). The specific 
cause for the different epidermal lipid metabolism remains to be established. 
However, it is known that peroxisome proliferator-activated receptors (PPARs) 
play a central role in the regulation of lipid homeostasis and differentiation in 




human keratinocytes. These PPARs are activated by endogenous fatty acids and 
their derivatives 29-32. Specifically polyunsaturated fatty acids such as arachidonic 
and linoleic acid are efficient activators of two PPAR isoforms, namely PPAR and 
PPAR/ 33. The level of linoleic acid, arachidonic acid and palmitic acid in the 
culture media may therefore lead to a change in the activation of the various PPAR 
isoforms and subsequent alterations in epidermal homeostasis and SC lipid 
properties. Optimization of the levels of these lipids is a focus of future research. 
The FT and ES explant cultures presented in this study may also serve as a model 
to study the wound healing process of the skin. These models can be used to 
determine the expression of basement membrane components and integrin 
subunits that play an important role in the re-epithilization process. Additionally,  
these models can be used to determine which exogenous factors can accelerate or 
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Previous results showed that our in-house human skin equivalents (HSEs) differ in 
their stratum corneum (SC) lipid organization compared to human SC. To elucidate 
the cause of the altered SC lipid organization in the HSEs a novel LC/MS method 
was used to study the free fatty acid (FFA) and ceramide composition in detail. In 
addition, the SC lipid composition of the HSEs and human skin was examined 
quantitatively with HPTLC. For the first time our results reveal that all our HSEs 
have an increased presence of mono-unsaturated FFAs compared to human SC. 
Moreover, the HSEs display the presence of ceramide species with a mono-
unsaturated acyl chain, which are not detected in human SC. All HSEs also exhibit 
an altered expression of stearoyl-CoA desaturase 1, the enzyme that converts 
saturated FFAs to mono-unsaturated FFAs. Furthermore, the HSEs show the 
presence of twelve ceramide subclasses, similar to native human SC. However, the 
HSEs have increased levels of ceramides EOS and EOH, ceramide species with a 
short total carbon chain, and a reduced FFA level compared to human SC. The 
presence of unsaturated lipid chains in HSEs offers new opportunities to mimic the 



















Human skin equivalents (HSEs) provide a valuable tool to predict the permeation 
of substances through the skin 1-8 or to determine whether compounds are toxins, 
irritants or sensitizers for the skin 9-12. However, in order to obtain a reliable in vitro 
– in vivo correlation it is a prerequisite that HSEs have a comparable skin barrier 
function as native human skin. The main barrier for compound penetration is 
located in the lipid matrix of the stratum corneum (SC). This lipid matrix is mainly 
composed of cholesterol, free fatty acids (FFAs) and ceramides 13, 14. The lipid 
composition determines the lipid organization in the SC and is therefore a key 
factor in determining the skin barrier function 15. We have previously investigated 
the SC lipid organization of four of our in-house HSEs, namely the fibroblast 
derived matrix model (FDM), Leiden Epidermal Model (LEM), Full Thickness 
collagen Model (FTM) and full thickness outgrowth (FTO). The LEM is a skin 
equivalent with only an epidermal compartment. The FDM is a model wherein 
fibroblasts produce their own extracellular matrix, while the FTM contains a 
dermal compartment that consists of rat tail collagen populated with human 
fibroblasts. In the FTO a full thickness explant of native human skin is placed onto 
rat tail collagen and is allowed to expand and develop an epidermis. The skin 
models mimic many aspects of native human skin. However, they display some 
differences in their SC lipid organization. These differences may play an important 
role in their decreased permeability barrier compared to human SC* 16. As the lipid 
organization is dictated by the lipid composition, we determined the SC lipid 
composition of each HSE in detail to unravel the cause of their altered SC lipid 
organization. For this purpose we quantitatively assessed the SC lipid composition 
of our in-house HSEs and native human SC with high performance thin layer 
chromatography (HPTLC).  Nine ceramide subclasses have been identified in 
native human SC using HPTLC 17, while twelve ceramide subclasses have been 
identified using a novel liquid chromatography/mass spectrometry (LC/MS) 
                                                 





method 18. In this study we used LC/MS to determine whether all identified 
ceramide subclasses in native human SC are also present in the SC of our HSEs. In 
addition, detailed information on the chain length distribution and degree of 
saturation of each ceramide subclass and FFAs is provided and compared to SC of 
native human skin. The expression pattern of several enzymes involved in the FFA 
and ceramide synthesis was also investigated to examine the biological cause of the 
altered SC lipid properties observed in the HSEs. This study has led to the 
identification of novel targets that offer new opportunities to optimize the SC lipid 
properties of HSEs and mimic the barrier properties of native human skin even 
more closely.   
 
 
MATERIALS AND METHODS 
Cell culture 
Native human mammary or abdomen skin was obtained from adults undergoing 
surgery. The collection of human skin was conducted after informed consent of the 
skin donors. The Declaration of Helsinki principles were followed when using 
human tissue. Normal human keratinocytes (NHKs) and human dermal fibroblasts 
were isolated as described before 19. NHKs used to generate LEMs were cultured 
with Dermalife K medium complete kit (Lifeline Cell Technology, Walkersville, 
MD) supplemented with 1% penicillin/streptomycin (Sigma) until they reached a 
maximum confluency of 80%. NHKs used to generate the FDM and FTM were 
grown in medium consisting of DMEM and Hams’s F12 (Invitrogen, Leek, The 
Netherlands) (3:1 v/v), 5% fetal bovine serum (FBS; Hyclone, Logan, UT) 1% 
penicillin/streptomycin (Sigma), 1 μM hydrocortisone (Sigma), 1 μM isoproterenol 
(Sigma) and 0.5 μg/mL insulin (Sigma). First and second passage NHKs were used 
to generate HSEs.  
Human dermal fibroblasts were cultured in DMEM (Invitrogen, Leek, The 
Netherlands) supplemented with 5% FBS and 1% penicillin/streptomycin.  






Collagen-type I containing dermal equivalents: a 1 mg/mL collagen (isolated form rat tails) 
solution was obtained by mixing a 4 mg/mL collagen solution in 0.1% acetic acid 
with Hank’s Buffered Salt Solution (Invitrogen, Leek, The Netherlands), 0.1% 
acetic acid, 1M NaOH and FBS on ice. One mL of this mixture was pipetted into a 
filter insert (Corning transwell cell culture inserts, membrane diameter 24 mm, pore 
size 3 μm, Corning Life Sciences, Amsterdam, The Netherlands) and polymerized 
for 15 minutes at 37ºC. Hereafter, a 2 mg/mL collagen layer was prepared as 
described, with the addition of fibroblasts to the FBS solution (final fibroblast cell 
density of 0.4x105 cells/mL collagen solution). Three mL of this fibroblast-
populated collagen mixture was pipetted onto the previous collagen layer and was 
polymerized as described. The dermal equivalents were transferred to a 6-well 
deep-well plate (Organogensis, Canton, MA) and cultured under submerged 
conditions in medium consisting of DMEM, 5% FBS, 1% penicillin/streptomycin 
and fresh supplementation of 45 mM vitamin C (Sigma). The medium was 
refreshed twice a week.  
Fully human dermal equivalents: 0.4x106 fibroblasts were seeded onto filter inserts 
(Corning Transwell culture inserts, membrane diameter 24 mm, pore size 0.4 μm; 
Corning Life Sciences, Amsterdam, The Netherlands) and were nourished with a 
similar medium as described for the collagen type I containing dermal equivalents. 
The fibroblasts were allowed to generate their own extracellular matrix for 3 weeks. 
The medium was refreshed twice a week.  
 
Generation of human skin equivalents (HSEs) 
HSEs generated on collagen dermal equivalents referred to as Full Thickness collagen Model 
(FTM): One week after preparation of the collagen type I containing dermal 
equivalents, 0.5x106 NHKs were seeded on top of each dermal equivalent. The first 
two days the HSEs were kept submerged in medium consisting of DMEM and 





penicillin/streptomycin, 0.5 μM hydrocortisone, 1 μM isoproterenol and 0.5 
μg/mL insulin. The following two days the HSEs were kept submerged in a similar 
medium, except that the FBS was reduced to 1% and 0.053 μM selenious acid 
(Johnson Matthey, Maastricht, The Netherlands), 10 mM L-serine (Sigma), 10 μM 
L-carnitine (Sigma), 1 μM -tocopherol acetate (Sigma), 25 mM vitamin C and a 
lipid mixture of 3.5 μM arachidonic acid (Sigma), 30 μM linoleic acid (Sigma), 25 
μM palmitic acid (Sigma) were added to the medium. Hereafter, the HSEs were 
lifted to the air/liquid interface and were nourished with a medium in which the 
FBS was omitted and the arachidonic acid concentration was increased to 7 μM. 
The medium was refreshed twice a week. The HSEs were harvested 16 days after 
seeding of the NHKs onto the dermal equivalents. 
HSEs generated on fully human dermal equivalents referred to as Fibroblast Derived matrix 
Model (FDM): three weeks after seeding fibroblasts onto filter inserts, 0.5x106 
NHKs were seeded onto each dermal equivalent. The HSEs were further cultured 
as described for the FTMs.   
HSEs generated on inert filter, referred to as Leiden Epidermal Model (LEM): LEMs were 
generated as described previously 10 with slight modifications. 0.2x106 NHKs were 
seeded onto cell culture inserts (Corning tranwell cell culture inserts, membrane 
diameter 12 mm, pore size 0.4 μm, Corning Life Sciences, Amsterdam, The 
Netherlands). The cells were kept submerged for 2-3 days in Dermalife medium 
until confluency. The following 2 days the HSEs were kept submerged in CnT 
medium (CellnTec, Bern, Switzerland) supplemented according to the 
manufacturer’s protocol and 1% penicillin/streptomycin solution, 1 μM -
tocopherol acetate, 25 mM vitamin C and a lipid mixture of 7 μM arachidonic acid, 
30 μM linoleic acid and 25 μM palmitic acid. Hereafter, the cells were nourished 
with the same medium, but were grown at the air/liquid interface. The LEMs were 
harvested 16 days after seeding the NHKs onto the inserts.   
Full thickness cultures (FTO): 4 mm full thickness fat free punch biopsies obtained 
from abdomen or mammary skin were gently pushed into freshly generated 





collagen type 1 containing dermal equivalents. These HSEs were cultured similarly 
as described for the FTMs and FDMs, except that they were directly cultured at the 
air/liquid interface. The FTOs were grown for approximately 16 days. 
 
Morphology and immunohistochemistry 
Harvested HSEs were fixed in 4% (w/v) paraformaldehyde (Lommerse Pharma, 
Oss, The Netherlands), dehydrated and subsequently embedded in paraffin. 5 μm 
sections were cut and used for immunohistochemical staining of human stearoyl-
CoA desaturase 1 (SCD1; 100x dilution) (Sigma), serine palmitoyltransferase (SPT; 
400x dilution) (Cayman Chemicals, MI) and ceramide synthase 3 (CERS3; 10x 
dilution) (Atlas Antibodies, Stockholm, Sweden). The paraffin sections were 
deparaffinized and rehydrated through xylene and graded ethanol series and finally 
washed with PBS. Antigen retrieval was performed by immersion in sodium citrate 
buffer (pH 6) for 30 minutes close to the boiling point. After cooling, the sections 
were blocked with normal horse serum for 20 min, followed by incubation with the 
primary antibody (diluted to the appropriate concentration in 1% BSA in PBS) 
overnight at 4ºC. After washing with PBS the sections were incubated with the 
secondary antibody for 30 minutes, washed again and incubated with ABC reagent 
for 30 minutes. The sections were consecutively washed with PBS, 0.1 M sodium 
acetate buffer and incubated for 30 minutes in amino-ethylcarbazole (Sigma) 
dissolved in N,N-dimethylformamide (1g/250 mL) (Sigma) supplemented with 
0.1% hydrogen peroxide and finally washed with water. Counterstaining was 
performed with haematoxylin. Incubations with normal horse serum, secondary 
antibody and ABC reagent were performed with the R.T.U. Vectastain Elite ABC 
Reagent Kit (Vector Laboratories, Burlingame, CA). 
 
Stratum corneum isolation and lipid extraction 
The SC of human abdomen or mammary skin was isolated as described previously 





a series of chloroform: methanol mixtures (1:2, 1:1 and 2:1 v/v) for 1 hour each. 
The extracts were combined and treated with 0.25M KCl and water. The organic 
phase was collected and evaporated under a stream of nitrogen at 40ºC. The 
obtained lipids were re-dissolved in a suitable volume of chloroform: methanol (2:1 
v/v) and stored at -20ºC until use. To obtain enough lipids for quantification, the 
lipid extracts of 2 - 4 HSEs from the same experiment and donor were pooled. The 
SC lipid composition of the FT explant could not be determined, because there was 
not enough material to extract.  
 
HPTLC lipid quantification 
The extracted SC lipids were quantified using HPTLC. The used solvent system to 
separate the lipids is provided elsewhere 21. Co-chromatography of serial dilutions 
of standards was used to identify and quantify each lipid class. The standards 
consisted of cholesterol, palmitic acid, stearic acid, arachidic acid, tricosanoic acid, 
behenic acid, lignoceric acid, cerotic acid and ceramides EOS, NS, NP, EOH and 
AP (ceramide nomenclature according to terminology of Motta et al. 22 and 
Masukawa et al. 23). The ceramides were provided by Cosmoferm (The 
Netherlands). All other compounds were purchased from Sigma (The 
Netherlands). The lipid fractions were visualized and quantified as described before 
24. For quantification SC lipid samples of two donors were used of each HSE type 
and native human skin.  
 
LC/MS lipid analysis 
The SC lipid species in the pooled lipid extracts of the HSEs and native human 
skin were analyzed by LC/MS according to the method described elsewhere 18. 
Briefly, an Alliance 2695 HPLC (Waters Corp., Milford, MA) was coupled to a 
TSQ Quantum MS (Thermo Finnigan, San Jose, CA) measuring in APCI mode. 
The total lipid concentration of all samples was around 1 mg/ml, the injection 
volume was set to 10 μl for the analysis of both ceramides and fatty acids. 





Ceramides were separated using a PVA-Sil analytical column (5 m particle size, 
100 × 2.1 mm i.d. YMC, Kyoto, Japan) using a gradient mobile phase from heptane 
to heptane/IPA/EtOH at a flow rate of 0.8 mL/min. The scan range of the MS 
was set between 500-1200 amu, measuring in positive ion mode. FFAs were 
analyzed by introducing some adaptations to the setup used for ceramide analysis 
as will be described in detail elsewhere (Van Smeden et al., in preparation). 
Separation was achieved using a LiChroCART Purospher STAR analytical column 
(55 x 2 mm i.d. Merck, Darmstadt, Germany) under a flow rate of 0.6 ml/min 
using a gradient system from ACN/H2O to MeOH/Heptane. 1% CHCl3 and 0.2% 
HAc were added to both mobile phases as ionization enhancers. The ionization 




HPTLC analysis reveals that the HSEs have a reduced SC free fatty acid 
content compared to human skin  
The SC lipids of the HSEs and human skin were extracted and quantified with 
HPTLC to determine whether the HSEs show differences in their lipid 
composition compared to human skin. Figure 1a shows that SC of the HSEs 
contains cholesterol, FFAs and all ceramide subclasses, which are also observed in 
human SC. In the LEM and FTM an additional band of an unidentified lipid, with 
an Rf value close to that of ceramide EOH, can be observed. This unidentified 
lipid, which may represent an unidentified ceramide, was occasionally also observed 
in the FDM and FTO. 
Figure 1b shows that human SC consists of approximately equal amounts of 
cholesterol, FFAs and ceramides. All HSEs, however, show a different distribution 
of the SC barrier lipids (figure 1b). The relative FFA content in the HSEs, 
especially in the FDM, LEM and FTO, is much lower compared to human SC. The 





the LEM is increased and reduced in FTO compared to human SC. This indicates 
that the relative ceramide and/or cholesterol levels in the SC of the LEM and FTO 




HSC Donor 1 1.3
HSC Donor 2 1.3
FDM Donor 1 1.3
FDM Donor 2 1.3
LEM Donor 1 1.8
LEM Donor 2 1.6
FTM Donor 1 1.5
FTM Donor 2 1.5
FTO Donor 1 0.8
FTO Donor 2 0.8
 
Most of the HSEs have an increased acylceramide content compared to 
native human SC 
In human SC twelve ceramide subclasses are identified. Each subclass is named 
according to its chemical structure 22, 23. In short, ceramides with a sphingosine (S), 
phytosphingosine (P), 6-hydroxysphingosine (H) or dihydrosphingosine (dS) 
backbone are linked via an amide to a fatty acid chain, which can either be an 
esterified -hydroxy (EO), -hydroxy (A) or non-hydroxy (N) fatty acid. Figure 1c 
shows the ratio between the total acylceramides (EO ceramides) and the other 
ceramide classes (sum of all -hydroxy + non-hydroxy ceramides) in the HSEs and 
native human skin. This figure clearly shows that the total acylceramides level is 
much higher in the FDM, LEM and FTO compared to native human skin. 
Focusing on the individual acylceramide levels, it is evident that the FDM, LEM 
and FTO have a higher content of ceramides EOS and EOH* compared to human 





SC. The difference in EOP level between FDM, LEM, FTO and human SC is 
somewhat smaller compared to the other acylceramides (figure 1d). FTM has a 
small increase in ceramide EOS and EOH* level compared to human SC, while the 
EOP level is very similar (figure 1d). 
On the TLC plate an unidentified lipid close to ceramide EOH is observed in the 
LEM and FTM (figure 1a). In the LC/MS ceramide profiles of the HSEs an 
unidentified group of lipids, which have a molecular weight similar to 
acylceramides, is also observed close to ceramide EOH (figure 2b, indicated by **). 
This suggests that the lipid band on the TLC plate most likely represents an 
acylceramide class. For this reason the unidentified lipid was quantified together 
with ceramide EOH (the two bands together are represented as EOH*). 
Comparison of the -hydroxy and non-hydroxy ceramides also shows some 
differences in distribution of these ceramide subclasses between the HSEs and  
human SC (figure 1e). Ceramide NP is the most abundant ceramide in human 
SC. Compared to human SC the ceramide NP content is reduced in the FTM and 
an even further reduction is observed in the FDM, LEM and FTO. Additionally, 
the ceramide AP content in FTM is close to the ceramide content in human SC, 
but reduced in the FDM, LEM and FTO. The relative content of ceramides NS + 
NdS, ceramides AS + NH and AH are similar in the HSEs and human SC. 
Ceramides NS + NdS and AS + NH were grouped together for quantification, 












All twelve ceramide subclasses detected in human SC are also observed in 
the HSEs 
LC/MS analysis of native human SC lipids shows the presence of at least twelve 
ceramide subclasses, as reported previously 18 (figure 2a). Additionally, within one 
ceramide subclass a large number of peaks are observed in the multi-mass 
chromatogram. Each peak represents a ceramide specie that has the same head 
group, but a different total carbon chain length and therefore a different molecular 
weight. In descending order each specie has 14 mass units less, which represents a 
reduction in one CH2-group compared to the previous specie. All twelve ceramide 
subclasses in human SC show a large variation in their total carbon chain length 
distribution. In human SC the acylceramides have a total chain length varying from 
63 to 78 carbon atoms. The -hydroxy and non-hydroxy ceramide subclasses have 
shorter total carbon chains which range from 34 to 50 and 34 to 56 carbon atoms, 
respectively. In addition to the twelve identified ceramide subclasses, human SC 
also shows the presence of some unidentified lipid classes. These unidentified lipid 
classes also consist of several species, indicated by the variation in total carbon 
chain length. The molecular structure of these lipids remains to be elucidated. The 
ceramide subclasses present in the FDM, including the total chain length 
distribution of each subclass, is provided in the multi mass chromatogram in figure  
 
Figure 1. SC barrier lipids of human skin (HSC), FDM, LEM, FTM and FTO were 
fractionated and quantified by HPTLC and photo densitometry. A: barrier lipid 
composition of human SC and HSEs. B: relative level of each SC lipid class, c: ratio of 
acylceramides (EO CERs) and non-acylceramides (non-EO CERs), d: relative level of 
acylceramides, e: relative level of -hydroxy and non-hydroxy ceramides. The data 
represents the sample mean + SD of at least 3 analytical points. CHOL= cholesterol, 
FFA= free fatty acids, CERs= ceramides, *= unidentified lipid. Ceramide nomenclature: 
A= -hydroxy fatty acids, E= ester-linked fatty acids, H= 6-hydroxy sphingosine, dS= 
dihydrosphingosine, N= non-hydroxy fatty acids, O= -hydroxy fatty acids, P= 











2b. This figure shows that all twelve ceramide subclasses present in native human 
SC are also detected in FDM. The other HSEs show a very similar LC/MS profile 
as the FDM and also show the presence of all twelve ceramide subclasses (figure 
4a-c). Each ceramide subclass in the HSEs shows a wide variation in total chain 
length distribution, similar to native human SC. In the HSEs the acylceramides 
have a total carbon chain that varies between 64 and 78 carbon atoms, which is 
almost similar to the chain length distribution observed for native human SC. The 
-hydroxy and non-hydroxy ceramide subclasses have a total carbon chain between 
32 and 50 and 34 and 56 carbon atoms, respectively. When focusing in more detail 
on the LC/MS profiles of the HSEs and native human SC some differences are 
observed. In the multi mass chromatograms of the HSEs a weak lipid band is 
located just below the stronger peaks of the ceramide species (figure 2c), which is 
observed for all ceramide subclasses. These additional weak lipid bands always have 
a mass of two units less than the stronger band of the ceramide specie above them 
(figure 2c, d). This specific difference of two mass units suggests that the lipid band 






Figure 2. LC/MS chromatograms of ceramide subclasses in human SC (a) and FDM (b). 
The retention time, mass and intensity of each peak are shown on the X-axis, Y-axis and 
Z-axis, respectively. The total carbon chain length variation of each ceramide subclass is 
provided in the inset. Ceramides with a low total carbon chain length, which are present 
in lower quantities in human SC, are indicated by # in the chromatogram of FDM. 
Unidentified lipids only observed in the chromatogram of FDM are specified with *. The 
unidentified lipid quantified together with ceramide EOH using HPTLC is indicated by 
**. Examples of ceramide species containing a MUFA chain are shown in (c). The masses 





The multi mass chromatograms of the HSEs also show low molecular weight 
ceramide species which are not detected in human SC. Furthermore, some low 
molecular weight ceramide species which have a mass below approximately 620 
amu have a higher intensity in the multi mass chromatograms of the HSEs 
compared to human skin. This is mainly observed for species of ceramides AS and 
AH which have a total chain length of 34 carbon atoms (figure 2b and 4a-c, 
indicated by #). The HSEs show the presence of several unidentified lipids, of 
which some are not present in the multi mass chromatogram of native human SC 
(figure 2b and 4a-c, indicated by *).  
 
HSEs show an increased presence of mono-unsaturated fatty acids 
compared to native human SC 
Figure 3 depicts the FFA chain length distribution and degree of saturation in 
human SC and FDM. The other HSEs showed a similar FFA composition as the 
FDM (figure 4d-f). Human SC shows a FFA chain length distribution from C16:0 
to C30:0. All HSEs contain FFAs with chain lengths varying from C16:0 to C28:0. 
This indicates that the HSEs are able to synthesize similar FFAs as native human 
skin. However, the FFA LC/MS profiles of all HSEs additionally show the 
presence of mono-unsaturated fatty acids (MUFAs), which are hardly detected in 
human SC. The MUFAs detected in the LC/MS profiles of the HSEs have a chain 
length varying from C16:1 up to C34:1. All HSEs also show a reduced level of 
FFAs with an odd carbon chain length compared to human SC. 
 





Figure 3. Three dimensional multi-mass LC/MS chromatograms of FFAs in native 
human SC (a) and FDM (b) are shown. The retention time is shown on the X-axis, the 
mass (in amu) is provided on the Y-axis and the intensity of each peak is depicted on the 
Z-axis. In human SC the FFA chain length distribution varies from C16:0 to C30:0. The 
FDM has a very similar FFA chain length distribution as human SC, but shows an 
increase in MUFAs with chain lengths varying from C16:1 to C34:1. Additionally, the odd 













Figure 4. Three dimensional multi-mass LC/MS chromatograms of ceramide subclasses 
in LEM (a), FTM (b) and FTO (c). The retention time is shown on the X-axis, the mass is 
provided on the Y-axis and the intensity of each peak is depicted on the Z-axis. The total 
carbon chain length variation of each ceramide subclass is indicated in the inset. 
Ceramides with a low total carbon chain length which are present in lower quantities in 
human SC are indicated by #. Unidentified lipids observed in the chromatogram of the 
LEM, FTM and FTO which are not observed in human SC are specified with *. The 
unidentified lipid quantified together with ceramide EOH using HPTLC is indicated by 
**. The FFA chain length distribution and degree of saturation of LEM, FTM and FTO 










The HSEs show an altered expression of stearoyl-CoA desaturase 1   
To investigate the biological cause of the altered SC lipid organization of the HSEs, 
the expression pattern of some enzymes involved in the FFA and ceramide 
synthesis were examined. Stearoyl-CoA desaturase 1 (SCD1) is the rate-limiting 
enzyme that catalyzes the synthesis of MUFAs from saturated fatty acids 25, 26. In 
native human epidermis SCD1 is only expressed in the basal layer (figure 5). In all  
HSEs the expression of SCD1 is observed in the basal layer as well as the in the 
differentiated layers of the viable epidermis (figure 5). This indicates that the 
expression of SCD1 is altered in the HSEs compared to human skin. 
The first step in ceramide synthesis is the coupling of serine to palmitic acid by 
serine palmitoyltransferase (SPT) 27. In human skin SPT expression is observed in 
the entire viable epidermis, showing both nucleic as well as cytoplasmic staining. 
No difference in expression pattern between human skin and the HSEs is observed 
(figure 5). Ceramide synthase 3 (CERS3), is one of the key enzymes involved in de 
novo ceramide synthesis pathway. CERS3 has a broad fatty acyl-coA preference and 
therefore n-acylates both long and very-long chain fatty acyl-CoAs to a sphingoid 
base. Among the six CERS members (CERS 1-6), the mRNA expression of 
CERS3 is found to be the highest in differentiated keratinocytes in vitro 28. 
Additionally, a recent publication by Jennemann et al. 29 demonstrated that CERS3 
is responsible for the synthesis of very-long chain ceramides in the skin. In human 
skin and in all HSEs CERS3 is expressed in the entire viable epidermis (figure 5). It 
should be noted that the expression of SCD1, SPT and CERS3 was weaker in the 






Figure 5. Immunohistochemical staining showing the expression pattern of stearoyl-CoA 
desaturase1 (SCD), serine palmitoyltransferase (SPT) and ceramide synthase 3 (CERS3) in 
human skin (HS), FDM, LEM, FTM and FTO. The negative control represents sections 
on which only the secondary antibody was applied. The micrographs were taken at a 20x 














In previous studies we have investigated the SC lipid organization of four in-house 
HSEs and native human skin. These studies showed that our in-house HSEs have a 
mainly hexagonal  packing* 16, while human SC has the dense orthorhombic packing 
(a schematic representation of the SC lipid organization is depicted in figure 6). The 
presence of a hexagonal lipid organization has been correlated to a decreased skin 
barrier function as monitored by transepidermal water loss compared to the 
orthorhombic packing 30. We examined the SC lipid composition of our HSEs in 
detail to verify the cause of their altered SC lipid properties and to determine how 
the latter can be optimized. In this study we show for the first time that the SC of 
HSEs contains MUFAs, which may be a key factor for their altered SC lipid 
organization. The increase in MUFA content in the SC of HSEs coincides with the 
altered expression of SCD1 in the viable epidermis of the HSEs compared to 
human epidermis. It has been demonstrated that lipid mixtures containing an 
equimolar ratio of cholesterol, FFAs and human ceramides predominantly form an 
orthorhombic packing 31. However, a reduction in FFAs or the addition of MUFAs 
in such mixtures enhances the formation of a hexagonal lateral packing†. This 
indicates that the reduction in FFA level and an increased presence of MUFAs 
contribute to the formation of the hexagonal packing in our HSEs, which thus may 
be key factors in the observed increased benzocaine penetration across the SC of 
HSEs compared to native human skin. With respect to the lamellar phases, the 
HSEs show the predominant presence of the LPP* 16, whereas in human SC both 
the LPP and SPP are formed 32. All HSEs have an increased relative content of 
ceramides EOS and EOH. As suggested in previous studies, these high 
acylceramide levels may favor the formation of the LPP in HSEs 33, but does not 
make the HSEs more permeable.  
 
                                                 
* Chapter 4 





Figure 6. In human SC the lamellar phases refer to the stack of lipid layers (i.e. lipid 
lamellae) between the corneocytes. The distance over which one lipid layer is repeated is 
referred to as the repeat distance (d). In human SC the lipid lamellae have a repeat 
distance of approximately 13 or 6 nm, the long and short periodicity phase (LPP and 
SPP), respectively. The lateral packing discloses the density of the lipids within the lipid 
lamellae. The orthorhombic packing has the highest lipid density and the liquid packing 
the lowest. In human SC the lipids are arranged in the orthorhombic packing, although 
some lipid domains also form the hexagonal or liquid packing.  
 
We show that all twelve ceramide subclasses observed in native human SC are also 
present in the SC of all HSEs. This indicates that the keratinocytes in our HSEs 
retain their ability to synthesize all ceramide subclasses that are also present in 
human SC. This observation represents a big step forward in the characterization 
of the SC lipid properties of HSEs, considering that until now a maximum of nine 
ceramide subclasses were detected in HSEs, while in the commercial HSEs even 
those nine ceramide classes were not always present 17, 34, 35.  
Masukawa et al. quantified the ceramide composition in native human SC using 
LC/MS 36. The relative prevalence of each ceramide class determined in this study 
and the study of Masukawa et al. are very similar. In this study five synthetic 
ceramides are used for quantification of the SC lipids in the HSEs and native 
human SC. The use of several ceramide subclasses for quantification is very 
important, since the charring intensities of the ceramide subclasses differ 
considerably when equal amounts are sprayed on TLC plates (figure 7).  






Figure 7. Figure a shows the charring intensities of the lipid standards used for the 
quantification of the SC lipid composition. The lipid standard contains equal weight 
amounts of each standard. The charring intensity of each spot was determined by 
densitometry and plotted against the amount sprayed to construct a calibration curve (b). 
 
The different composition of ceramide subclasses in the FDM, LEM and FTO 
compared to human skin is indicative of an altered ceramide subclass synthesis in 
these HSEs. The reason for this difference remains to be elucidated.  
Our results demonstrate that the HSEs show a similar expression of CERS3 as 
human skin. The LC/MS multi mass chromatograms indeed show that the HSEs 
are able to synthesize ceramides with a large variety in total carbon chain lengths, 
which are very similar to human skin. The expression of SCD1 in the proliferating 
and differentiating layers of the epidermis of the HSEs may result in an increased 
activity of SCD1 in the differentiated epidermal layers and thus an increased 
intracellular content of MUFAs in the keratinocytes. Due to the increase in 
intracellular MUFA content the CERS enzymes, including CERS3, n-acylate both 
MUFAs and saturated FFAs to the sphingoid bases. The observation that an 
increase in MUFA content in the SC is accompanied by the presence of ceramide 





the SC and the fatty acyl chains of ceramides have a common source or synthetic 
pathway.  
The results of this study indicate that the SC lipid properties of the HSEs can be 
improved by increasing the FFA content in the SC. The culture medium used to 
generate the HSEs is supplemented with FFAs. Optimization of FFA 
supplementation to the culture medium may lead to SC FFA levels that more 
closely resemble the SC FFA level of native human skin. It remains to be 
established whether increased expression of SCD1 in the suprabasal layers of the 
HSEs is truly associated with an increased activity of SCD1 compared to native 
human epidermis. If this appears to be true, the SC lipid properties can additionally 
be improved by reducing SCD1 activity and thereby the MUFA level in the SC of 
HSEs. SCD activity is regulated by many factors, such as insulin, temperature, 
leptin or synthetic inhibitors 25, 37. SCD1 activity in the HSEs may therefore be 
reduced by using e.g. SCD inhibitors in the culture medium. Studies performed by 
Miyazaki et al. 38 have demonstrated that SCD deficient mice show skin 
permeability barrier defects, such as an insufficient lipid deposition in the SC due to 
the presence of immature lamellar bodies with a reduced lipid content, and a 
reduction in acylceramide content. The reduction in SCD1 activity should therefore 
be performed with care to prevent different types of SC barrier defects in HSEs 
that may occur by a too severe suppression of SCD1 activity. Optimization of the 
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Previous studies demonstrated that our in-house human skin equivalents show the 
presence of all stratum corneum (SC) barrier lipid classes, but show a reduced level 
of free fatty acids, of which a part is mono-unsaturated. In this study we aimed to 
improve the SC lipid properties of the Leiden Epidermal Model (LEM) by specific 
media supplements. For this purpose, the level of the fatty acid mixture (consisting 
of palmitic, linoleic and arachidonic acid) supplemented to the medium was 
increased four times or was modified by 1) replacing protonated palmitic acid with 
deuterated palmitic acid, 2) a fourfold increase in palmitic acid concentration or 3) 
addition of deuterated arachidic acid. Furthermore, the effect of insulin on the SC 
mono-unsaturated fatty acid content was studied. The results demonstrate that 
deuterated palmitic and arachidic acid are taken up into the LEM and are 
subsequently elongated and incorporated in the SC. Increasing the concentration 
of arachidonic and linoleic acid resulted in a decreased level of very long chain fatty 
acids and an increased level of mono-unsaturated fatty acids, while insulin did not 
affect the fatty acid profile. These results indicate that SC lipid properties can be 
modulated by specific supplements in the culture medium. This study therefore 
signifies the importance of medium composition on the SC lipid properties during 

















Human skin has a dual function: it prevents the entry of pathogens and harmful 
substances into the body and at the same time prevents excess water and 
electrolyte loss from the body. The permeability barrier of the skin is located in the 
extracellular lipid domains that surround the corneocytes in the stratum corneum 
(SC). The predominating lipid classes in human SC are cholesterol, free fatty acids 
and ceramides. The composition of these lipids in the SC plays an essential role in 
maintaining the permeability barrier 1-4.  
In our previous studies we have demonstrated that our in-house human skin 
equivalents (HSEs) mimic many aspects of human skin, such as its morphology 
and the expression of early and late differentiation markers 5. Nevertheless, these 
HSEs showed a decreased permeability barrier compared to human skin when the 
diffusion of bezocaine was analyzed 5. Detailed examination of the SC lipids of the 
HSEs revealed that the total SC fatty acid content was reduced, while an increase 
in mono-unsaturated fatty acid (MUFA) content was observed (Thakoersing et al., 
submitted). Additionally, the SC of the HSEs contains ceramide species with a 
mono-unsaturated acyl chain. The observation of MUFAs and ceramides with a 
mono-unsaturated acyl chain indicates that both lipid classes have a common 
synthetic pathway.  
In the previous studies the MUFA level in the SC of the HSEs was not quantified. 
It is therefore not known to which extent the MUFA level in the HSEs differs 
from native human SC and to which extent it affects the lipid properties of the SC. 
The altered fatty acid level and composition are expected to be the key factors for 
the presence of the mainly hexagonal packing in the HSEs 5 compared to the dense 
orthorhombic packing observed in human SC 6-8. Optimization of the SC fatty acid 
level and composition of HSEs may therefore improve the SC barrier properties of 
HSEs to allow a better prediction of compound penetration through the skin.  
Stearoyl-CoA desaturase (SCD) is an enzyme that catalyzes the biosynthesis of 





the basal and differentiated layers of the epidermis, while this protein is strictly 
localized in the basal layer of human skin (Thakoersing et al., submitted). The 
increase in MUFA content in the HSEs may therefore be attributed to the 
increased presence of SCD1 in the differentiated layers of the epidermis, which 
may result in an increased activity of SCD1. The culture medium used to generate 
HSEs is supplemented with a fatty acid mixture consisting of palmitic acid, 
arachidonic acid and linoleic acid. The supplementation of this mixture may 
influence the SC fatty acid level and composition in the HSEs. Furthermore, the 
activity of SCD is affected by a variety of factors, including insulin 9-12. Since the 
culture medium is also supplemented with insulin, this may influence the activity of 
SCD1 and therefore affect the SC fatty acid composition of HSEs. In this study we 
aimed to improve the fatty acid composition and organization in the SC of the 
Leiden Epidermal Model (LEM) by supplementing and altering the fatty acid and 
insulin levels in the culture medium. To determine whether the supplemented fatty 
acids are incorporated in the SC of LEM, protonated palmitic acid was replaced by 
deuterated palmitic acid. In some experiments the medium of LEM was 
additionally supplemented with deuterated arachidic acid. SC fatty acid profiling of 
LEM was performed by a novel LC/MS method. To our knowledge we report for 
the first time the effect of fatty acid supplementation on the SC lipid organization 
and composition in epidermal skin models.   
 
 
MATERIALS AND METHODS 
Cell culture 
Normal human keratinocytes (NHKs) were established from mammary or 
abdomen skin, obtained from adult donors undergoing surgery, as described 
previously 13. The Declaration of Helsinki principles were followed when working 
with human tissue. The NHKs were cultured with the Dermalife K medium 
complete kit (Lifeline Cell Technology, Walkersville, MD) and grown to 80% 





confluency before trypsin digestion. First and second passage NHKs were used to 
generate LEMs.  
 
Generation of the Leiden Epidermal Model (LEM) 
LEMs were generated as described previously 5 with minor changes. NHKs (0.2 x 
106 cells/filter) were seeded onto cell culture inserts (Corning Transwell cell culture 
inserts, membrane diameter 12 mm, pore size 0.4 μm; Corning Life Sciences, 
Amsterdam, The Netherlands) and were kept submerged in Dermalife medium 
until confluency. Hereafter the HSEs were kept submerged in CnT medium 
(CellnTec, Bern, Switzerland), which was supplemented according to the 
manufacturer’s protocol, and 1% penicillin/streptomycin solution (Sigma, 
Zwijndrecht, The Netherlands), 0.25 μg/mL insulin (Sigma) and a lipid mixture 
consisting of 7 μM arachidonic acid (Sigma), 30 μM linoleic acid (Sigma) and 25 
μM palmitic acid (Sigma). The LEMs were lifted to the air-liquid interface after two 
days and were cultured for an additional 12 days before harvesting. In order to 
improve the SC lipid properties of LEMs, modifications were made to the culture 
medium that was used during the time the LEMs were air-exposed. The specific 
modifications are provided in table 1.  
 
Immunohistochemistry 
Harvested HSEs were fixed in 4% (w/v) paraformaldehyde (Lommerse Pharma, 
Oss, The Netherlands), dehydrated and embedded in paraffin. 5 μm sections were 
cut and used for immunohistochemical staining of stearoyl-CoA desaturase 1 
(SCD1; 100x dilution) (Sigma), peroxisome proliferator-activated receptor  and 
/ (PPAR; 200x dilution and PPAR/; 400x dilution) (Acris Antibodies, San 
Diego, CA). The sections were deparaffinized and rehydrated with xylene and 
graded ethanol series and finally washed with PBS. The sections were immersed in 
sodium citrate buffer (pH 6) for 30 minutes close to the boiling point for antigen 





and incubated overnight at 4ºC with the primary antibody. Next, the sections were 
incubated with the secondary antibody for 30 minutes, washed with PBS and 
incubated with ABC reagent for 30 minutes. The sections were consecutively 
washed with PBS, 0.1 M sodium acetate buffer and incubated for 30 minutes in 
amino-ethylcarbazole (Sigma) dissolved in N,N-dimethylformamide (1g/250 mL) 
(Sigma) supplemented with 0.1% hydrogen peroxide and finally washed with water. 
The sections were counterstained with haematoxylin. R.T.U. Vectastain Elite ABC 
Reagent Kit (Vector Laboratories, Burlingame, CA) was used for incubations with 
normal horse serum, secondary antibody and ABC reagent.  
 
Table 1 Adjustment of the culture media 
Modification Specification
LEM Control 
FFA mix: 25 μM palmitic acid, 30 μM linoleic acid, 7 μM 
arachidonic acid 
LEM C16:0D31 
Replacement of protonated palmitic acid with deuterated palmitic 
acid (C16:0D31) (Isotec, Sigma) 
LEM 4x FFA mix Supplementation of FFA mix increased 4x 
LEM 4x C16:0 Supplementation of palmitic acid increased to 100 μM (4x increase)
LEM + C20:0D39 
Addition of 47μM deuterated arachidic acid (C20:0D39) 
(Cambridge Isotope Laboratories, Andover, MA) to FFA mix 
LEM No insulin No insulin added to culture medium 
LEM 0.5x insulin 
Supplementation of insulin (Sigma) lowered to 0.125 μg/mL 
medium (2x reduction) 
Modifications made to the culture medium during generation of LEMs under air-exposed 
conditions.  C16:0D31= deuterated palmitic acid with 31 deuterium atoms. C20:0D39= 










Stratum corneum isolation 
SC of LEM was isolated by overnight incubation on a 0.1% trypsin (Sigma) soaked 
filter followed by incubation at 37ºC for 1 hour. The SC was separated from the 
viable epidermis and washed with a 0.1% trypsin inhibitor (Sigma) solution and 
water. The obtained SC sheets were dried and stored under argon. When using 
fresh human abdomen or mammary skin, fat tissue was removed and the skin was 
dermatomed to a thickness of approximately 300 μm. The SC was then isolated as 
described above.  
 
Lipid extraction and HPTLC analysis 
SC samples were extracted according to the Bligh and Dyer procedure with the 
addition of 0.25M KCl to extract polar lipids as described before 14, 15. The 
extracted lipids were analyzed by means of one-dimensional high performance thin 
layer chromatography (HPTLC) as described before 15. A standard lipid solution 
consisting of cholesterol, palmitic acid, stearic acid, arachidic acid, tricosanoic acid, 
behenic acid, lignoceric acid, cerotic acid and ceramides EOS, NS, NP, EOH and 
AP was used to identify each lipid (sub)class. Ceramides are named according to 
the nomenclature defined by Motta et al. 16 and extended by Masukawa et al. 17. 
Briefly, sphingosine (S), dihydrosphingosine (dS), phytosphingosine (P) or 6-
hydroxysphingosine (H) represent the sphingoid base structures to which an 
esterified -hydroxy (EO), -hydroxy (A) or non-hydroxy (N) fatty acid specie is 
attached via an amide bond.  The SC lipid composition of at least 2 human SC 
donors and 2 LEMs, each generated with the same modified medium, were 
examined. 
 
Fourier transform infrared spectroscopy (FTIR)  
SC samples for FTIR measurements were hydrated at room temperature for 24 
hours over a 27% (w/v) NaBr solution. The hydrated SC samples were measured 





4000 cm-1 was obtained during 4 minutes in transmission mode as a co-addition of 
256 scans with a resolution of 1 cm-1 with a Varian 670-IR FTIR (Agilent 
Technologies, Santa Clara, CA) equipped with a mercury-cadmium-telluride 
detector. The phase transitions of the SC lateral lipid organization were examined 
as a function of temperature from 0ºC to 90ºC with a heating rate of 1ºC/4 min. 
The FTIR spectra were analyzed with Win-IR pro 3.0 from Bio-Rad (Bio-Rad 
Laboratories, Cambridge, Massachusetts, USA). At least 2 SC sheets of human SC 
and LEMs generated with a modified medium composition were measured.   
 
Small angle x-ray diffraction (SAXD) 
SAXD measurements were performed at the European Synchrotron Radiation 
Facility (ESRF) at station BM26B in Grenoble as described before 2, 18. Prior to the 
measurement, SC samples were hydrated as described above. The SC samples were 
placed in specially designed holders and measured at room temperature for 10 
minutes. The intensity of scattered x-rays was measured as function of q. Repeat 
distances of lamellar phases are calculated from the peak positions (q-values) as 
described elsewhere 5. At least 2 samples of human SC and LEMs generated with a 
modified medium content were measured.   
 
Free fatty acid analysis and quantification by LC/MS 
Extracted SC lipids were dissolved in chloroform/methanol/heptane (2½:2½:95) 
to obtain a final lipid concentration of 1 mg/ml. In addition, deuterated stearic acid 
and deuterated lignoceric acid were added to each sample as internal standards, 
both with a final concentration of 10 μM. An Alliance 2695 HPLC system (Waters 
Corp., Milford, MA) was used to inject 10 μl of each sample. A C18 analytical 
column (LiChroCART Purospher STAR, 55 x 2 mm i.d. Merck, Darmstadt, 
Germany) was used to separate all free fatty acids using gradient elution at a flow 
rate of 0.5 ml/min starting from acetonitrile: water (90:10) to methanol: heptane 
(90:10). In addition, 0.1% acetic acid and 1% chloroform were added to both 





mobile phases to obtain chloro adducts, greatly enhancing the ionization efficiency 
19, 20. A TSQ Quantum MS (Thermo Finnigan, San Jose, CA) was used to analyze 
all free fatty acids as [M+Cl]- ions. Using an APCI source, the MS was scanning in 
negative ion mode using a scan range from 200-600 amu while maintaining a 
discharge current of 5 μA. The scan time was set to 500 ms while the resolution at 
full width half maximum was 0.7. The capillary and vaporizer temperature were set 
to respectively 250 and 450ºC. An extensive method description will be reported 
elsewhere (Van Smeden et al., in preparation). Afterwards, data was analyzed and 




Human SC fatty acids mainly consists of saturated fatty acids, while the SC 
of LEM shows an increased presence of mono-unsaturated fatty acids  
The SC fatty acid chain length distribution and saturation of LEM and human skin 
were quantified from LC/MS data to determine to which extent they differ from 
each other. Figure 1 shows the free fatty acid species present in human SC (A) and 
in LEM (B). In order to compare the relative chain length distribution of the fatty 
acids in human SC and LEM, the fatty acids were divided into two groups. The 
long chain fatty acids (LCFAs) are defined as fatty acids with 16-21 carbon atoms, 
while the very long chain fatty acids (VLCFAs) are defined as fatty acids with 22-
38 carbon atoms. In these groups both the saturated fatty acids and MUFAs are 
included. LEM has an almost 1:1 molar distribution of VLCFAs and LCFAs, while 
human SC contains approximately three times more VLCFAs compared to LCFAs 
(figure 1C). The seven most prevailing fatty acid species in human SC and LEM 
are provided in table 2. In human SC lignoceric acid (C24:0) and cerotic acid 
(C26:0) account for more than 50% of the total amount of fatty acids. In LEM, 
however, a drastic reduction in lignoceric and especially cerotic acid (both account 





Figure 1. Three dimensional multi-mass LC/MS chromatogram of FFAs in native 
human SC (A) and control LEM (B) are shown. The retention time is shown on the X-
axis, the mass (in amu) is provided on the Y-axis and the intensity of each peak is 
depicted on the Z-axis. Figure C: relative molar distribution of long chain fatty acids 
(LCFAs) and very long chain fatty acids (VLCFAs) in the SC of native human skin, 
control LEM (LEM) and LEM generated with deuterated palmitic acid (LEM C16:0D31). 
Figure D: relative molar distribution of saturated fatty acids (SFAs) and MUFAs. D1= 










large increase in stearic (C18:0) and oleic (C18:1) acid. When comparing the 
MUFA level, LEM contains 21-26% MUFAs (figure 1D), while this is only 4% in 
native human SC. These results clearly demonstrate that LEMs have a decreased 
VLCFA content and an increased MUFA content compared to native human SC.  
 
Substitution of protonated palmitic or arachidic acid with their deuterated 
counterparts does not alter the SC lipid composition or organization 
It is unknown whether the fatty acids that are supplemented to the culture medium 
are taken up by keratinocytes and are subsequently incorporated into SC lipids. To 
investigate this fatty acid uptake, protonated palmitic acid (C16:0), which is part of 
the standard supplement of the LEM culture medium, was substituted by 
deuterated palmitic acid (C16:0D31). HPTLC analysis revealed that the SC lipid 
composition of the LEMs fed with deuterated palmitic acid does not differ from 
the control (data not shown). Both LEMs show the presence of all SC barrier lipid 
classes, namely cholesterol, free fatty acids and all ceramides subclasses. The free 
fatty acid chain length distribution and saturation remains similar compared to the 
control (figure 1C and D). Additionally, both the controls as well as the LEMs 
treated with deuterated palmitic acid show the presence of only the long periodicity 
phase with a repeat distance of approximately 12 nm. Additionally, from around 
20ºC and higher the lipids form only a hexagonal packing (table 3). This indicates 
that the lipid composition and organization does not differ between the control 
and LEMs generated with deuterated palmitic acid.  
Deuterated arachidic acid (C20:0D39) was used to determine whether fatty acids 
with carbon chains longer than that of palmitic acid are taken up from the medium 
and are incorporated in the SC lipids and thereby increase the fraction of SC fatty 
acids with longer acyl chains. The addition of deuterated arachidic acid does not 
affect the SC lateral and lamellar lipid organization (table 3) or SC fatty acid 






Table 2. Prevailing free fatty acids in human SC and LEMs 
Table 2 shows an overview of the relative prevalence (mole %) of free fatty acid species 
in human skin and LEMs generated with a different medium composition. The seven 
most prevailing free fatty acids in each sample (highlighted in bold) were determined to 
examine shifts in prevailing free fatty acid species between different samples. D1= donor 
1, D2= donor2, ND= not detected. 
 












 C16:1 C16:0 C18:1 C18:0 C20:0 C22:0 C24:0 C25:0 C26:0 C28:0 SUM
Human skin 1.9 11.5 2.2 8.5 0.7 4.5 34.8 6.0 20.9 4.0 93.1
Control (D1) ND 11.2 14.4 16.9 4.0 8.4 24.2 0.2 9.5 1.6 90.5
Control (D2) 2.7 12.8 10.7 16.1 4.6 9.2 23.4 0.7 9.5 2.0 89.1
+C20:0D39 (D1) 0.8 9.1 9.4 13.7 3.6 8.9 29.5 0.4 15.7 2.7 93.0
+C20:0D39 (D2) 2.1 14.6 17.4 16.1 4.1 8.3 19.8 0.4 8.1 1.4 90.3
 4x FFA mix (D1) 4.2 18.0 25.2 19.8 2.8 4.8 12.5 0.1 4.3 0.7 88.2
4x FFA mix (D2) 5.3 17.8 33.9 17.3 2.5 4.1 9.1 0.5 3.1 0.6 88.9
4x C16:0 (D1) 1.2 11.3 7.5 15.4 3.6 9.0 28.2 0.4 15.2 2.5 93.1
4x C16:0 (D2) 4.8 17.2 23.3 14.4 2.5 5.7 16.8 0.2 8.0 1.3 89.3
1/2 insulin (D1) 1.6 16.3 13.8 18.8 3.9 7.7 21.2 0.2 7.9 1.3 91.1
1/2 insulin (D2) 1.1 12.6 12.8 15.7 3.6 8.3 24.0 0.5 11.1 1.8 90.4
No insulin (D1) 1.2 14.9 16.6 19.4 4.0 7.7 19.7 0.3 7.1 1.1 90.7
No insulin (D2) 2.1 20.4 13.9 24.3 3.0 6.0 15.8 0.3 6.7 1.1 91.4
 
2nd order LPP (nm) Hexagonal packing (ºC) 
Donor 1 Donor 2 Donor 1 Donor 2
LEM control 6.0 ± 0.1 (n=8) 23.4 ± 3.8 (n=7)
LEM C16:0D31 5.9 6.0 20 22
LEM +C20:0D39 5.9 5.9 28 20
LEM 4x FFAs 5.3 5.5 12 0
LEM 4x C16:0 5.9 5.9 30 24
LEM no insulin 5.7 5.9 12 18
LEM 0.5x insulin 5.8 5.7 20 20





Deuterated palmitic and arachidic acid are incorporated in the SC lipid 
matrix of LEM 
FTIR offers the opportunity to determine whether deuterated palmitic and 
arachidic acid are incorporated in the SC lipids. The vibrations of the deuterated 
lipids result in shifted peak positions in the FTIR spectrum compared to the peak 
positions belonging to the vibrations of their protonated counterparts. The FTIR 
symmetric CH2 stretching vibration observed around 2850 cm-1 provides 
information about the conformational disordering. The frequency of the CH2 
symmetric stretching vibration indicates whether the lipids are present in a 
crystalline phase, namely the orthorhombic or hexagonal phase, or in the liquid 
phase 21, 22. When lipids are arranged in a crystalline packing the symmetric CH2 
stretching frequency is below 2850 cm-1, but when they are in a liquid packing the 
conformational disorder increases. This is reflected in a steep increase in symmetric 
stretching frequency to 2852-2854 cm-1. In the FTIR spectrum the symmetric 
stretching frequency of deuterated lipids is located around 2090 cm-1. The 
transition from a crystalline to liquid phase can be recognized by a steep increase in 
wavenumber to 2096 cm-1. The order-disorder transition temperature observed for 
the controls and LEMs treated with deuterated palmitic or arachidic acid overlap 
(figure 2A). The presence of the 2090 cm-1 CD2 stretching vibration peak in the 
spectrum of the LEMs cultured with deuterated palmitic or arachidic acid clearly 
demonstrates that the deuterated fatty acids added to the culture medium are taken 
up by basal keratinocytes and are present in the SC lipids. To determine whether 
the deuterated lipids were incorporated into the SC lipid phases or formed separate 
lipid domains, the CD2 scissoring vibrations around 1090 cm-1 were examined. If 
deuterated palmitic or arachidic acid form separate lipid domains an orthorhombic 
lateral packing is observed, which is characterized by two vibrations. However, 
only one peak is observed in the FTIR spectrum of the LEMs treated with 





that separate domains of palmitic or arachidic acid are present in the SC of the 
LEMs. 
The deuterated symmetric stretching vibration around 2090 cm-1 and scissoring 
vibration around 1090 cm-1 of LEMs treated with deuterated arachidic acid have a 
lower intensity than observed for LEMs treated with deuterated palmitic acid. This 
indicates that a higher amount of deuterated palmitic acid is present in the SC of 
LEM, even though a higher molar amount of deuterated arachidic acid is added to 
the medium. Taking this into consideration, it is of more interest to supplement 
the medium with palmitic acid than arachidic acid.  
 
Figure 2. A: protonated and deuterated symmetric stretching frequencies around 2850 
and 2090 cm-1, respectively. B: deuterated scissoring vibration in the control LEM and 
LEM treated with deuterated palmitic or arachidic acid. The arrow head indicates the 
deuterated scissoring vibration at 1088 cm-1.  
 
Deuterated palmitic and arachidic acid are present as various elongated 
fatty acid species in the SC of LEM  
The SC fatty acid composition of LEMs treated with deuterated palmitic or 
arachidic acid was studied by LC/MS to verify whether deuterated lipids are indeed 
present in the SC. As can be observed from figure 3, the LC/MS method is able to 
detect deuterium labelled fatty acids since the added internal standard (C24:0D47) 
is observed in the chromatograms, bearing a mass of 47.3 amu higher than 
protonated lignoceric acid (C24:0). The LC/MS profile of LEMs treated with 





deuterated palmitic acid show the presence of lipid peaks (figure 3B) which are not 
observed in the control LEM (figure 3A). The molecular weight of these lipids 
corresponds exactly to the molecular weight of saturated fatty acid species with a 
chain length varying from C20:0 to C28:0 with the addition of 31.2 mass units. The 
increase in 31.2 mass units corresponds to the higher molecular weight of 
deuterated palmitic acid compared to protonated palmitic acid. These results 
demonstrate that palmitic acid added to the culture medium is taken up by the 
keratinocytes and is subsequently elongated in the viable epidermis to longer fatty  
 
Figure 3. Three dimensional multi mass chromatogram and retention times of individual 
fatty acids in the SC of control LEM (A) and LEM generated with deuterated palmitic (B) 
or arachidic acid (C). The deuterated fatty acids have a slightly shifted retention time 
compared to the corresponding protonated fatty acids, similarly as observed for the 





acid species. At the final differentiation step it is used to generate the extracellular 
lipid matrix in the SC. The LC/MS fatty acid profile of LEMs treated with 
deuterated arachidic acid also shows the presence of lipid peaks which are not 
present in the control (figure 3C and A, respectively). These lipid peaks have an 
increase of 39.2 mass units compared to protonated fatty acids (ranging from 
C20:0 to C28:0), which corresponds to the molecular weight difference between 
deuterated and protonated archidic acid. This indicates that arachidic acid can also 
be elongated to longer fatty acid species in LEM. 
 
High amounts of polyunsaturated fatty acids added to the culture medium 
result in a deteriorated SC lipid organization and free fatty acid composition 
After having demonstrated that palmitic acid in the culture medium can be 
elongated and incorporated in the SC lipids of LEMs, different approaches were 
used to increase the SC fatty acid content and to shift their composition in the 
direction of the VLCFA level observed for human SC. The total fatty acid mixture 
(palmitic acid, arachidonic acid and linoleic acid; FFA mix) concentration in the 
culture medium was increased four times. Since we observed elongation of 
supplemented deuterated palmitic acid to fatty acids with longer carbon chains in 
the viable epidermis of LEMs, the addition of extra palmitic acid may not only 
increase the total fatty acid content, but also increase the content of VLCFAs.  
HPTLC analysis reveals that the intensity of cholesterol and free fatty acid bands 
are similar in the control and one LEM donor generated with a fourfold increased 
FFA mix, while the other donor even showed a reduced free fatty acid intensity 
compared to the control (figure 4A). This indicates that there is no increase in fatty 
acid content in SC of LEM when the fatty acid mixture is increased four times. 
FTIR and SAXD analyses, however, show that the SC lipid organization is altered, 
albeit not in the desired manner. A fourfold increase in FFA mix supplementation 
reduces the repeat distance of the lipid lamellae and the temperature at which only 
a hexagonal phase is present (table 3). The LC/MS results demonstrate that the 





increased addition of the FFA mix markedly reduces the level of VLCFAs and 
increases the MUFA content (figure 4B and C). The main differences in fatty acid 
composition between the LEMs treated with a fourfold higher FFA mix and the 
control is an increase in oleic acid and a decrease in lignoceric acid (table 2). 
Although the palmitic acid concentration is increased in the culture medium, no 
major increase in palmitic acid level is observed compared to the control (table 2). 
This study demonstrates that the VLCFA and MUFA content in LEM even 
further deviates from the VLCFA and MUFA content of human SC when 
supplementation of linoleic, arachidonic acid and palmitic acid is increased. 
 
Figure 4. A: SC cholesterol (CHOL) and free fatty acid (FFA) content of control LEM 
(lane 1), LEM with deuterated arachidic acid (lane 2), LEM with a fourfold higher fatty 
acid mixture (lane 3) and LEM with a fourfold higher palmitic acid content (lane 4). D: 
SC cholesterol and free fatty acid content of control LEM (lane 1), LEM with a twofold 
reduction in medium insulin concentration (lane 2) and LEM with medium containing no 
supplemented insulin (lane 3). B and E: relative molar distribution of long chain fatty 
acids (LCFAs) and very long chain fatty acids (VLCFAs). C and F: relative molar 





Increase of palmitic acid supplementation does not alter SC lipid 
composition and organization in LEM 
Another approach to increase the SC fatty acid content of LEMs was to increase 
the palmitic acid concentration four times, while the arachidonic (C20:4) and 
linoleic acid (C18:2) concentration remained similar. These LEMs show no 
differences in intensity of the fatty acid and cholesterol bands compared to the 
control in their HPTLC lipid profile (figure 4A). This indicates that the increase in 
palmitic acid concentration does not lead to dramatic differences in the total free 
fatty acid level in SC. The increase in palmitic acid concentration also did not affect 
the lamellar lipid organization or lead to a pronounced difference in the 
temperature at which only the hexagonal phase is present compared to the controls 
(table 3). LEMs treated with a fourfold increase in palmitic acid concentration also 
show no considerable difference in their VLCFA and MUFA content compared to 
the controls (figure 4B and C). Furthermore, they do not show marked differences 
in the relative content of individual fatty acid species, including palmitic acid (table 
2), compared to the controls. This demonstrates that no pronounced differences in 
the fatty acid chain length distribution or degree of saturation occurs by only 
increasing the palmitic acid concentration in the medium four times. 
The fourfold increased FFA mix has four times more arachidonic and linoleic acid 
compared to the four fold increase in palmitic acid supplementation. This indicates 
that the increased addition of these two polyunsaturated fatty acids to the medium 
is probably the cause of the deteriorated lipid organization observed in LEMs 











Reduction of insulin concentration in the medium does not reduce SCD1 
expression 
It has been reported that a reduction in insulin level leads to decreased SCD 
activity 10, 11 and thus a reduction in MUFA levels. For this reason the insulin 
concentration of the medium was lowered. No difference in free fatty acid content 
can be detected with HPTLC (figure 4D) regardless of the insulin concentration in 
the medium. Additionally, reduction of insulin supplementation does not lead to 
differences in lipid organization (table 3), fatty acid chain length distribution or a 
decrease in MUFA level compared to the control (figure 4E and F). Concurrently, 
expression of SCD1 in LEMs generated with media containing a reduced insulin 
concentration remains unaltered compared to the control (figure 5A). Under these 
conditions SCD1 is expressed in the basal and differentiated layers in LEM, while 
in human skin the expression of SCD1 is strictly localized in the basal layer.  
Peroxisome proliferator-activated receptors (PPARs) are important in the 
regulation of lipid homeostasis in human keratinocytes. Endogenous fatty acids 
and their derivatives are activators of PPARs 23-25. Forman et al. 26 demonstrated 
that polyunsaturated fatty acids such as arachidonic and linoleic acid are efficient 
activators of two PPAR isoforms, namely PPAR and PPAR/. The expression 
pattern of these two PPARs were therefore determined in LEM (control) and 
compared to native human skin. LEM shows a similar expression pattern of 
PPAR and PPAR/ in the viable epidermis as native human skin (figure 5B). 
PPAR is mainly expressed in the nuclei of the keratinocytes in the viable 
epidermis, but also shows some staining of the cytosol. PPAR/ is detected in the 
nuclei and cytosol of the entire viable epidermis. Altering the free fatty acid 
supplementation or reducing the insulin concentration in the medium did not 






Figure 5. A: Immunohistochemical staining showing the expression pattern of stearoyl-
CoA desaturase 1 in native human skin (1), control LEM (2), LEM generated in medium 
with a twofold lower insulin concentration (3) and LEM generated without insulin in the 
culture medium (4). B:  Immunohistochemical staining showing the expression pattern of 




Reconstructed epidermal models mimic epidermal morphogenesis of human skin 
to a high degree. For this reason a number of commercial HSEs have been used 
for safety testing of compounds 27-30. However, these models do not fully mimic 
the SC barrier properties of human skin and therefore can provide an 
overestimation of compound penetration 31-36. Only a few studies have been 
dedicated to optimize the SC barrier properties of HSEs 31, 37. Generally the culture 
medium is modulated by supplementing compounds that have beneficial effects on 
the SC lipid properties of HSEs. This indicates that optimization of the culture 
medium shows potential to improve the SC barrier properties of HSEs. We 
demonstrated that the SC of LEM, our in-house HSE, has a decreased free fatty 
acid level and an increased presence of MUFAs compared to human SC. These 
two factors may be key factors for the decreased permeability barrier observed for 
LEM 5. We aimed to improve the SC fatty acid composition of LEM by adding 
fatty acids to the culture medium or reducing the medium insulin level. A number 
of SC barrier properties were examined in great detail by different techniques. 





Additionally, a novel LC/MS method was used to quantitatively determine the 
MUFA level and distribution of FFA species in the SC of LEM. The presented 
results show that LEM has approximately 1.5x less VLCFAs and 5-6x more 
MUFAs than observed in human SC. The detection of elongated deuterated fatty 
acid species in the SC of LEMs after supplementation of the medium with 
deuterated palmitic or arachidic acid explicitly demonstrates that SC lipids do not 
necessarily need to be derived from de novo synthesis, but may also originate from 
external sources. Increasing the amount of fatty acids added to the culture medium 
therefore appeared to be a straightforward approach to increase the SC fatty acid 
level in LEM. Increasing the palmitic acid supplementation four times, however, 
does not result in an improved chain length distribution of free fatty acids in LEM. 
This indicates that the altered free fatty acid distribution observed in LEM 
compared to human SC is not caused by a deficiency of palmitic acid in the culture 
medium.  
Palmitic acid is a building block for many lipid species, such as longer fatty acids, 
phospholipids, ceramides, diacylglycerides (DAG) and triacylglycerides (TAG). It is 
possible that the extra palmitic acid added to the culture medium is incorporated 
into the latter two lipid species, considering that LEMs have an increased DAG 
and TAG content (data not shown). Fatty acids may therefore be available to a 
lesser extent for the synthesis of phospholipids, which are degraded to fatty acids 
at the stratum granulosum/SC interface 38. 
LEMs generated without fatty acids supplemented to the culture medium did not 
show reproducible results concerning their morphology, SC lipid organization and 
composition. This indicates that fatty acid supplementation is required to generate 
LEMs. The irreproducible results may be due to keratinocyte donor variations in 
fatty acid synthesis or differentiation and proliferation responses when free fatty 
acids are omitted from the culture medium.  
LEM has a reduced VLCFA content compared to native human SC. Increasing the 





medium with fatty acids longer than palmitic acid, since they are taken up to a 
lesser extent by keratinocytes than palmitic acid. In native human epidermis 
VLCFAs are generated by the activity of several elongases 39, 40. The reduction of 
VLCFAs in LEMs may therefore be caused by a reduced activity of elongases.  
The deteriorated SC lipid organization of LEMs in which the FFA mix 
supplementation was increased four times is most probably due to the increased 
MUFA level. As far as the increased hexagonal packing is concerned, we observed 
that an increased level of MUFAs in lipid mixtures comprised of fatty acids, 
ceramides and cholesterol increases the formation of the hexagonal packing 
(Janssens et al., unpublished data). By increasing the supplementation of the FFA 
mix four times, the endogenous levels of palmitic, linoleic and arachidonic acid in 
the keratinocytes may have increased. This may have led to an imbalanced 
activation of PPARs and consequently an altered SC lipid composition and 
organization in LEMs treated with a fourfold higher FFA mix.  
Insulin is a potent hormone that regulates carbohydrate and fat metabolism in the 
body. However, the reduction or complete omission of insulin supplementation to 
the culture medium does not lead to apparent changes in the SC lipid organization 
or fatty acid composition. It still remains to be established why the LEMs 
generated with lower insulin concentrations compared to the control show only 
minor changes in the SC lipid composition and organization. However, several 
studies have shown that the accumulation of e.g. DAG decrease insulin action 41, 42. 
Since LEM have an increased DAG content in the SC compared to human SC, it 
may indicate that the keratinocytes may have a reduced response to insulin.  
Novel approaches are required to improve the SC lipid properties of LEM. SCD1 
activity in HSEs needs to be determined and compared to native human skin. If 
needed, a reduction of SCD1 activity to decrease the MUFA content may be 
achieved by adding (synthetic) SCD inhibitors 10, 11, 43 to the culture medium.  
LEMs show a relatively higher content of DAG and TAG in their SC compared to 
human SC. DAG and TAG are generated through the action of monoacylglycerol 





acyltransferase (MGAT) and diacylglycerol acyltransferase (DGAT), respectively 44. 
An increase in total fatty acid content may be achieved by partial inhibition of 
MGAT and DGAT activity 44.  
In conclusion, we have clearly shown that modification of lipid supplementation is 
not sufficient to improve the SC lipid composition and consequently the SC barrier 
function of LEM. Therefore, different approaches are needed to optimize the SC 
lipid composition of LEM. The increased content of MUFAs, DAG and TAG in 
SC of LEM suggest that the SC lipid composition might be improved by 
modulating the activity of enzymes such as SCD1, MGAT en DGAT. This may 
contribute to the development of a new generation of HSEs that harbor a 
competent SC barrier that even more closely resembles the SC lipid composition 
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SHEDDING LIGHT ON THE EXPRESSION AND ACTIVITY OF 

















Human skin equivalents (HSEs) resemble human skin to a great extent. However, 
one limitation of HSEs is their increasing stratum corneum (SC) thickness as the 
culture period is prolonged. In human skin the superficial layers of the SC are 
normally shed off in a process referred to as desquamation. The aim of this study 
was to identify possible causes for the impaired desquamation process observed 
for HSEs. For this purpose the number of SC layers, expression pattern and 
activity of specific desquamatory enzymes of our in-house HSEs, fresh native 
human skin and native human skin cultured for one or two weeks were 
determined. The results demonstrate that the HSEs and human skin cultured for 
two weeks have an increased number of SC layers compared to native human skin. 
All HSEs and cultured human skin show a similar expression of kallikrein 5 as 
native human skin. However, almost all HSEs show the expression of Lympho-
epithelial Kazal type related inhibitor (LEKTI) in more differentiated epidermal 
layers compared to native human skin. In one of the HSEs the activity of kallikrein 
5 and 7 was determined in the uppermost SC layers: a decreased kallikrein 5 
activity was observed compared to native human SC. These results suggest that a 
reduced kallikrein 5 activity and altered expression of LEKTI may contribute to 
















The stratum corneum (SC) is the outermost layer of the epidermis. It is composed 
of dead cells, referred to as corneocytes, which are embedded in a lipid matrix. The 
SC forms the first and main barrier against penetration of exogenous substances 
and pathogens into the body. In order to maintain a proper skin barrier function, 
the SC is continuously renewed and thereby maintains approximately the same 
number of SC layers. The inner SC layers are replenished by new corneocytes, 
while the upper SC layers are shed off. The latter is referred to as the desquamation 
process. The turnover time of the SC depends on the anatomical location and 
takes around four weeks 1. 
The adhesion of corneocytes in the SC is maintained by corneodesmosomes and 
lipid lamellae. In order to shed off the most superficial SC layers 
corneodesmosomes are degraded by several proteases. In this process cadherins 
and kallikreins (KLKs) play a central role 1-4. When focusing on kallikreins 
especially KLK 5 (stratum corneum tryptic enzyme) and KLK 7 (stratum corneum 
chymotryptic enzyme) are involved in the desquamation process. In the viable 
epidermis the KLKs are located in lamellar bodies. Once the lamellar bodies are 
extruded at the stratum granulosum/SC interface, KLK 5 will activate KLK 7 and 
itself. However, the proteolytic activity of the KLKs is regulated by Lympho-
epithelial Kazal type related inhibitor (LEKTI) in a pH dependent matter 5. Human 
SC has a pH gradient that ranges from pH 7.5 at the inner SC layers to ~pH 5 at 
the SC surface 6. At a physiological pH LEKTI and the KLKs form a stable 
complex. The association of LEKTI and KLKs at this pH therefore prevents 
premature proteolysis of corneodesmosomes in the inner SC layers. As the pH 
decreases towards the SC surface, LEKTI dissociates from the KLKs and thereby 
enables the start of the desquamation process. At acidic pH KLK activity is 
sufficient to complete corneodesmolysis.  
Human skin equivalents (HSEs) form a fully differentiated epidermis, which 





increases in thickness, indicating that the desquamation process does not occur in 
vitro 7, 8. A proper desquamation process is important, as the gradual increase in SC 
thickness affects skin permeation and thus the outcome of studies in which the 
effect of topical agents is examined when using HSEs. Although the absence of 
desquamation is unwanted for the latter purpose, HSEs provide a unique 
opportunity to investigate the mechanisms involved in the desquamation process. 
HSEs can for instance be used to determine whether their impaired desquamation 
process is caused by the inhibitory effects of LEKTI.   
To investigate the desquamation process in vitro three different in-house HSEs 
were generated: the full-thickness collagen model (FTM), fibroblast-derived matrix 
model (FDM) and Leiden epidermal model (LEM). These HSEs are cultured at a 
constant temperature of 37ºC, a high relative humidity of approximately 92% and 
are not exposed to daily stressors that occur in vivo, such as exposure to friction, 
tension and washing. To determine whether the desquamation process is 
maintained if the formed epidermis is derived from the native tissue rather than 
from isolated cells (used to generate HSEs), small explants of full-thickness (FT) 
native human skin were expanded in vitro. Additionally, ex vivo human skin was 
cultured to determine whether the superficial SC layers of human skin will 
desquamate in vitro when it is cultured under the same conditions as the HSEs. The 
expression pattern of KLK 5 and LEKTI was determined in the above mentioned 
cultures. Additionally, KLK 5 and KLK 7 activity in the superficial SC layers of 
FTM was compared to in vivo KLK 5 and KLK 7 activity. This study provides new 
insights on the expression and activity of specific desquamatory enzymes in HSEs 
and could therefore contribute to a better understanding of the desquamation 









MATERIALS AND METHODS 
Cell culture   
Normal human keratinocytes (NHKs) and human dermal fibroblasts were 
obtained from adult donors undergoing mammary or abdomen surgery. The 
Declaration of Helsinki principles were followed when working with human tissue. 
NHKs were cultured in medium consisting of a 3:1 mixture of Dulbecco’s 
Modified Eagle Medium (DMEM) (Invitrogen, Leek, The Netherlands) and Ham’s 
F12 medium (Invitrogen, Leek, The Netherlands) supplemented with 5% newborn 
fetal bovine serum (FBS) (Hyclone, Logan, UT), 1% penicillin/streptomycin 
solution (Sigma), 0.4 μg/mL hydrocortisone (Sigma), 0.5 μM isoproterenol (Sigma) 
and 0.5 μg/mL insulin (Sigma). The cells were grown to at least 80% confluency 
(but never reaching full confluency) and were harvested by trypsin digestion. First 
and second passage NHKs were used to generate HSEs. NHKs used to create 
HSEs with only an epidermal compartment were cultured with the Dermalife K 
medium complete kit (Lifeline Cell Technology, Walkersville, MD) supplemented 
with 1% penicillin/streptomycin (Sigma) until they reached a maximum confluency 
of 80%. First and second passage NHKs were used to generate HSEs.  
Human dermal fibroblasts were cultured in DMEM, supplemented with 5% FBS 
and 1% penicillin/streptomycin solution. This medium is further referred to as F-
medium. The cultures were grown to full confluence and were harvested by trypsin 
digestion. First to fifth passage fibroblasts were used for the generation of HSEs. 
 
Dermal equivalents 
Collagen-type I containing dermal equivalents: these dermal equivalents were generated as 
described earlier 9.  A 4 mg/mL collagen solution, isolated from rat tails, was 
mixed at 4oC with Hank’s Buffered Salt Solution to obtain a final collagen 
concentration of 1 mg/mL or 2 mg/mL. 1 mL of the 1 mg/mL collagen solution 
was pipetted into a filter insert (Corning Transwell cell culture inserts, membrane 





to polymerize for 15 minutes at 37oC. Subsequently, 3 mL of the 2 mg/mL 
collagen solution, mixed at 4oC with a fibroblast suspension (final density of 0.4 x 
105 cells/mL collagen solution) was pipetted into the inserts. After polymerization, 
the dermal compartments were kept submerged in F-medium supplemented with 
0.45 mM vitamin C (Sigma). The dermal compartments were either used on the 
same day or after one week.  
Fully human dermal equivalents: the dermal matrices for the FDMs were generated as 
described previously 10. In short, 0.4x106 fibroblasts were seeded onto filter inserts 
(Corning transwell culture inserts, membrane diameter 24 mm, pore size 0.4 m, 
Corning Life Sciences, Amsterdam, The Netherlands). The fibroblasts were kept 
submerged in the medium described for the collagen type I containing dermal 
equivalents for three weeks. During this period the fibroblasts developed their own 
dermal matrix. The medium was refreshed twice a week. 
 
Generation of human skin equivalents (HSEs) 
Full Thickness collagen Model (FTM): One week after preparation of the fibroblast 
populated collagen dermal equivalents, 0.5x106 NHKs were seeded on top of each 
dermal equivalent. The first two days the HSEs were kept submerged in medium 
consisting of DMEM and Ham’s F12 (Invitrogen, Leek, The Netherlands) (3:1 
v/v) supplemented with 5% FBS, 1% penicillin/streptomycin solution, 0.5 M 
hydrocortisone, 1 M isoproterenol and 0.5 g/mL insulin. The following two 
days the HSEs were kept submerged in a similar medium, except that the FBS was 
reduced to 1% and 0.053 M selenious acid (Johnson Matthey, Maastricht, The 
Netherlands), 10 mM L-serine (Sigma), 10 M L-carnitine (Sigma), 1 M -
tocopherol acetate (Sigma), 25 mM vitamin C and a lipid mixture of 3.5 M 
arachidonic acid (Sigma), 30 M linoleic acid (Sigma), 25 M palmitic acid (Sigma) 
were added to the medium. Hereafter, the HSEs were lifted to the air/liquid 
interface and were nourished with medium in which the FBS was omitted and the 
arachidonic acid concentration was increased to 7 M. The medium was refreshed 




twice a week. The HSEs were grown at 37oC, 92% relative humidity and 8% CO2 
for 16 days after seeding the NHKs onto the dermal equivalents.  
Fibroblast Derived matrix Model (FDM): three weeks after seeding fibroblasts onto 
filter inserts 0.5x106 NHKs were seeded onto each dermal equivalent. The HSEs 
were further cultured as described for the FTMs.   
Leiden Epidermal Model (LEM): LEMs were generated as described previously 11 
with slight modifications. 0.2x106 NHKs were seeded onto cell culture inserts 
(Corning tranwell cell culture inserts, membrane diameter 12 mm, pore size 0.4 
m, Corning Life Sciences, Amsterdam, The Netherlands). The cells were kept 
submerged for 2-3 days in Dermalife medium until confluency. The following 2 
days the HSEs were kept submerged in CnT medium (CellnTec, Bern, Switzerland) 
supplemented according to the manufacturer’s protocol and 1% 
penicillin/streptomycin solution, 1 M -tocopherol acetate, 25 mM vitamin C and 
a lipid mixture of 7 M arachidonic acid, 30 M linoleic acid and 25 M palmitic 
acid. Hereafter, the cells were nourished with the same medium, but were grown at 
the air/liquid interface. The LEMs were harvested 16 days after seeding the NHKs 
onto the inserts.   
Full Thickness Outgrowth (FTO): 4 mm full thickness fat free punch biopsies obtained 
from abdomen or mammary skin were transferred onto freshly generated collagen 
type 1 containing dermal equivalents. These HSEs were cultured similarly as 
described for the FTMs except that they were directly cultured at the air/liquid 
interface. The FTOs were grown for approximately 16 days. 
 
Ex vivo human skin 
20 mm punch biopsies of dermatomed abdomen and mammary human skin were 
placed onto filter inserts (Corning Transwell cell culture inserts, membrane 
diameter 24 mm, pore size 3 m; Amsterdam, The Netherlands). The biopsies 
were cultured at the air/liquid interface for 1 or 2 weeks with the serum-free 





Counting of stratum corneum layers 
Harvested FTMs, FDMs, LEMs, FTOs and native human skin cultured for one or 
two weeks were fixed in Tissue Tek O.C.T. compound (Sakura Finetek Europe, 
Zoeterwoude, The Netherlands) and frozen in liquid nitrogen. 5 m sections were 
cut and stained with an aqueous 1% safranin red (Sigma) solution (w/v) for 1 
minute and were subsequently washed with deionized water. A 2% KOH solution 
(w/v) was applied on the sections for 20 minutes to allow the corneocytes to swell. 
The sections were visualized with a light microscope and at least five images per 
sample were taken with a digital camera (Carl Zeiss axioskop, Jena, Germany) 
connected to the microscope. The number of SC layers of at least three different 
skin cultures or ex vivo skin samples were counted. The provided data represent the 
mean and standard deviation.  
 
Immunohistochemistry 
Harvested HSEs were fixed in 4% (w/v) paraformaldehyde (Lommerse Pharma, 
Oss, The Netherlands), dehydrated and embedded in paraffin. 5 m sections were 
cut and used for immunohistochemical staining of kallikrein 5 (KLK 5; 400x 
dilution) (Santa Cruz, CA) and LEKTI (20x dilution) (Invitrogen, Leek, The 
Netherlands). The sections were deparaffinized and rehydrated through xylene and 
graded ethanol series and finally with PBS. Antigen retrieval was performed by 
immersion in sodium citrate buffer (pH 6) for 30 minutes close to the boiling 
point. After cooling the sections were blocked with normal horse serum for 20 
min, followed by incubation with the primary antibody overnight at 4ºC. The 
sections were successively incubated with the secondary antibody and ABC reagent 
for 30 minutes each. Between each incubation step the sections were washed with 
PBS. Hereafter the sections were consecutively washed with PBS, 0.1 M sodium 
acetate buffer and incubated for 30 minutes in amino-ethylcarbazole (Sigma) 
dissolved in N,N-dimethylformamide (1g/250 mL) (Sigma) supplemented with 
0.1% hydrogen peroxide and finally washed with water. Counterstaining was 




performed with haematoxylin. Incubations with normal horse serum, secondary 
antibody and ABC reagent were performed with the R.T.U. Vectastain Elite ABC 
Reagent Kit (Vector Laboratories, Burlingame, CA).  
 
Kallikrein activity assay 
FTMs were tape-stripped as described previously 9. The tape-strips were extracted 
as described by Voegeli et al. 12. Tape-strips were transferred to Eppendorf tubes, 
to which 250 L buffer was added. The buffer was composed of 0.1 M Tris/HCl 
and 0.5% Triton X-100 at pH 8. Blank tape strips were used as a negative control. 
The tape-strips were extracted for 15 minutes at 25ºC while shaking at 1000 rpm. 
To obtain enough sample for analysis, the extracts (200 L) of four tape strips 
were pooled together. Aminomethyl coumarin (AMC) labelled peptide substrate 
(kindly provided by DSM, Basel, Switzerland) Boc-Phe-Ser-Arg-AMC for KLK5 
or MEOSuc-Arg-Pro-Tyr-AMC for KLK7 were each added to 200 L of the 
pooled extracts. The final substrate concentration in the pooled extracts was 25 
M. The pooled extracts were incubated with the substrates for 2 hours at 37ºC 
while shaking at 1000 rpm. The enzymatic reaction was stopped by addition of 200 
L of 1% acetic acid. The KLK activity was determined by the release of AMC 
from the peptides. The released AMC was quantified by reverse phase high 
performance liquid chromatography. A gradient elution system of H2O: 
acetonitrile: trifluoroacetic acid (TFA) (80: 20: 0.07) and H2O: acetonitrile: TFA 
(50: 50: 0.07) was used (see table 1 for details of the gradient system) with a flow 
rate of 1 mL/ min and injection volume of 5 L. The column used was a 
Symmetry C18, 3.5 m, 4.6 mm x 75 mm (Waters, Milford, MA). The excitation 
and emission wavelengths were set at 354 nm and 442 nm, respectively.  
The protein content of the pooled extracts was determined with the micro BCA 
protein assay reagent (Pierce, Rockford, IL) according to the manufacturer’s 
protocol. A calibration curve of BSA was used to quantify the protein content of 





absorbance was measured at 562 nm with a plate reader (Tecan Infinite M1000, 
Männedorf, Switzerland). The activity of KLK 5 and KLK 7 in FTM was 
compared to in vivo KLK 5 and KLK 7 activity in two healthy Caucasian volunteers 
between 25 and 30 years. No MEC approval was needed to perform the kallikrein 
activity assay on human volunteers, since tape-stripping represents a non-invasive 
technique. 
 
Table 1. Gradient elution system  
Time Gradient
6 minutes 100% solvent A
10 minutes 100% solvent B
13 minutes 100% solvent A
15 minutes 100% solvent A
Solvent A consists of H2O: acetonitrile: trifluoroacetic acid (TFA) (80: 20: 0.07). Solvent 




Neither HSEs nor native human skin desquamate in vitro 
First we determined the number of SC layers in HSEs and ex vivo human skin using 
safranin red staining. The results revealed that after 16 days of culture FTM, FDM 
and LEM have 25.4 ± 0.6, 21.7 ± 3.0 and 30.9 ± 10.4 SC layers respectively, while 
native human skin has 11.3 ± 1.9 SC layers (table 2). The increased number of SC 
layers in the HSEs compared to native human skin indicates that the desquamation 
process is impaired in vitro. To investigate whether the culture conditions influence 
the desquamation process FT skin explants were expanded in vitro. After two weeks 
of culture the FT explants have 24.1 ± 1.4 SC layers, while the FT outgrowths 
(FTOs) that developed from the explants have 13.9 ± 0.9 SC layers (table 2). 
Additionally, when ex vivo human skin is placed in the incubator, the number of SC 
layers remains similar to native human skin after one week (11.8 ± 1.0 SC layers). 




However, after two weeks the number of SC layers of ex vivo skin (16.9 ± 0.4 SC 
layers) is increased compared to native human skin (table 2). These results clearly 
demonstrate that native human skin does not desquamate under the selected 
culture conditions.  
 











The number of stratum corneum (SC) layers per sample are provided. The data represent 
the mean ± STD of at least three different cultures.  
 
Most HSEs show expression of LEKTI in deeper layers of the viable 
epidermis compared to native human skin 
Next we evaluated the expression of KLK 5 and LEKTI by 
immunohistochemistry to compare the expression pattern of these desquamatory 
proteins between native human skin, FTM, FDM, LEM, FTO and ex vivo human 
skin cultured for one or two weeks (figure 1).  
In native human skin KLK 5 expression is detected as a thin layer in the 
uppermost stratum granulosum layers. When focussing on the HSEs and cultured 
human skin, KLK 5 expression in FTM, FDM, FTO and cultured skin is similar to 
that observed for native human skin. In LEM, however, KLK 5 expression is 
observed in the stratum granulosum as well as in the upper stratum spinosum, 
Sample Number of SC  layers
Native human skin 11.3 ± 1.9
FTM 25.4 ± 0.6
FDM 21.7 ± 3.0
LEM 30.9 ± 10.4
FT explant 24.1 ± 1.4
FT outgrowth 13.9 ± 0.9
Ex vivo human skin 1 week 11.8 ± 1.0





indicating that LEM has a different KLK 5 expression compared to native human 
skin.  
When focussing on LEKTI expression, in human skin the expression is confined 
to the stratum granulosum. However, the expression of LEKTI is observed in 
deeper layers of the stratum granulosum compared to KLK 5. In the HSEs the 
expression of LEKTI is detected in the stratum granulosum and in the (upper) 
stratum spinosum layers in FTM, FDM and LEM. This indicates that these HSEs 
have an altered expression of LEKTI compared to native human skin. FTO on the 
other hand shows the expression of LEKTI only in the stratum granulosum, which 
is similar to native human skin. Ex vivo human skin that is cultured for one week 
shows the expression of LEKTI only in the granular layer, just as native human 
skin. After placing ex vivo human skin in the incubator for two weeks, LEKTI 
expression is observed in the granular layer, but occasionally also extends into the 
upper stratum spinosum layers.  
 
FTM has decreased KLK 5 activity in the superficial SC layers compared to 
in vivo human skin 
The activity of KLK 5 and KLK 7 was investigated in the superficial SC layers (the 
first four tape-strips) of FTM and healthy volunteers. The activity of KLK 5 and 
KLK 7 is expressed as the AMC/protein ratio. The AMC content reflects the 
amount of AMC that has been cleaved from the AMC-labelled substrates of KLK 
5 and KLK 7. The measured activity is corrected for the total amount of proteins 
present in the pooled samples of the first four tape-strips. In the superficial layers 
of native human skin KLK 5 activity is approximately six times higher compared 
to KLK 7 activity (figure 2). In the superficial layers of FTM, however, the activity 
of KLK 5 and KLK 7 are found to be equal (figure 2). Compared to human skin 
FTM shows a drastic reduction in KLK 5 activity, while KLK 7 activity appears to 
be equal.  
 





Figure 1. Immunohistochemical staining was performed to determine the expression 
pattern of KLK 5 and LEKTI in fresh native human skin (HS), FTM, FDM, LEM, FTO 
and native human skin cultured for one week (HS 1 wk) or two weeks (HS 2 wks). The 
negative controls are sections to which only the secondary antibody was applied. Original 






Figure 2. The activity of KLK 5 and KLK 7 in the first four SC tape-strips from two 
healthy Caucasian volunteers (HS V1 and HS V2) and from two FTMs (FTM D1 and 
FTM D2) have been determined. The KLK activity is presented as the amount of AMC 
that has been cleaved from the AMC-labelled KLK 5 and KLK 7 substrates. The cleaved 
amount of AMC is corrected for the total amount of protein that is tape-stripped. The 
data represent the sample mean + STD of 3 analytical points. 
 
DISCUSSION 
The observed increase in SC thickness in all HSEs indicates that the desquamation 
process does not occur in vitro. Moreover, even human skin will not retain its ability 
to desquamate under the used culture conditions. The increased number of SC 
layers observed for FTM correlates well with the decreased KLK 5 activity in the 
superficial SC layers compared to native human skin. The decreased KLK 5 
activity may partially be caused by the altered expression profile of LEKTI 
observed in most HSEs. The expression of LEKTI observed in the upper stratum 
spinosum and stratum granulosum may result in a stronger inhibition of 
corneodesmolysis by KLKs. The reason for the altered expression of LEKTI in 
most of the HSEs remains to be established. It is known that inhibition of KLK 
activity by LEKTI depends on the environmental pH 5 and water content 4, 13. 
Factors that contribute to the SC surface acidification are thought to be proton 




donors from free amino acids, urocanic acid, pyrrolidone carboxylic acid (all 
collectively referred to as natural moisturizaing factors), lactic acid, free fatty acids 
and the skin moisture level 14, 15. These components may be derived from sebum, 
sweat or degradation of filaggrin. The latter is needed to generate natural 
moisturizing factors that regulate SC hydration 16, 17. HSEs do not contain skin 
appendages like sweat glands or sebaceous glands. Additionally, the SC of FTM 
and FDM contain less natural moisturizing factors and are therefore less hydrated 
9, 10. These findings suggest that a reduction in SC water content and/or SC surface 
pH may be the cause of the impaired desquamation process in HSEs. In order to 
increase the SC hydration level of FTM, the cultures were repeatedly treated with 
topical application of glycerol. This treatment increased the SC hydration level of 
FTM, as observed from cryo-scanning electron micrographs, but no desquamation 
of the superficial SC layers was observed (Bouwstra et al., unpublished data). 
Additionally, Ponec et al. 7 used various repetitive treatments, such as mechanical 
scraping of the SC surface and topical application of acids and trypsin, to induce 
desquamation in vitro. From all these treatments only mechanical scraping was 
shown to be effective in reducing the number of SC layers in HSEs. This indicates 
that friction plays an important role in shedding of the superficial SC layers. This 
correlates well with the results demonstrating that ex vivo human skin cultured for 
two weeks in the incubator does not desquamate, despite its mostly similar 
expression of LEKTI as native human skin. It is possible that the absence of 
others factors, such as tension, washing, UV exposure, changes in environmental 
conditions and other daily stressors human skin is normally exposed, also have an 
inhibitory effect on the desquamation process in vitro.  
It should be noted that KLK 7 activity in the superficial SC layers is similar 
between native human skin and FTM. This indicates that the impaired 
desquamation observed for HSEs is not caused by a decreased activity of KLK 7.  
The simplest method to maintain a physiological number of SC layers in vitro can 





be time consuming and is not desirable when topical treatments are tested in vitro. 
Therefore additional studies are required to determine how desquamation can be 
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The skin forms an effective permeability barrier against penetration of foreign 
substances into the body and excessive water loss from the body. To generate this 
barrier the keratinocytes in the basal layer of the epidermis undergo a complex 
maturation process that finally results in the formation of the stratum corneum 
(SC), the outermost layer of the epidermis 1, 2. The SC is the main permeability 
barrier of the skin and consists of terminally differentiated dead keratinocytes, 
called corneocytes, which are embedded in a lipid-rich extracellular environment. 
Due to the rather impermeable character of the cornified envelope surrounding the 
corneocytes, the main penetration pathway of most substances is suggested to 
proceed via the SC lipid domains 3, 4. This is the reason why the SC lipids are 
considered to play a crucial role in the barrier function of the skin. The SC lipids 
are primarily composed of cholesterol, free fatty acids and ceramides in an 
approximately equimolar ratio 5. The lipids are organized in lipid layers (referred to 
as lamellae) stacked on top of each other approximately parallel to the skin surface. 
In human SC two lamellar phases are formed with repeat distances of 
approximately 13 and 6 nm, referred to as the long and short periodicity phase 
(LPP and SPP), respectively 6. The LPP is characteristic for the SC lipid 
organization and is considered to be important for a competent skin barrier 
function 7, 8. The lipids within the lamellae are predominantly arranged in the dense 
orthorhombic packing, while a subpopulation of lipids also forms the less dense 
hexagonal or liquid organization 9, 10. In order to determine whether active 
compounds hold potential for (trans)dermal application, their penetration through 
the skin has to be investigated. Ex vivo human or animal skin has extensively been 
used for this purpose. However, the use of human skin is limited due to its scarce 
availability. Furthermore, animal skin shows differences in e.g. dermal and 
epidermal thickness, hair density and SC lipid composition and therefore in skin 
barrier function. Additionally, from March 2013 a complete ban on animal testing 





means that there is an urgent need for a suitable replacement for human or animal 
skin, which may be provided by three-dimensional human skin equivalents (HSEs).  
When HSEs were initially developed, keratinocytes were seeded in culture vessels 
and grown under submerged conditions. This resulted in an incomplete 
differentiation of the keratinocytes and consequently an epithelium that did not 
fully resemble native human skin. A major step forward in the development of 
HSEs was achieved by generating HSEs at the air-liquid interface 11. Due to this 
and many other modifications of the culture conditions HSEs nowadays mimic 
many aspects of native human skin and have improved SC barrier properties. They 
show great resemblance in tissue morphology and have an almost similar 
expression of early and late differentiation markers as native human skin. 
Furthermore, the SC barrier lipids of native human skin are also detected in the SC 
of HSEs.  
It is more than a decade ago that the SC lipid composition and organization of 
HSEs were reported extensively. The published reports demonstrated that the SC 
lipid composition and organization of HSEs differed to some extent from native 
human SC 12. Due to the differences in SC lipid properties, HSEs have a decreased 
SC barrier function compared to native human SC 12-14. They generally 
overestimate compound penetration and therefore do not provide a reliable in vitro 
- in vivo correlation with regard to permeation studies 15-18. Additionally, the 
desquamation process, which regulates the shedding of the superficial SC layers, is 
impaired in HSEs 19, 20. This leads to gradual thickening of the SC as the culture 
period is prolonged, which may also influence the outcome of permeation studies. 
This indicates that HSEs can be improved further to achieve an even higher 
resemblance to native human skin. During the last few years the culture conditions 
have been further optimized and two novel in-house HSEs have been developed in 
Leiden. The novel fibroblast-derived matrix model (FDM) and Leiden epidermal 





(FTM). These models were used to answer the main questions of this thesis, 
namely: 
1. Can fully differentiated HSEs be generated under submerged conditions and 
how does this affect the epidermal differentiation and lipid composition? 
2. Do the SC barrier properties of our novel in-house HSEs resemble the SC 
barrier properties of native human skin? 
3. How does the SC lipid composition of the in-house HSEs relate to the SC lipid 
organization?  
4. To what extent do the culture conditions influence the SC barrier properties of 
HSEs? 
5. How can the SC barrier properties of HSEs be improved? 
 
Submerged versus air-exposed HSEs 
In chapter 2 studies are reported in which HSEs were generated under submerged 
and air-exposed conditions. The aim of the study was to determine whether the 
difference in micro-environment during keratincoyte differentiation affects skin 
architecture of HSEs. HSEs generated under submerged conditions have a similar 
tissue morphology, expression of several differentiation markers and show the 
presence of all SC barrier lipids as their air-exposed counterparts. However, they 
contain less fatty acids and one of the ceramide subclasses with a very long fatty 
acid chain (referred to as acylceramides) than the air-exposed HSEs. Additionally, 
the results demonstrate that the SC of FTMs generated under air-exposed 
conditions contain more natural moisturizing factors than FTMs generated under 
submerged conditions, but nevertheless has a reduced SC hydration level. The 
results presented in chapter 2 show for the first time that HSEs can form a well-








SC barrier properties of the novel HSEs 
In chapter 3 the SC barrier function, SC lipid composition and organization of 
FDM, LEM and FTM are presented. The HSEs have a similar morphology and 
expression of several early and late differentiation markers as native human skin, 
except for the observed expression of keratin 16 and premature expression of 
involucrin. To compare the SC barrier function of FDM, LEM, FTM and native 
human skin permeation studies, using benzocaine as a model drug, were 
performed. The SC of FDM and LEM showed a three times higher permeability, 
while the SC of FTM showed a five time higher permeability for benzocaine 
compared to native human SC. These results indicate that all HSEs have a 
decreased barrier function compared to native human SC. Therefore, the SC lipid 
organization and composition of the HSEs was investigated. All HSEs showed the 
presence of the LPP, which is considered to be important for a competent skin 
barrier. However, no indication of the presence of the SPP was observed. 
Furthermore, all HSEs have a mainly hexagonal arrangement of the SC lipids, a 
less dense packing than the orthorhombic packing observed in human SC. 
Additionally, the HSEs have an increased lipid disordering and form a liquid phase 
at a lower temperature compared to native human SC. All HSEs showed the 
presence of cholesterol, free fatty acids and eight ceramide subclasses that can be 
distinguished using high performance thin layer chromatography (HPTLC), 
similarly as human SC. Although the lipid composition was not determined in a 
quantitative manner, the results strongly indicate that the HSEs have a reduced 
free fatty acid content and an increased level of some acylceramides compared to 
human SC.  
 
The effect of culture conditions on the SC barrier properties of HSEs 
After establishing that the HSEs show differences in their SC barrier properties 
compared to native human SC, we examined whether these differences are caused 





latter involves enzymatic digestion of native human skin and is required to generate 
HSEs. The experiments conducted to answer this question are described in chapter 
4. Intact full-thickness native human skin explants and epidermal sheets were 
expanded on fibroblast-populated collagen matrices. The morphology, 
differentiation process and barrier properties of the explants and outgrowths were 
examined. The outgrowths from the skin explants have a similar morphology and 
expression of several differentiation markers, except for an increased expression of 
involucrin and observed expression of keratin 16, as native human skin. The 
presence of keratin 16 indicates that the keratinocytes in the outgrowths are 
activated. Interestingly, the SC of the explants increased during the culture period, 
exceeding the number of SC layers found in vivo. This indicates that the 
desquamation process is impaired when native human skin is cultured in vitro. 
HPTLC results show that the SC lipid profiles of the outgrowths are very similar 
to that of HSEs. They also have a reduced free fatty acid content in their SC 
compared to native human skin. All ceramide classes are present in the outgrowths 
of these cultures, but an increase in the very long chain acylceramides is observed 
compared to native human SC. The SC lipid organization of the outgrowths is also 
similar to that of HSEs, which includes a predominant presence of the LPP and a 
mainly hexagonal lateral lipid organization. In addition, there is an indication of an 
increased presence of a liquid phase. This unambiguously demonstrates that the 
observed differences in SC barrier properties between the HSEs and native human 
skin are not caused by isolation of primary cells, but by the culture conditions. 
Efforts made to improve the SC lipid properties of HSEs should therefore be 
focused on optimizing the culture conditions.  
 
The correlation between the SC lipid composition and SC lipid organization 
of HSEs 
In the studies described in chapter 3, the SC lipid composition of HSEs was 





compared to native human skin. In order to provide more insight in these 
differences, quantitative analysis of the SC lipid composition was performed using 
HPTLC. As no information was obtained concerning the chain lengths of the 
ceramides and free fatty acids, a novel liquid chromatography/mass spectroscopy 
(LC/MS) method was additionally used to further analyze the SC lipids of the 
HSEs. These experiments are described in chapter 5. Quantification of the SC lipids 
showed that all HSEs have a reduced free fatty acid content compared to human 
SC. Additionally, LC/MS analysis revealed that all HSEs have an increased 
presence of mono-unsaturated fatty acids (MUFAs) compared to human SC. Fatty 
acids induce the orthorhombic packing 21 and their reduced level and altered 
composition are expected to be the key factors for the presence of the mainly 
hexagonal packing observed in the HSEs. Therefore these two changes in fatty 
acid profile may play an important role in the decreased permeability barrier 
observed for FDM, LEM and FTM. Additionally, the increased presence of 
MUFAs are at least partially responsible for the increased lipid disordering of the 
SC lipids of HSEs and the reduction in temperature at which the formation of the 
liquid phase occurs. 
With respect to the ceramides, the LC/MS results demonstrated for the first time 
that the HSEs show the presence of twelve ceramide subclasses in their SC, similar 
to native human SC. However, the HSEs have increased levels of two ceramide 
subclasses with a very long fatty acid chain and ceramide species with an 
exceptionally short total carbon chain length. In addition, low fractions of 
ceramides with a mono-unsaturated acyl chain were detected. The latter ceramide 
species are not detected in human SC. Previous studies have shown that 
acylceramides induce the formation of the LPP 22. The increased presence of the 
two acylceramide subclasses in the SC of the HSEs may therefore favour the 
formation of the LPP over the SPP.  
All HSEs also show the expression of stearoyl-CoA desaturase 1 (SCD1), the 





differentiated layers of the viable epidermis. In native human skin, however, the 
expression of SCD1 is strictly localized in the basal layer. This suggests that the 
HSEs may have an increased MUFA content in their SC due to increased activity 
of SCD1 in the suprabasal layers of the viable epidermis. The results described in 
chapter 5 indicate that the SC lipid properties of the HSEs can be improved by 
increasing the free fatty acid content in the SC and by reducing the SCD1 activity 
to decrease the amount of MUFAs in the SC.  
 
Examining ways to improve the SC barrier properties of LEMs 
After establishing that the SC barrier properties of HSEs may be improved by 
increasing the free fatty acid content and by reducing the MUFA content, we 
aimed to improve the SC lipid properties of LEM by specific media supplements. 
These studies are described in chapter 6. The SC fatty acid chain length distribution 
and saturation of LEM and human skin were quantified with LC/MS to determine 
to which extent they differ from each other. The results demonstrate that LEMs 
have a ~1.5x decreased very long chain fatty acid (fatty acids with 22-38 carbon 
atoms) content and a ~5x increased MUFA content compared to native human 
SC. The culture medium of LEM is supplemented with palmitic (C16:0), linoleic 
(C18:2) and arachidonic acid (C20:4). To examine the fatty acid uptake from the 
medium, protonated palmitic acid (C16:0) was substituted by deuterated palmitic 
acid, or deuterated arachidic acid (C20:0) was added to the fatty acid mixture which 
was supplemented to the culture medium. LC/MS analysis revealed that deuterated 
palmitic and arachidic acid are taken up, elongated and incorporated in the SC of 
LEM. However, fatty acids with a deuterated arachidic acid backbone were present 
in lower quantities in the SC of LEM than fatty acids with a deuterated palmitic 
acid backbone. In subsequent studies the level of the fatty acid mixture 
supplemented to the medium was increased four times or was modified by a 
fourfold increase in palmitic acid concentration. Furthermore, the effect of insulin 





studied. The results demonstrate that increasing the concentration of arachidonic 
and linoleic acid results in a decreased content of very long chain fatty acids and an 
increase in MUFAs, whereas increasing the supplementation of palmitic acid had 
no effect on the fatty acid profile compared to the control. Additionally, 
modification of the insulin content in the culture medium did not affect the fatty 
acid profile or reduce the expression of SCD1 compared to the controls. All 
modifications in medium supplements did not affect the lateral or lamellar lipid 
organization compared to the control, except the condition wherein arachidonic 
and linoleic acid supplementation was increased. In the latter case the LEMs 
showed a reduction in the repeat distance of the LPP and the temperature at which 
the SC lipids are only arranged in a hexagonal packing compared to the controls.  
The HSEs are known to have an increased triacyl- (TAG) and diacylglyceride 
(DAG) content compared to native human SC. TAG and DAG are formed by 
linking fatty acids to a glycerol backbone. The increased presence of TAG and 
DAG in the SC may be a reason why the LEM has a decreased SC fatty acid 
content.  
Chapter 6 demonstrates that the medium composition can have a considerable 
influence on the SC lipid properties of HSEs. However, modifications made to the 
culture medium so far did not lead to an improved SC barrier in LEMs. This 
indicates that other media modifications are required to improve the SC lipid 
properties of HSEs.  
 
Impairment of the desquamation process in vitro 
The results presented in chapter 4 indicated that the desquamation process is 
impaired in vitro. Based on these findings the expression and activity of specific 
desquamatory enzymes were further investigated in native human skin, HSEs and 
native human skin cultured for one or two weeks. These studies are described in 
chapter 7. The results demonstrate that the HSEs and human skin cultured for two 





skin show a similar expression of kallikrein 5, one of the important enzymes 
involved in the desquamation process, as native human skin. However, almost all 
HSEs show the expression of Lympho-epithelial Kazal type related inhibitor 
(LEKTI), an inhibitor of kallikreins, in more differentiated epidermal layers 
compared to native human skin. In FTM a decreased kallikrein 5 activity was 
observed in the superficial SC layers compared to native human skin. These results 
suggest that the impairment of the desquamation process in HSEs may partially be 




The results presented in this thesis demonstrate that HSEs are able to form a 
completely stratified epidermis, including a SC, when generated under submerged 
conditions. However, under these conditions the HSEs have a reduced SC fatty 
acid and acylceramide content compared to HSEs generated at the air-liquid 
interface. This is an important finding since the SC is formed under submerged 
conditions in utero. The presented data also show that the culture conditions are of 
crucial importance concerning the protein expression and SC lipid properties of 
HSEs. Furthermore, we demonstrate that the SC lipid composition and 
organization of HSEs can be affected by the composition of the culture media.   
Novel targets (e.g. SCD1) have been identified or proposed, which can guide 
future research focused on improving the SC barrier function of HSEs. 
Optimization of the culture conditions may improve the epidermal lipid 
metabolism in HSEs. This may contribute to the development of a new generation 
of HSEs that harbor a competent SC barrier that even more closely resembles the 









Further investigation of the SC lipid properties and barrier function of HSEs 
In order to achieve more insight into the correlation between the SC lipid 
composition, organization and barrier function of each HSE type, it would be 
interesting to quantify the SC fatty acid chain length distribution and saturation of 
FDM and FTM, just as performed for LEM. This is of importance since the fatty 
acid composition plays an important role in the lateral lipid organization 21, which 
is different in all HSEs compared to native human skin. Quantification of the SC 
fatty acid species may also provide indications as to why FTM has a higher fatty 
acid level, but nevertheless does not show improved SC barrier properties, and 
even has a decreased SC permeability barrier for benzocaine compared to FDM 
and LEM. 
The permeation pathway of compounds through the SC is suggested to mainly 
proceed through the lipid domains 3, 4. Therefore our studies are primarily focused 
on the SC lipids of HSEs to understand and improve their impaired barrier 
function. Whether the cornified envelope also contributes to the increased 
permeability across HSEs compared to native human skin, should also be 
investigated. This can be done by visualizing the permeation pathway of a 
fluorescent marker through the SC of HSEs and native human skin using confocal 
laser scanning microscopy. Such studies are needed to determine whether changes 
in the SC lipid composition are the only cause of the decreased barrier function 
observed for the HSEs.  
The SC barrier function of the HSEs was examined with benzocaine, which has 
been chosen for its low molecular weight and medium lipophilicity (mw = 165.2 
g/mole, LogP = 1.44), resulting in an efficient permeation through human SC. In 
future studies the permeation of compounds with a broad range of lipophilicity 
and molecular weights should be assessed as well to compare the SC permeability 
barrier of the HSEs with human SC further. Additionally, the SC barrier function 





to determine whether the novel HSEs show an improved in vitro - in vivo correlation 
when they are used for permeability studies.  
 
Identifying differences in epidermal lipid metabolism between HSEs and 
native human skin 
The results presented in this thesis demonstrate that HSEs resemble human skin to 
a great extent with regard to their morphology, expression of various 
differentiation markers and ability to synthesize all SC barrier lipids. However, the 
SC lipid composition of HSEs shows some differences compared to native human 
SC. These differences indicate that epidermal lipid metabolism of HSEs deviates in 
some aspects from native human skin. In order to improve the SC lipid properties 
of HSEs, it is essential to bring the epidermal lipid metabolism of HSEs closer to 
the in vivo situation. To achieve this, it is first important to understand how 
epidermal lipid metabolism of HSEs differs from native human skin. This can be 
done by quantifying the mRNA expression level (using RealTime PCR) or protein 
abundance (using gel electrophoresis or mass spectrometry) of enzymes involved 
in epidermal lipid metabolism and their expression/activity regulators. Peroxisome 
proliferator-activated receptors (PPARs) play a central role in regulation of 
epidermal differentiation and lipid metabolism 23, 24. Although our results showed 
that PPAR and PPAR/ have a similar expression pattern in the HSEs as native 
human skin, they might be expressed at different levels, which may lead to 
disturbance of epidermal homeostasis. It would also be of particular interest to 
determine the expression level of enzymes involved in the fatty acid synthesis, 
elongation and desaturation (such as SCD1) or synthesis and degradation of DAG 
and TAG, since all HSEs have a reduced fatty acid content and increased MUFA, 
DAG and TAG level in their SC compared to human SC. These differences in SC 
lipid composition are partially the cause of the altered SC lipid organization 
observed for HSEs, which may consequently be the cause of their decreased 





A more accurate method to assess the differences in epidermal lipid metabolism 
between HSEs and native human skin would be to quantify enzyme activity. 
However, determining enzyme activity in a 3D tissue may prove to be quite 
challenging. Identification of enzymes involved in epidermal lipid metabolism that 
are differentially expressed or active in human skin and HSEs can be considered as 
targets to improve the SC lipid properties of HSEs.  
One potential enzymatic target could be SCD1.  Immunohistochemical staining 
revealed that the HSEs show suprabasal expression of SCD1, whereas native 
human skin only shows expression of SCD1 in the basal layer. It is likely that the 
increased expression of SCD1 in the suprabasal layers of the viable epidermis in 
HSEs coincides with an increased SCD1 activity, resulting in higher SC MUFA 
levels compared to native human skin. SCD activity depends on various factors, 
such as the insulin level 25. However, reduction of insulin content in the culture 
medium of LEM did not result in changes in SC MUFA content.  
 
Optimization of culture conditions to improve SC lipid properties of HSEs 
Optimization of the culture environment and/or culture media provides an 
opportunity to improve epidermal lipid metabolism of HSEs and thereby their SC 
lipid properties. A decrease in SCD1 activity in HSEs may be achieved by addition 
of specific SCD inhibitors to the culture medium. This may lead to a decrease in 
SC MUFA content of HSEs and thereby improve their SC lipid properties. An 
advantage of using specific SCD inhibitors rather than general changes made to the 
culture medium is the absence or reduction of any off-target effects. Changes 
observed in HSE morphology, differentiation or SC lipid properties can therefore 
more easily be correlated to the activity of one enzyme.  
We showed that the SC lipid properties of HSEs can differ depending on the 
culture conditions. HSEs generated under submerged conditions show a reduction 
in SC free fatty acid level compared to HSEs generated at the air-liquid interface. 





100% relative humidity (RH), while air-exposed HSEs are generated at a RH of 
92%. The mechanism underlying the difference in SC fatty acid level between the 
submerged and air-exposed HSEs is unknown. However, it is possible that a 
reduction in environmental humidity below 92% will further increase the SC fatty 
acid level in HSEs. An increase in SC fatty acid level may promote the formation 
of the orthorhombic packing, as shown by Bouwstra et al 21. This may consequently 
lead to improved SC barrier properties in HSEs.   
The described HSEs show an altered expression of involucrin and presence of 
keratin 16 expression, which indicates that epidermal homeostasis is not reached. 
This may be due to the fast maturation of keratinocytes in vitro. The culture 
conditions used to generate HSEs do not reflect the in vivo situation. An improved 
balance between proliferation and differentiation in HSEs may therefore be 
achieved by adopting culture conditions that mimic the in vivo environment of 
human skin more closely. HSEs are generally cultured at 37ºC, while in daily life 
human skin is exposed to a fluctuating environmental temperature. Additionally, 
the skin surface has a temperature of approximately 32ºC, while the body’s interior 
has a temperature of 37ºC. Studies performed by Gibbs et al. 26 showed that 
generating HSEs at 33ºC instead of 37ºC results in an improved balance between 
epidermal proliferation and differentiation. Furthermore, the oxygen level of in vivo 
skin ranges from 1.5-5%, while ambient oxygen concentration is around 21% 27. It 
is thus also reasonable to take the environmental oxygen tension into consideration 
when HSEs are generated. It has been shown that low oxygen levels enhance 
fibroblasts growth 28. Furthermore, an oxygen level of 5% has a minor effect on 
keratinocyte proliferation, but impedes keratinocyte differentiation compared to 
keratinocytes grown at atmospheric oxygen levels 29. It is possible that fine tuning 
of the environmental temperature and/or oxygen level, at different stages of HSE 
generation, is needed to optimize fibroblast and keratinocyte growth and 
differentiation. This may lead to an improved epidermal homeostasis and 





A closer look at the in vitro desquamation process 
HSEs show an increased expression of LEKTI in the suprabasal layers of the 
epidermis compared to native human skin. Additionally, FTM shows a reduced 
KLK 5 activity compared to in vivo human skin. This suggests that the impaired 
desquamation process in HSEs, specifically in FTM, may be caused by an increased 
LEKTI inhibition of KLK 5 activity. Studies described by Deraison et al. 30 
demonstrated that LEKTI inhibition occurs in a pH dependent manner. The SC of 
native human skin has a pH gradient that ranges from approximately pH 7.5 in the 
inner SC and pH 5 in the superficial SC layers 31. At physiological pH LEKTI 
binds to KLKs and thereby inhibits corneodesmolysis. At lower pH LEKTI 
disassociates from KLKs rendering them free to degrade corneodesmosomes. The 
SC pH gradient is therefore essential for a proper desquamation process. In order 
to investigate whether impairment of the desquamation process in HSEs is caused 
by an increased KLK inhibition by LEKTI, it is necessary to determine whether 
HSEs also have a similar pH gradient as native human SC. Accurate determination 
of SC pH in HSEs can be done by using a pH-sensitive fluorescent probe in 
conjunction with two-photon fluorescence lifetime imaging microscopy as 

















1. Eckert, R.L. and Rorke, E.A. Molecular biology of keratinocyte differentiation. Environ 
Health Perspect 80, 109, 1989. 
2. Fuchs, E. Epidermal differentiation: the bare essentials. J Cell Biol 111, 2807, 1990. 
3. Johnson, M.E., Blankschtein, D. and Langer, R. Evaluation of solute permeation through 
the stratum corneum: lateral bilayer diffusion as the primary transport mechanism. J 
Pharm Sci 86, 1162, 1997. 
4. Meuwissen, M.E., Janssen, J., Cullander, C., Junginger, H.E. and Bouwstra, J.A. A cross-
section device to improve visualization of fluorescent probe penetration into the skin by 
confocal laser scanning microscopy. Pharm Res 15, 352, 1998. 
5. Wertz, P.W. Lipids and barrier function of the skin. Acta Derm Venereol Suppl (Stockh) 
208, 7, 2000. 
6. Bouwstra, J.A., Gooris, G.S., van der Spek, J.A. and Bras, W. Structural investigations of 
human stratum corneum by small-angle X-ray scattering. J Invest Dermatol 97, 1005, 
1991. 
7. De Jager, M., Groenink, W., Bielsa i Guivernau, R., Andersson, E., Angelova, N., Ponec, 
M. and Bouwstra, J. A novel in vitro percutaneous penetration model: evaluation of 
barrier properties with p-aminobenzoic acid and two of its derivatives. Pharm Res 23, 
951, 2006. 
8. Groen, D., Poole, D.S., Gooris, G.S. and Bouwstra, J.A. Is an orthorhombic lateral 
packing and a proper lamellar organization important for the skin barrier function? 
Biochim Biophys Acta 2010. 
9. Bouwstra, J.A., Gooris, G.S., Dubbelaar, F.E. and Ponec, M. Phase behavior of lipid 
mixtures based on human ceramides: coexistence of crystalline and liquid phases. J Lipid 
Res 42, 1759, 2001. 
10. Damien, F. and Boncheva, M. The extent of orthorhombic lipid phases in the stratum 
corneum determines the barrier efficiency of human skin in vivo. J Invest Dermatol 130, 
611, 2010. 
11. Prunieras, M., Regnier, M. and Woodley, D. Methods for cultivation of keratinocytes 
with an air-liquid interface. J Invest Dermatol 81, 28s, 1983. 
12. Ponec, M., Boelsma, E., Weerheim, A., Mulder, A., Bouwstra, J. and Mommaas, M. Lipid 






13. Bouwstra, J.A., Gooris, G.S., Weerheim, A., Kempenaar, J. and Ponec, M. 
Characterization of stratum corneum structure in reconstructed epidermis by X-ray 
diffraction. J Lipid Res 36, 496, 1995. 
14. Ponec, M., Weerheim, A., Kempenaar, J., Mulder, A., Gooris, G.S., Bouwstra, J. and 
Mommaas, A.M. The formation of competent barrier lipids in reconstructed human 
epidermis requires the presence of vitamin C. J Invest Dermatol 109, 348, 1997. 
15. Ackermann, K., Borgia, S.L., Korting, H.C., Mewes, K.R. and Schafer-Korting, M. The 
Phenion full-thickness skin model for percutaneous absorption testing. Skin Pharmacol 
Physiol 23, 105, 2010. 
16. Asbill, C., Kim, N., El-Kattan, A., Creek, K., Wertz, P. and Michniak, B. Evaluation of a 
human bio-engineered skin equivalent for drug permeation studies. Pharm Res 17, 1092, 
2000. 
17. Netzlaff, F., Lehr, C.M., Wertz, P.W. and Schaefer, U.F. The human epidermis models 
EpiSkin, SkinEthic and EpiDerm: an evaluation of morphology and their suitability for 
testing phototoxicity, irritancy, corrosivity, and substance transport. Eur J Pharm 
Biopharm 60, 167, 2005. 
18. Schafer-Korting, M., Bock, U., Diembeck, W., Dusing, H.J., Gamer, A., Haltner-
Ukomadu, E., Hoffmann, C., Kaca, M., Kamp, H., Kersen, S., Kietzmann, M., Korting, 
H.C., Krachter, H.U., Lehr, C.M., Liebsch, M., Mehling, A., Muller-Goymann, C., 
Netzlaff, F., Niedorf, F., Rubbelke, M.K., Schafer, U., Schmidt, E., Schreiber, S., 
Spielmann, H., Vuia, A. and Weimer, M. The use of reconstructed human epidermis for 
skin absorption testing: Results of the validation study. Altern Lab Anim 36, 161, 2008. 
19. Ponec, M., Kempenaar, J. and Weerheim, A. Lack of desquamation - the Achilles heel of 
the reconstructed epidermis. Int J Cosmet Sci 24, 263, 2002. 
20. Vicanova, J., Mommaas, A.M., Mulder, A.A., Koerten, H.K. and Ponec, M. Impaired 
desquamation in the in vitro reconstructed human epidermis. Cell Tissue Res 286, 115, 
1996. 
21. Bouwstra, J., Pilgram, G., Gooris, G., Koerten, H. and Ponec, M. New aspects of the 
skin barrier organization. Skin Pharmacol Appl Skin Physiol 14 Suppl 1, 52, 2001. 
22. De Jager, M., Gooris, G., Ponec, M. and Bouwstra, J. Acylceramide head group 
architecture affects lipid organization in synthetic ceramide mixtures. J Invest Dermatol 
123, 911, 2004. 
23. Feingold, K.R. and Jiang, Y.J. The mechanisms by which lipids coordinately regulate the 





oxysterols, cholesterol sulfate and ceramides as signaling molecules. Dermatoendocrinol 
3, 113, 2011. 
24. Schmuth, M., Jiang, Y.J., Dubrac, S., Elias, P.M. and Feingold, K.R. Thematic review 
series: skin lipids. Peroxisome proliferator-activated receptors and liver X receptors in 
epidermal biology. J Lipid Res 49, 499, 2008. 
25. Mauvoisin, D. and Mounier, C. Hormonal and nutritional regulation of SCD1 gene 
expression. Biochimie 93, 78, 2011. 
26. Gibbs, S., Vicanova, J., Bouwstra, J., Valstar, D., Kempenaar, J. and Ponec, M. Culture of 
reconstructed epidermis in a defined medium at 33 degrees C shows a delayed epidermal 
maturation, prolonged lifespan and improved stratum corneum. Arch Dermatol Res 289, 
585, 1997. 
27. Evans, N.T. and Naylor, P.F. The systemic oxygen supply to the surface of human skin. 
Respir Physiol 3, 21, 1967. 
28. Balin, A.K. and Pratt, L. Oxygen modulates the growth of skin fibroblasts. In Vitro Cell 
Dev Biol Anim 38, 305, 2002. 
29. Ngo, M.A., Sinitsyna, N.N., Qin, Q. and Rice, R.H. Oxygen-dependent differentiation of 
human keratinocytes. J Invest Dermatol 127, 354, 2007. 
30. Deraison, C., Bonnart, C., Lopez, F., Besson, C., Robinson, R., Jayakumar, A., Wagberg, 
F., Brattsand, M., Hachem, J.P., Leonardsson, G. and Hovnanian, A. LEKTI fragments 
specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-
dependent interaction. Mol Biol Cell 18, 3607, 2007. 
31. Hanson, K.M., Behne, M.J., Barry, N.P., Mauro, T.M., Gratton, E. and Clegg, R.M. Two-
photon fluorescence lifetime imaging of the skin stratum corneum pH gradient. Biophys 






























De huid vormt een effectieve barrière tegen het binnendringen van ongewenste 
stoffen en het uitdrogen van het lichaam. Om deze barrière te vormen ondergaan 
de keratinocyten in de basale laag van de epidermis een complex 
differentiatieproces (d.w.z. een veranderingsproces) dat uiteindelijk resulteert in de 
vorming van het stratum corneum (SC), ook wel bekend als de hoornlaag, de 
bovenste laag van de epidermis 1, 2. Het SC vormt de voornaamste 
transportbarrière van de huid. Het bestaat uit dode keratinocyten, genaamd 
corneocyten, die ingebed zijn in een lipidrijke, oftewel vetrijke, extracellulaire 
matrix. Aangezien de corneocyten een redelijk ondoordringbare structuur hebben, 
wordt aangenomen dat stoffen voornamelijk via de lipiddomeinen tusen de 
corneocyten het SC passeren 3, 4. De SC lipiden zijn daarom van cruciaal belang 
voor de barrièrefunctie van de huid. De SC lipiden bestaan voornamelijk uit 
cholesterol, vrije vetzuren en ceramiden in een ongeveer equimolaire verhouding 5. 
Ze zijn gerangschikt in lamellaire structuren (d.w.z. lipidenlagen) die op elkaar 
gestapeld zijn parallel aan het huidoppervlak. De lamellaire structuren kunnen een 
repeterende afstand van ongeveer 13 en 6 nm hebben, de lange periodiciteitsfase 
(LPP) en korte periodiciteitsfase (SPP), respectievelijk 6. De LPP is een 
karakteristieke eigenschap van de SC lipiden en is belangrijk voor een competente 
barrièrefunctie 7, 8. De lipiden binnen deze lagen vormen een dichte regelmatige 
(kristallijn) structuur en zijn voornamelijk gerangschikt in een zogenaamd 
orthorhombisch rooster, hoewel enkele lipidendomeinen ook een minder dichte 
regelmatige structuur (een hexagonaal) of zelfs een vloeibare structuur vormen 9, 10. 
De orthorhombische rooster heeft de hoogste lipiddichtheid en de vloeibare 
rooster de laagste.  
Het is van belang om het transport van stoffen door de huid te bepalen om vast te 
stellen of deze gebruikt kunnen worden voor toepassingen via de huid. Ex vivo 
humane huid en dierlijk huid wordt veelvuldig gebruikt om het transport van 






beperkt door de geringe beschikbaarheid. Dierlijk huid verschilt van humane huid 
in een aantal aspecten, zoals epidermale en dermale dikte, haardichtheid en SC 
lipidensamenstelling, en daardoor dus ook in barrièrefunctie. Bovendien is het 
vanaf 2013 binnen de EU verboden om cosmetische producten en ingrediënten 
daarvan te testen op dierlijke modellen. Er is daarom een dringende behoefte aan 
een adequate vervanging voor humane en dierlijke huid. Het gebruik van huid 
gekweekt met behulp van geïsoleerde huidcellen, de zogenaamde 3-dimensionale 
humane huidequivalenten (HHEs), zou dit probleem kunnen oplossen.  
HHEs werden in eerste instantie gegenereerd door keratinocyten in te zaaien op 
kweekplaten en deze in z’n geheel in het kweekmedium te houden. Dit resulteerde 
in een onvolledige differentiatie van keratinocyten en de vorming van een 
epidermis dat niet vergelijkbaar was met natieve humane huid. Een grote stap 
voorwaarts in de ontwikkeling van HHEs werd gerealiseerd door tijdens het 
kweken HHEs bloot te stellen aan de lucht 11. Door deze en vele andere 
modificaties in de kweekcondities lijken HHEs tegenwoordig in veel opzichten op 
humane huid en hebben ze sterk verbeterde barrière-eigenschappen. HHEs 
hebben een vergelijkbare morfologie en brengen veel vroege en late 
differentiatiemarkers tot expressie op dezelfde manier als gezonde humane huid. 
Verder zijn de SC lipiden die aanwezig zijn in normale humane huid ook aanwezig 
in HHEs.  
Het is meer dan een decennium geleden dat de SC lipidensamenstelling en -
organisatie van HHEs uitgebreid onderzocht zijn. Uit literatuur blijkt dat de SC 
lipidensamenstelling en –organisatie van HHEs enige mate afwijken van humane 
huid 12. Door de afwijkingen in SC lipideneigenschappen is de barrièrefunctie van 
HHEs minder efficient dan die van humane huid 12-14. Hierdoor geven ze vaak een 
overschatting van de hoeveelheid stof dat door de huid getransporteerd wordt, 
waardoor er geen goede correlatie bestaat tussen in vitro en in vivo resultaten die 
betrekking hebben op transportstudies 15-18. Bovendien is het desquamatieproces, 





HHEs. Dit leidt geleidelijk tot verdikking van het SC als de kweekperiode verlengd 
wordt 19, 20. Dit is ook van invloed op het transport van stoffen door HHEs. 
Hieruit blijkt dat de barrièrefunctie van HHEs verder verbeterd kan worden om 
humane huid nog beter na te bootsen. De afgelopen jaren zijn er in het Leids 
Universitair Medisch Centrum twee nieuwe HHEs ontwikkeld. De nieuwe 
‘fibroblast-derived matrix model’ (FDM) en de ‘Leiden epidermal model’ (LEM) 
werden gekweekt samen met de ‘full thickness collagen model’ (FTM). Deze 
HHEs werden gebruikt om de hoofdvragen van dit proefschrift te beantwoorden, 
namelijk: 
1. Kunnen HHEs gekweekt worden in een waterrijke omgeving, zoals in uterus, en 
hoe beïnvloedt dit de epidermale differentiatie en lipidensamenstelling? 
2. Zijn de SC barrière-eigenschappen van de nieuw ontwikkelde HHEs en 
humane huid vergelijkbaar? 
3. Wat is de correlatie tussen de SC lipidensamenstelling en lipidenorganisatie in 
de HHEs? 
4. In hoeverre beïnvloeden de kweekcondities de SC barrière-eigenschappen van 
HHEs? 
5. Hoe kunnen de SC barrière-eigenschappen van HHEs verbeterd worden?  
 
HHEs gekweekt in een waterrijke omgeving en HHEs gekweekt aan het 
luchtoppervlak 
In hoofdstuk 2 staan studies beschreven waarin HHEs gekweekt worden in een 
volledig waterrijke omgeving, door onderdompeling in kweekmedium of 
vruchtwater, om de vorming van huid in de uterus na te bootsen. Het doel van 
deze studies was om vast te stellen of de micro-omgeving invloed heeft op de 
morfologie van HHEs tijdens het differentiatieproces van keratinocyten. HHEs 
gegenereerd in een volledig waterrijke omgeving, waarbij de keratinocyten van 
onder gevoed worden met medium, hebben een vergelijkbare morfologie en 






luchtoppervlak. Bovendien bevat het SC alle barrièrelipiden net als de HHEs die 
gekweekt worden door blootstelling aan de lucht. HHEs gekweekt in een 
waterrijke omgeving hebben echter een lager gehalte aan vrije vetzuren en een lager 
gehalte aan één van de ceramide subklassen met een zeer lange vetzuurketen (een 
van de acylceramides) in het SC ten opzichte van HHEs gekweekt aan de lucht. 
Verder blijkt uit de resultaten dat het SC van HHEs die blootgesteld worden aan 
de lucht tijdens het kweken meer waterminnende stoffen (natural moisturizing 
factors) bevatten dan HHEs gekweekt in een volledig waterrijke omgeving, maar 
desondanks een minder gehydrateerde SC hebben. De resultaten van hoofdstuk 2 
laten voor het eerst zien dat HHEs die gegenereerd worden in een waterrijke 
omgeving een volledig gedifferentieerde epidermis kunnen vormen.  
 
SC barrière-eigenschappen van de nieuwe HHEs 
In hoofdstuk 3 worden de SC barrièrefunctie, SC lipidensamenstelling en –
organisatie van FDM, LEM en FTM beschreven. De HHEs hebben een 
vergelijkbare morfologie en expressie van een aantal belangrijke 
differentiatiemarkers als normale humane huid, afgezien van de expressie van 
keratine 16 en de vroegtijdige expressie van involucrine. Om de barrièrefunctie van 
FDM, LEM, FTM en humane huid te vergelijken, werd het transport van 
benzocaine door het SC van de HHEs en humane huid onderzocht. Het SC van 
FDM en LEM heeft een driemaal hogere doorlaatbaarheid van benzocaine in 
vergelijking met humaan SC, terwijl de FTM een vijfmaal hogere doorlaatbaarheid 
heeft. Deze resultaten geven aan dat de HHEs een verminderde barrièrefunctie 
hebben in vergelijking met humane huid. Om de oorzaak van de verminderde 
barrièrefunctie van de HHEs te onderzoeken werden de SC lipidenorganisatie en –
samenstelling onderzocht. De SC lipiden van alle HHEs vormen de LPP, wat 
belangrijk wordt geacht voor de barrièrefunctie. Er is echter geen indicatie voor de 
vorming van de SPP. Verder zijn de SC lipiden van HHEs voornamelijk 





gerangschikt zijn in de dichtere orthorhombische structuur. Bovendien gaan de SC 
lipiden van HHEs bij een lagere temperatuur al over naar de vloeibare fase in 
vergelijking met humane huid. Alle HHEs bevatten net als humaan SC cholesterol, 
vrije vetzuren en alle acht ceramide subklassen die met dunnelaag chromatografie 
(HPTLC) gemeten kunnen worden. Hoewel de lipidencompositie niet quantitatief 
bepaald is, blijkt uit de resultaten dat het SC van de HHEs minder vrije vetzuren 
en meer acylceramides bevat dan humaan SC.  
 
De invloed van kweekcondities op de SC barrière-eigenschappen van 
HHEs 
Nadat bleek dat SC barrière-eigenschappen van de HHEs niet hetzelfde zijn als die 
van natief humaan SC, werd onderzocht of deze verschillen veroorzaakt worden 
door de kweekcondities of door de isolatieprocedure van de huidcellen.  De 
experimenten die zijn uitgevoerd om deze vraag te beantwoorden staan beschreven 
in hoofdstuk 4. Biopten bestaande uit intacte huid of alleen de epidermale laag 
werden geplaatst op een fibroblast-bevattende collageen matrix. Uit deze studies 
blijkt dat de epidermale uitgroei van beide type biopten een vergelijkbare 
morfologie en expressie van de onderzochte differentiatiemarkers heeft als natieve 
humane huid. Er was echter wel sprake van vroegtijdige expressie van involucrine 
en aanwezigheid van keratine 16. De detectie van keratine 16 in de uitgroei van de 
biopten geeft aan dat de keratinocyten geactiveerd zijn. Het aantal SC lagen in de 
biopten nam toe gedurende de kweekperiode en was groter dan het aantal SC lagen 
in natief humaan SC. Hieruit blijkt dat het desquamatieproces niet op dezelfde 
manier plaatsvindt in de biopten als in natieve humane huid. Uit de lipidenanalyse 
blijkt dat de uitgroei van beide type biopten en de in hoofdstuk 3 beschreven HHEs 
een vergelijkbare lipidensamenstelling hebben. De uitgegroeide epidermis van 
beide typen biopten heeft een lager vetzuurgehalte ten opzichte van humaan SC. 
Beide typen uitgroei bevatten alle ceramide subklassen, maar hebben een toename 






beide typen uitgroei is te vergelijken met die van de HHEs. De SC lipiden van de 
uitgegroeide epidermis vormen alleen de LPP en zijn voornamelijk gerangschikt in 
een hexagonale structuur. Bovendien zijn er aanwijzingen dat de lipiden iets meer 
vloeibare lipiddomeinen vormen dan in humaan SC. Deze resultaten laten 
overtuigend zien dat de verschillen in SC barrière-eigenschappen tussen de HHEs 
en humane huid niet het gevolg zijn van de celisolatie procedure, maar veroorzaakt 
worden door de kweekcondities. Dit is een positief resultaat, omdat hieruit blijkt 
dat een verdere verbetering van de SC lipideneigenschappen van HHEs 
gerealiseerd zou kunnen worden door vooral de kweekcondities te optimaliseren.   
 
De correlatie tussen de SC lipidensamenstelling en SC lipidenorganisatie in 
HHEs 
In de studies beschreven in hoofdstuk 3 zijn de SC lipidensamenstelling van HHEs 
onderzocht. In deze studies werden enkele verschillen in lipidenprofielen gevonden 
tussen de HHEs en natief humaan SC. Om meer inzicht te verkrijgen in deze 
verschillen werden de SC lipiden kwantitatief geanalyseerd met behulp van 
HPTLC. Bovendien werd er gebruik gemaakt van een recent ontwikkelde 
vloeistofchromatografie/massaspectrometrie (LC/MS) methode om de 
ketenlengtes van de vrije vetzuren en ceramides te bepalen. Deze experimenten 
staan beschreven in hoofdstuk 5. Uit de kwantificatie van de SC lipiden met  HPTLC 
blijkt dat het SC van de HHEs inderdaad minder vrije vetzuren bevat dan SC van 
natieve humane huid. Bovendien blijkt uit de LC/MS resultaten dat de HHEs meer 
enkel onverzadigde vrije vetzuren bevatten dan humaan SC. Vrije vetzuren 
induceren de orthorhombische fase 21. Het verlaagde vrije vetzuurgehalte en het 
verhoogde gehalte aan onverzadigde vetzuren spelen naar verwachting een cruciale 
rol bij de vorming van de hexagonale structuur in de SC lipidenorganisatie van 
HHEs. Deze twee veranderingen in de vrije vetzuursamenstelling in HHEs spelen 
waarschijnlijk ook een essentiële rol in de verminderde barrièrefunctie van de 





in het SC van HHEs is waarschijnlijk ook deels verantwoordelijk voor de 
toegenomen lipidenwanorde en de verlaagde temperatuursovergang waarbij de 
vloeibare fase wordt gevormd. 
Humaan SC bevat twaalf verschillende ceramide subklassen. Echter met behulp 
van HPTLC kunnen er acht ceramide klassen gescheiden worden, terwijl met 
LC/MS alle twaalf ceramide klassen gedetecteerd worden. Uit de LC/MS 
resultaten blijkt dat ook in het SC van de HHEs alle twaalf ceramide subklassen 
aanwezig zijn. In HHEs zijn echter twee acylceramides en ceramides met een 
uitzonderlijk korte totale koolstofketen in een verhoogde hoeveelheid aanwezig. 
Bovendien werden lage fracties onverzadigde ceramides gedetecteerd in HHEs. 
Deze werden niet gedetecteerd in humaan SC. Uit voorgaande studies blijkt dat 
acylceramides de vorming van de LPP induceren 22. Hieruit mogen we concluderen 
dat de relatief hogere aanwezigheid van de twee acylceramide subklassen 
waarschijnlijk verantwoordelijk is voor de vorming van alleen de LPP in het SC 
van de HHEs. 
Alle HHEs laten een verhoogde expressie zien van stearoyl-CoA desaturase 1 
(SCD1), het enzym dat verantwoordelijk is voor de omzetting van verzadigde vrije 
vetzuren in enkel onverzadigde vrije vetzuren. SCD1 is aanwezig in zowel de 
basale als de gedifferentieerde lagen van de vitale epidermis in HHEs, terwijl in 
natieve huid SCD1 alleen aanwezig is in de basale laag. Dit suggereert dat de 
toename van enkel onverzadigde vrije vetzuren in het SC van HHEs veroorzaakt 
kan worden door een toegenomen activiteit van SCD1 in de suprabasale lagen van 
de vitale epidermis. Uit de resultaten van hoofdstuk 5 blijkt dat de SC 
lipideneigenschappen verbeterd zouden kunnen worden door het vrije 
vetzuurgehalte in het SC te verhogen en de activiteit van SCD1 te verlagen, om 
zodoende de hoeveelheid enkel onverzadigde vrije vetzuren in het SC van de 








Het onderzoeken van methodes om de SC barrière-eigenschappen te 
verbeteren 
Omdat uit de in hoofdstuk 5 beschreven resultaten blijkt dat de SC barrière-
eigenschappen verbeterd zouden kunnen worden door het totale SC 
vetzuurgehalte te verhogen en het enkel onverzadigde vetzuurgehalte te verlagen, 
besloten we de SC lipideneigenschappen van de LEM te optimaliseren door de 
samenstelling van het kweekmedium aan te passen. Deze studies staan beschreven 
in hoofdstuk 6. Om te bepalen in hoeverre de ketenlengtes en verzadigingsgraad van 
de vetzuren in LEM en humaan SC van elkaar verschillen, werd het vetzuurgehalte 
gekwantificeerd met behulp van LC/MS. Hieruit blijkt dat de LEMs ongeveer een 
1.5x lagere hele lange vrije vetzuurgehalte (vrije vetzuren met 22-38 
koolstofatomen) en ongeveer een 5x hogere enkel onverzadigde vrije 
vetzuurgehalte hebben in vergelijking met humaan SC. 
Aan het medium van LEM wordt standaard palmitinezuur (C16:0), linolzuur 
(C18:2) en  arachidonzuur (C20:4) toegevoegd. Om uit te zoeken of er vrije 
vetzuren uit het kweekmedium worden opgenomen door kweekjes, werd 
geprotoneerde palmitinezuur vervangen door gedeutereerde palmitinezuur, of werd 
er gedeutereerde arachidinezuur (C20:0) toegevoegd aan het standaard medium 
lipidensupplement. Uit de LC/MS analyse blijkt dat gedeutereerde palmitinezuur 
en arachidinezuur worden opgenomen. Deze vetzuren worden verlengd tot langere 
vrije vetzuren en worden vervolgens geïncorporeerd in het SC van LEM. Lipiden 
die afkomstig zijn van gedeuteerde arachidinezuur zijn echter in mindere mate 
aanwezig dan lipiden die afkomstig zijn van gedeutereerde palmitinezuur. In 
vervolgstudies werd i) de hoeveelheid lipidensupplement viermaal verhoogd of ii) 
het gehalte arachidonzuur en linolzuur gelijk gehouden, maar de hoeveelheid 
palmitinezuur viermaal verhoogd. Verder werden er verschillende concentraties 
insuline toegevoegd aan het medium om het effect van insuline op het gehalte van 
enkel onverzadigde vrije vetzuren in het SC van LEM en de expressie van SCD1 in 





supplementatie van arachidonzuur en linolzuur resulteert in een vermindering van 
de hoeveelheid hele lange vrije vetzuren en een toename in het gehalte van enkel 
onverzadigde vrije vetzuren. Het verhogen van de palmitinezuur in het 
kweekmedium had geen effect op het vetzuurprofiel in vergelijking met de 
controle. Ook de verandering in insuline concentratie in het kweekmedium had 
geen effect op het vetzuurprofiel van LEM of op de expressie van SCD1 ten 
opzichte van de controles. Alle veranderingen in het kweekmedium hadden geen 
invloed op de lipidenorganisatie van LEM, met uitzondering van de conditie 
waarbij arachidonzuur en linolzuur supplementatie viermaal verhoogd was. In het 
laatste geval vormden de SC lipiden van de LEMs een LPP met een kortere 
repetitieafstand en waren de lipiden al bij een lagere temperatuur volledig 
gerangschikt in een hexagonale fase in vergelijking met de controles.  
HHEs hebben een toegenomen hoeveelheid di- en triglyceriden in het SC ten 
opzichte van humaan SC. Di- en triglyceriden worden gevormd door vrije vetzuren 
te koppelen aan een glycerol molecuul. De verhoogde aanwezigheid van di- en 
triglyceriden zou een reden kunnen zijn voor het verlaagde vrije vetzuurgehalte in 
het SC van LEM. De studies beschreven in hoofdstuk 6 tonen aan dat de 
mediumsamenstelling een grote invloed kan hebben op de SC 
lipideneigenschappen van HHEs. Echter, de modificaties in het kweekmedium 
hebben tot dusver niet geleid tot een verbetering in de SC barrièrefunctie van 
LEMs. Dit geeft aan dat andere aanpassingen aan het medium of 
kweekomstandigheden nodig zijn om de SC lipideigenschappen van HHEs te 
verbeteren.  
 
De afwezigheid van het desquamatieproces in vitro 
Uit de resultaten beschreven in hoofdstuk 4 blijkt dat het desquamatieproces niet 
plaatsvindt in vitro. Daarom werd er vervolgonderzoek uitgevoerd naar de expressie 
en activiteit van specifieke enzymen die betrokken zijn bij het desquamatieproces 






in de incubator. Deze studies staan beschreven in hoofdstuk 7. Uit de resultaten 
blijkt dat de HHEs en humane huid gekweekt gedurende twee weken nagenoeg 
geen desquamatie vertonen. Alle HHEs en humane huid in dezelfde 
kweekomstandigheden hebben dezelfde expressie van kallikreine 5, een van de 
belangrijke enzymen in het desquamatieproces, als humane huid. Bijna alle HHEs 
tonen echter de expressie van Lympho-epithelial Kazal type related inhibitor 
(LEKTI), een eiwit dat de activiteit van kallikreines inhibeert, in meerdere lagen 
van de vitale epidermis in vergelijking met natieve humane epidermis. In de FTM 
werd een verminderde kallikreine 5 activiteit gemeten in de oppervlakkige SC lagen 
in vergelijking met natieve humane huid. Uit deze resultaten blijkt dat de 
afwezigheid van het desquamatieproces in HHEs gedeeltelijk veroorzaakt zou 




Uit de resultaten in dit proefschrift blijkt dat HHEs een compleet gedifferentieerde 
epidermis vormen wanneer ze gekweekt worden in een waterrijke omgeving. 
Onder deze kweekomstandigheden hebben HHEs echter een verlaagde vrije 
vetzuur- en acylceramidegehalte in het SC ten opzichte van HHEs die gekweekt 
worden door blootstelling aan de lucht. Dit is een belangrijke bevinding, aangezien 
in vivo de huid gevormd wordt in uterus. Uit de gepresenteerde data blijkt dat de 
kweekomstandigheden van cruciaal belang zijn voor de eiwitexpressie en SC 
lipideneigenschappen van HHEs. Verder blijkt dat de SC lipidencompositie en –
organisatie van HHEs beïnvloed wordt door de mediumsamenstelling. 
In de studies beschreven in dit proefschrift zijn nieuwe aangrijpingspunten (zoals 
SCD1) geïdentificeerd die als richtlijn kunnen dienen voor toekomstig onderzoek 
gericht op het optimaliseren van de barrièrefunctie van HHEs. Optimalisatie van 
de kweekcondities kan leiden tot een verbetering in epidermale lipidmetabolisme 





die beschikken over een competent SC barrière dat nog meer overeenkomsten 
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Na zo lang gezwoegd te hebben kan ik nu dan eindelijk beginnen met het laatste - 
maar zeker niet het minst belangrijke – gedeelte van mijn proefschrift. De 
afgelopen vier jaren waren fantastische jaren en hebben mij veel bijzondere 
ervaringen opgeleverd, zowel op wetenschappelijk als persoonlijk vlak. Ik heb veel 
mensen leren kennen en dankzij jullie zal ik altijd met een brede lach en fijn gevoel 
terug denken aan mijn AIO-tijd.  
 
Wouter, jij bent mijn ‘guru’ wat celkweek betreft. Jij was een goede leraar, want 
tijdens mijn stage heb ik nooit een infectie gehad in mijn kweekjes! Zonder jouw 
training zou ik niet in staat zijn om de honderden kweekjes te maken tijdens mijn 
AIO-periode. Aan het begin van mijn AIO-tijd heeft ook Nazmoen mij het een en 
ander bijgebracht over huidkweek. Nazmoen, ook jij bedankt hiervoor. Dennis, jij 
stond altijd klaar om IHC kleuringen te doen voor mij. Mojgan, jij hebt mij 
ingewijd in de wereld van de diffusiestudies. Beiden bedankt voor jullie hulp tijdens 
onze korte tijd samen bij DDT.  
 
Robert, jij was een super goede begeleider en later een fijne collega en 
kamergenoot. Jij hebt mij laten zien dat DDT een gezellige en boven alles een zeer 
sociale vakgroep is. Juul, wij zijn gelukkig ook een paar weekjes collega’s geweest 
van elkaar (want ook jij was ooit mijn begeleider tijdens het GTA blok). Ik heb veel 
van jou geleerd en heb met veel plezier achter ‘ons’ bureau gewerkt. Ook nu na 
mijn AIO-tijd voorzie je me nog van advies. 
 
Suus, wat hebben wij veel beleefd samen! Naast het werken hebben wij ook 
gefeest, gekookt en vakantie gevierd. Het cellab was onze toevluchtsoord als het 
leven even iets te spannend of frustrerend werd. Het was een vanzelfsprekende 
beslissing dat jij een van mijn paranimfen zou worden. Ik ben blij dat je me ook 





Bram, werken in het cellab was altijd veel leuker als jij er ook bezig was. Jij was 
onze radio, informant (!), adviseur en was altijd bereid om voor mijn cellen te 
zorgen. Het voelde alsof ik een grote broer had bij DDT.  
 
Daniel, dankzij jou heb ik erg veel gelachen en ook steun gehad in de wat 
moeilijkere tijden. Samen hebben wij enkele DDT events georganiseerd. Al zeg ik 
het zelf, dat hebben we best goed gedaan. In ons laatste jaar bij DDT zorgde jij 
voor de organisatie van de vrijdagmiddagborrels of BBQs en daardoor voor de 
nodige ontspanningsmomenten. Olly, ook jij zorgde voor een gezellige sfeer in het 
lab. Jij was altijd vrolijk en voorzag ons van goede stapplaatsen tijdens onze 
congressen in België. Daarnaast heb je mij samen met Mojgan geleerd hoe ik huid 
moet dermatomiseren, een kunst dat nu zeer gewaardeerd wordt.  
 
Na enige tijd veranderde ik van junior AIO naar senior AIO in kamer 718. Jeroen 
jij was ‘ying’ en ik was ‘yang’ (of was het andersom?). Het klinkt voor anderen 
misschien raar, maar wij weten wat karma met je kan doen! Het zal wel duidelijk 
zijn dat wij heel goed met elkaar hebben samengewerkt, aangezien jij een van mijn 
paranimfen bent. Onze trip naar New York en de Gordon was erg gezellig! 
Dankzij jouw LC/MS methode heb ik leuke resultaten gekregen dat heeft geleid tot 
twee gezamenlijke artikelen. Michelle, jij bracht orde in onze kamer. Onze tripjes 
naar conferenties waren ook altijd goed gepland en gezellig. Aat, jij was en bent 
altijd bereid om mij zo goed en zo snel mogelijk te helpen. Veel van de mooie IHC 
en TEM plaatjes in mijn proefschrift heb ik aan jou te danken. Jeroen, Michelle en 
Aat, het was erg fijn om een kamer met jullie te delen. Met z’n vieren hadden we 
leuke discussies over werk en andere zaken en konden we bij elkaar ons hart 








Sun, we have some great memories together: France road trip, trip to Euro Disney, 
improving our cooking skills and all the great talks about whatever was on our 
minds. I’m happy you came to our lab and luckily you are not too far away to visit. 
Miranda, jij had het ook vaak heel druk, maar bleef altijd kalm en had altijd een 
glimlach op je gezicht. Jij hebt ook bijgedragen aan de parties van DDT: ons 
onvergetelijke uitstapje naar de Baja Beachclub en je geweldige bruiloft aan het 
strand! Andrea, wij hadden op wetenschappelijke vlak niet vaak met elkaar te 
maken, maar op het sociale vlak natuurlijk wel. Ons avondje cocktail drinken in 
München blijft nog heel lang in mijn herinneringen.  
 
Vasco and Christophe, we started our PhD around the same time. I really had a lot 
of fun thanks to you guys. Even the conferences we went to felt like going to 
parties. Christophe, you hosted many dinners at your (old) place and Vasco, luckily 
you moved often and threw many house-warming parties.  Thank you for all the 
parties, talks and cool programs. 
 
Lolu, it was nice to finally have another person in the lab who was also working on 
skin cultures and who could understand the frustration when the cells did not grow 
well. Thank you for the nice discussions and the chance to be a bride’s maid.  
 
Diogenes and Tomo, you were also my room mates for a while. We had so much 
fun together. I could always count on you guys to leave the lab even later than I 
did! Hopefully our paths will cross again in the future. 
 
I would like to thank the students who helped me with my project: Ida, Naila, 
Soedish and Walter. You worked very hard and sometimes experienced some bad 






One of the things that I like so much about DDT is its international character. We 
had/have such an eclectic mix of nationalities of PhDs, post-docs, technicians, 
visiting scientists and students. Ana, Riccardo, Koen, Enamul, Eleni, Ding, Elly, 
Myrra, Robert P, Basak, Romano, Line, Anna, Tue, Nuch, Guri, Iwan, Hugo, 
Fransisco, Christian, Maria Chiara, Andreas, Abdoel, Ahmed, Anthippi and Daniel 
thank you all for the great moments. For those who are left, I hope you keep the 
DDT spirit alive. 
 
En dan hebben we nog de vaste kern van DDT: Stefan, Connie en Gert. Stefan, ik 
kon altijd bij jou terecht voor technische hulp, vooral als het ging om de HPLC of 
de microscoop. Connie, jij maakt het leven van AIO’s vaak (ongemerkt) veel 
makkelijker. Daarnaast biedt jij ook een luisterend oor. Bedankt voor alle hulp en 
steun! Gert, ook van jou heb ik veel geleerd. Onze tripjes naar Grenoble waren 
gezellig, zelfs tot in de late uurtjes. Ik kon altijd bij jou terecht voor mijn vraagjes 
over lipiden en voor discussies over films. Zoals ik altijd al zei “Jammer dat ik je 
niet mee kan nemen naar mijn nieuwe werkplek”. 
 
Natuurlijk mag ik mijn ‘buren’ bij Dermatologie in het LUMC niet vergeten. 
Marion, jij hebt me vooral in het begin flink geholpen. Bedankt voor alle tips en 
tricks. Vincent, jij ook bedankt voor alle hulp in je studententijd en als AIO. Suzan 
en Coby, jullie ook bedankt voor het delen van kennis en lenen van spullen.  
 
During my PhD I was lucky enough to visit the ESRF twice to measure my 
samples. I would like to thank Dr. Wim Bras and co-workers for their kind 
assistance during these measurements. 
 
Tish, jou kan ik natuurlijk niet vergeten. Heel erg bedankt voor het ontwerpen van 
de cover van mijn proefschrift. Pieter, jij ook bedankt voor het meedenken over de 






Lieve familie, ook jullie wil ik heel graag bedanken voor jullie steun. Jullie boden 
me de noodzakelijke ontspanning tussen al het werken door. Soms kwamen jullie 
zelfs met ideeën om mijn doelen voor dit project te realiseren. Het is fijn om te 
weten dat er zo veel mensen zijn die mij steunen en succes toe wensen.  
 
Died (Arshana), ook jij hebt mij de afgelopen vier jaar gesteund. Hoewel ik het niet 
vaak – misschien zelfs nooit – zeg, wil ik je hiervoor bedanken. Ook jij bent druk 
bezig met het opbouwen van een goede carrière. Veel succes! Met jouw inzet weet 
ik zeker dat je het nog veel verder zult schoppen.  
 
Als allerlaatste zou ik dan mijn lieve pap en mam willen bedanken. Jullie liefde en 
steun kent geen grenzen. Jullie hebben Suriname verlaten voor een betere 
toekomst voor mij en Died. Het opbouwen van een nieuw bestaan in Nederland 
was moeilijk in het begin, maar jullie hebben met wilskracht en 
doorzettingsvermogen het uiteindelijk heel goed voor elkaar gekregen. Ik kan niet 
in woorden uitdrukken wat jullie voor mij betekenen. Een simpel bedankje is bij 
lange na niet voldoende en dat is dan ook de reden waarom ik dit proefschrift aan 
jullie opdraag. Als het in de toekomst mijn beurt is om een ouder te zijn, hoop ik 
het net zo goed te doen als jullie! 
 
 
